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Eukaryotic membrane fusion is a highly conserved process that is necessary to maintain cellular 
homeostasis. Ultimately, two membrane compartments are brought to each other, direct contact is 
established, and the bilayers and lumenal contents mix. In Saccharomyces cerevisiae, homotypic 
vacuole fusion occurs through a series of well-defined phases. SNAREs are activated by their co-
chaperones Sec18 (mammalian NSF) and Sec17 (mammalian α-SNAP) in an ATP dependent 
priming stage. Tethering first brings two fusing compartments into contact with each other via 
interactions between the Rab GTPase Ypt7 and its effector HOPS complex. Once tethered, 
compartments are pulled into tight contact with each other through the formation of trans-SNARE 
complexes during a docking stage. The final fusion stage proceeds through a hemifusion 
intermediate to pore formation and lumenal content mixing. 
 
The roles of proteins that carry out membrane fusion stages are well established, however the roles 
regulatory lipids at the membrane play are still unclear. Many specific regulatory lipids localize to 
the site of fusing vacuoles termed the “vertex ring” implying an important role for them throughout 
the fusion process. It has been shown that the minimal membrane lipid content necessary for fusion 
to occur includes ergosterol, phosphatidic acid (PA), diacylglycerol (DAG), and 
phosphoinositides. However, the interactions and effects each of these lipids has throughout the 
stages of membrane fusion has not been elucidated. This project aimed to identify specific 
regulatory roles for the lipids PA and DAG. Previous work identified the interconversion of the 
two lipids by the DAG kinase Dgk1 and PA phosphatase Pah1 may be important for vacuole fusion 
to effectively occur. 
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Pah1 conversion of PA to DAG was shown to be necessary for SNARE priming activity and 
localization of key protein factors. We found that Sec18, the SNARE chaperone that carries out 
priming, is a PA binding protein. Addition of a PA-specific binding domain blocked this binding 
and displaced Sec18 from vacuolar membranes. Furthermore, exogenous PA addition blocked 
Sec18 priming activity similarly to chemical inhibition of Pah1. Vacuoles lacking Pah1 showed 
decreased recruitment of Sec18 to inactive SNAREs. This recruitment defect was reversible upon 
the introduction of Pah1 by complementation or exogenous addition. Taken together, our data 
suggest a direct role for the regulation of SNARE priming at the vacuole by membrane PA. 
 
We further investigated the effects PA has on Sec18 protein conformation by looking at effects on 
the protein’s structure during binding. We found that PA induced a conformation change in Sec18 
protomers, but active hexameric Sec18 does not readily bind PA. Sec18 binding to PA resulted in 
different protein interactions with 1,8 ANS and different limited proteolysis profiles suggesting 
changes in protein conformation. No significant changes in secondary structure were determined 
by circular dichroism and no shifts in intrinsic tryptophan fluorescence of Sec18 were observed in 
the presence of PA. Molecular dynamic simulations predicted that significant protomer 
conformation changes occur between the monomeric and hexameric forms of Sec18. Furthermore, 
simulations predicted that PA binds to Sec18 at the protein’s hexamer interface. Together, our data 
suggest that PA may regulate Sec18 function by stabilizing its inactive monomeric form preventing 
formation of an active hexamer. 
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At the endoplasmic reticulum, Dgk1 and Pah1 have been shown to direct oppose each other in the 
interconversion of DAG and PA. We deleted DGK1 and observed no reversal of vacuolar 
morphology from pah1∆ cells indicating the two enzymes do not directly offset each other at the 
vacuole. However, vacuoles from dgk1∆ cells did show enhanced fusion. This elevated fusion was 
attributed to an increase in the fusogenic lipid DAG at the vacuole. These vacuoles also had an 
increased resistance to inhibitors of the Rab GTPase Ypt7. Taken together, our results suggest a 
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CHAPTER 1: INTRODUCTION 
 
Eukaryotic membrane fusion is of key importance in maintaining cellular homeostasis. Cargo is 
specifically trafficked between organelles and the plasma membrane through the creation, 
movement, and fusion of transport vesicles. This process is carried out through a series of highly 
conserved events utilizing mechanisms that are found in all eukaryotes (Jahn and Südhof, 1999). 
Because of this conservation, vacuoles from Saccharomyces cerevisiae, organelles similar to 
mammalian lysosomes, serve as an ideal model for studying the mechanisms and regulation of 
membrane fusion. The stages of homotypic vacuole fusion are experimentally well defined and 
the core protein machinery necessary for the process is well known. However, the roles of key 
regulatory players in the process including membrane lipids remain largely underappreciated. This 
dissertation examines the regulatory roles of lipids during the process of yeast homotypic vacuole 
fusion. In this chapter, I introduce the process of membrane fusion and provide an overview of the 
known lipid regulation of the yeast vacuole fusion process. 
 
The stages of homotypic vacuole fusion 
Yeast vacuole fusion occurs in a series of stages that are previously well described. The process 
begins with a priming stage in which previously used SNAREs (soluble N-ethylmaleimide-
sensitive factor attachment protein receptors) are activated in an ATP dependent process. SNAREs 
in complex on the same membrane (cis) are recognized by the AAA+ ATPase Sec18 and its co-
chaperone Sec17. Upon ATP hydrolysis by Sec18, Sec17 and the soluble SNARE Vam7 are 
released from the membrane and the previously inactive SNAREs are able to participate in future 
rounds of fusion (Mayer et al., 1996; Boeddinghaus et al., 2002). During the next tethering stage, 
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membranes from separate vacuoles are connected through interactions between the Rab GTPase 
Ypt7 and its effector complex HOPS (homotypic fusion and vacuole protein sorting complex) 
(Mayer and Wickner, 1997; Seals et al., 2000). Here Vam7 associates with the vacuolar membrane 
through interactions with HOPS and the lipid phosphatidylinositol 3-phosphate (PI3P) 
(Boeddinghaus et al., 2002). SNARE complexes including one R-SNARE and three Q-SNAREs 
from apposing membranes form a stable complex that brings the two vacuoles in close contact 
(Ungermann et al., 1998). During this docking stage, the two membranes are enriched in regulatory 
lipids and proteins at the edge of their interface, the “vertex ring” (Fratti et al., 2004; Wang et al., 
2002, 2003b). The cascade then enters the fusion stage in which the outer leaflets of the membrane 
bilayers mix to form a hemifusion intermediate (Jahn et al., 2003). The fusion stage ends with pore 
formation between the hemifused compartments and luminal content mixing (Reese and Mayer, 
2005). 
 
Lipids in membrane trafficking  
Regulatory lipids serve an important role in various membrane trafficking pathways. Functions 
have been described in cargo sorting, membrane budding, membrane fission, actin organization, 
membrane transport via cytoskeletal elements, and membrane fusion (Wang et al., 2007; Ford et 
al., 2002; Jost et al., 1998; Karunakaran et al., 2012; Hokanson et al., 2006; Boeddinghaus et al., 
2002; Fratti et al., 2004; Kato and Wickner, 2001; Mayer et al., 2000). In many of these pathways, 
lipids such as phosphoinositides and diacylglycerol (DAG) promote association of necessary 
protein factors with the membrane. Elsewhere in the cell, phosphatidic acid (PA) is required for 
Glut4 trafficking and mitochondrial fusion and in yeast membrane fusion during spore formation 
(Vicogne et al., 2006; Nakanishi et al., 2006; Choi et al., 2006; Liu et al., 2007). Both PA and 
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phosphoinositides promote fusion in PC12 cells (James et al., 2008). In higher eukaryotes, 
cholesterol has been shown to mediate SNARE protein conformation and affect the organization 
of the SNAREs syntaxin and SNAP-23 in biological membranes (Chang et al., 2009; Predescu et 
al., 2005). Because these lipids are essential for processes throughout the stages of fusion across 
multiple processes in eukaryotic cells, it is of critical importance to understand how they influence 
the other necessary factors facilitating these processes. 
 
Lipid requirements for vacuole fusion 
It was originally suggested that membrane fusion was completely catalyzed by protein factors and 
that membranes served no purpose beyond providing a structural scaffold. Many more recent 
studies have shown that the presence of specific lipids at the site of fusion are in fact necessary for 
the process to occur. Specific lipid requirements for fusion may differ between organelles within 
a cell. For optimal vacuole fusion to occur the lipids PI3P, phosphatidylinositol 4,5-bisphosphate 
(PI(4,5)P2), ergosterol, and DAG must be present in the membrane (Fratti et al., 2004; Mayer et 
al., 2000; Kato and Wickner, 2001; Seeley, 2002). Addition of PI(4,5)P2 ligand or phosphatase to 
vacuoles significantly inhibited fusion (Fratti et al., 2004; Mayer et al., 2000; Collins and Wickner, 
2007).  PI3P ligand and phosphatase had a similar inhibitory effect on fusion, and PI3P is known 
to specifically bind the PX domain of the SNARE Vam7 (Fratti et al., 2004; Collins and Wickner, 
2007; Cheever et al., 2001). Ergosterol extraction from vacuoles and supplementation of the lipid 
both affected fusion, and later the ergosterol ligand filipin was shown to inhibit fusion (Kato and 
Wickner, 2001; Fratti et al., 2004). DAG is a known fusogenic lipid whose ligand also significantly 
inhibited vacuole fusion (Villar et al., 2000; Fratti et al., 2004). Later studies using reconstituted 
proteoliposomes (RPLs) and purified vacuolar protein components showed that PA and 
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phosphatidylethanolamine (PE) are also required for vacuole fusion to occur (Mima et al., 2008; 
Mima and Wickner, 2009). The minimum lipid requirements for fusion of RPLs include 
phosphatidylcholine (PC), PE, PA, and PI3P (Mima and Wickner, 2009). PA is necessary for full 
association of HOPS and Sec18 to RPL membranes, and both PA and PE are required for SNARE 
complex assembly (Mima and Wickner, 2009). Removing DAG, ergosterol, PI3P, or PI(4,5)P2 
from RPLs also significantly reduced their capacity for fusion confirming each as a requirement 
for optimal fusion to occur (Mima et al., 2008). Later work using RPLs found neutral lipids that 
promote non-bilayer structure formation, including DAG, PE, and ergosterol, are also a 
requirement for vacuole fusion to occur (Zick et al., 2014). 
 
Fusion effects of other lipids at the vacuole 
While not considered necessary for vacuole fusion to occur, other lipids found at the organelle 
have been shown to have potential effects on fusion. For example, addition of phosphatidylinositol 
4-phosphate (PI4P) ligand to in vitro vacuole assays has been shown to inhibit trans-SNARE 
complex formation (Collins and Wickner, 2007). Additionally, vacuole fusion and fission 
processes are closely linked to the synthesis and turnover of the vacuole marker lipid 
phosphatidylinositol (3,5) bisphosphate (PI(3,5)P2) (Dove et al., 1997; Bonangelino et al., 1997, 
2002; Rudge et al., 2004). This regulation of the fusion and fission of vacuoles is likely tied to 
PI(3,5)P2 levels directing calcium release from the vacuole lumen (Dong et al., 2010). Cardiolipin 
was once considered a vacuole membrane component and key lipid regulator of fusion (Zinser et 
al., 1991; Schneiter et al., 1999; Mima et al., 2008; Mima and Wickner, 2009). However, 
cardiolipin is only made in mitochondria and later work using RPLs showed it is not necessary for 
fusion if the tethering protein Ypt7 is present (Stroupe et al., 2009). Its inclusion in the original 
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vacuole lipid composition may have been due to mitochondrial contamination in vacuole isolations 
or from mitophagy (Wickner, 2010). 
 
Roles of lipids in vacuole fusion 
Different regulatory lipids have functions specific to the different stages of vacuole fusion. 
Ergosterol, PI(4,5)P2, and PA all influence the early priming stage of the fusion cascade (Mayer et 
al., 2000; Kato and Wickner, 2001;see Chapter 2). PI(4,5)P2 has also been shown to stimulate 
fusion of RPLs when in the presence of Sec17 and Sec18 (Xu and Wickner, 2010). During 
tethering and docking, PI3P serves an important role in protein factor recruitment to the membrane 
(Boeddinghaus et al., 2002; Cabrera et al., 2014). Interestingly, PI3P has been shown to have 
different functions on apposed membranes both facilitating formation of a 3Q-SNARE complex 
on one and promoting tethering on the other via the Vam7 PX domain (Xu and Wickner, 2010). 
Experiments using RPLs have shown that acidic lipids such as phosphatidylinositol and PA also 
assist in vacuole tethering likely through associations with the HOPS complex (Orr et al., 2015).  
 
The lipids that help catalyze the different stages of vacuole fusion are produced and modified by 
a suite of enzymes that localize to biological membranes. The fusogenic lipid DAG is generated 
by phospholipase C activity on PI(4,5)P2 or dephosphorylation of PA by PA phosphatases and is 
found at the membrane interface before the fusion stage occurs (Jun et al., 2004; Han et al., 2004, 
2006; Toke et al., 1998; Fratti et al., 2004). DAG can then be converted back to PA by the CTP-
dependent DAG kinase Dgk1 (Han et al., 2008a; b). Additional lipid production and turnover 
during vacuole fusion has been shown for PI3P, PI4P, PI(3,5)P2, and PI(4,5)P2 (Mayer et al., 2000; 
Thorngren et al., 2004). The cyclic nature of specific lipids present at the different stages of 
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vacuole fusion suggests they may help direct the progression of the fusion cascade from one stage 
to another in a regulated manner. 
 
Regulatory Lipids at the Vertex Ring 
The requirement for specific lipids throughout the vacuole fusion cascade is additionally inferred 
by their presence at the site of fusion. When vacuoles come into contact with each other prior to 
fusion, they do so with the two compartments drawn together at an interface rather than at a single 
point. This interface, termed the boundary membrane, resembles flattened discs and at its edge is 
a microdomain environment known as the “vertex ring” (Wang et al., 2002). It is at the vertex ring 
that vacuole fusion factors become enriched prior to vacuole fusion. Specifically, the Rab GTPase 
Ypt7 initiates formation of the vertex ring and in concert with the disassembly of F-actin directs 
the localization of SNAREs and the HOPS complex (Wang et al., 2003b). Importantly, it is not 
only protein factors that make up the components of the vertex ring. Additionally, many of the 
regulatory lipids previously mentioned have been shown to localize to the vertex ring during 
vacuole docking (Fratti et al., 2004). These include DAG, ergosterol, PI(4,5)P2, and PI3P. DAG is 
also enriched at the boundary membrane prior to fusion. The localization of these lipid and protein 
factors at the site of fusion occurs in an interdependent manner. Addition of inhibitory levels of 
lipid ligands including those for PI3P, PI(4,5)P2, ergosterol, and DAG results in a redistribution of 
lipids at the vertex ring. In the same inhibitory conditions, necessary fusion proteins including 
Ypt7, the HOPS protein Vps33, and vacuolar SNAREs do not enrich at the vertex ring. Together 
this shows that the proteins and lipids that carry out vacuole fusion work in concert with each other 
to properly assemble and carry out their functions. Later work showed that deletion of the PA 
phosphatase Pah1 also decreases the enrichment of PI3P at the vertex ring (Sasser et al., 2012). 
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Inhibition of Pah1 activity also affects localization of Ypt7. Together these results pointed to a role 
for PA or DAG in affecting the localization of other fusion factors at the vacuole vertex ring. 
Additional studies found a link between PI3P enrichment at the vertex and actin polymerization 
(discussed below) providing more evidence for lipid involvement in fusion microdomain assembly 
(Karunakaran et al., 2012; Sasser et al., 2013). 
 
Regulation of actin dynamics by regulatory lipids at the vertex ring 
While its direct function remains largely unknown actin has been clearly demonstrated to be 
present at the vertex ring of docked vacuoles (Eitzen et al., 2002). Vacuole fusion requires actin 
dynamics and turnover which are closely linked to the activity of two Rho GTPases, Cdc42 and 
Rho1 (Eitzen et al., 2001; Isgandarova et al., 2007; Jones et al., 2010). Cdc42 is activated early 
during in vitro fusion reactions and promotes the polymerization of actin while Rho1 is necessary 
for fusion but its exact role is unknown (Eitzen et al., 2001, 2002; Isgandarova et al., 2007). 
Activation of Rho1 has been linked to the generation of PI(4,5)P2 and activation of Cdc42 requires 
ergosterol, both lipids that are enriched at the vacuole vertex ring (Logan et al., 2010; Jones et al., 
2010; Fratti et al., 2004). In many membrane trafficking pathways actin polymerization depends 
on regulatory sterols, PI(4,5)P2, and 3-phosphoinositides (Bohdanowicz et al., 2010; Rozelle et al., 
2000). Experiments using vacuoles showed that ergosterol is necessary for actin enrichment at the 
vertex ring while increased PI(4,5)P2 levels reduces this enrichment (Karunakaran et al., 2012). 
Interestingly, polymerizing actin with the ligand jasplakinolide leads to an increase in the vertex 
localization of PI(4,5)P2.  Furthermore, vertex localization of PI3P is decreased when actin is 
polymerized and increased when it is depolymerized (Karunakaran et al., 2012). Additional work 
using vacuoles lacking the ABC transporter Ycf1 further demonstrated a link between the 
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regulatory lipid PI3P and actin accumulation at the vertex ring (Sasser et al., 2013). Ycf1 directly 
interacts with the GTPase Rho1 and its activating nucleotide exchange factor Tus1 (Lee et al., 
2011; Hall, 1998). It is thought that on ycf1∆ vacuoles Rho1 may be less active leading to a 
reduction in actin polymerization. Vacuoles lacking Ycf1 show a significant increase in PI3P 
vertex enrichment (Sasser et al., 2013). Taken together these results suggested that an intricate link 
exists between actin dynamics and regulatory lipid organization at the vacuole. It appears that a 
cycle of actin polymerization and depolymerization may influence the proper organization of 
vertex ring lipids which likely affects the downstream assembly of other fusion factors. 
 
The interconversion of phosphatidic acid and diacylglycerol mediates vacuole fusion  
In 2012, it was found that the PA phosphatase Pah1 plays a significant role in endosome to vacuole 
maturation and vacuole fusion (Sasser et al., 2012). Vacuoles lacking Pah1 show dramatically 
reduced fusion levels which can be restored by complementation. The role of Pah1 during fusion 
was first hypothesized and later shown to occur across two stages of the fusion cascade. First, 
inhibition of Pah1 activity showed an inhibitory effect on priming by altering the recruitment of 
the SNARE chaperone Sec18 to inactive cis-SNARES. Second, vacuoles lacking Pah1 showed a 
loss of key fusion factors from the membrane. This suggested that membrane PA or DAG help 
control SNARE activation and progression of the fusion cascade from priming to PI3P generation 
and vertex ring assembly. These ideas were further explored in later works and are discussed in 
more detail below. Work in other systems showed that deletion of the DAG kinase Dgk1 reversed 
phenotypes seen in pah1∆ cells (Han et al., 2008a). Surprisingly, deletion of Dgk1 does not reverse 
the fusion defect seen for pah1∆ vacuoles (see Chapter 4). Deletion of Dgk1 alone, however, does 
have an opposite effect on fusion compared to deletion of Pah1. Vacuoles lacking Dgk1 have a 
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marked increase in fusion levels. This is attributed to both an increase in the fusogenic lipid DAG 
in vacuole membranes and altered activity of the Rab Ypt7. These results suggest that PA and 
DAG levels at the vacuole must maintain a balance that is crucial for regulation of multiple fusion 
stages. 
 
Regulation of SNARE priming by phosphatidic acid 
Inhibiting the PA phosphatase Pah1 prevents the recruitment of Sec18 to cis-SNARE complexes 
without decreasing the protein’s abundance at the vacuole membrane (Sasser et al., 2012). It was 
hypothesized that Pah1 could regulate the transition of Sec18 from a membrane lipid bound state 
to an active SNARE bound state. This hypothesis was supported by previous unrelated work that 
unexpectedly identified NSF, the Sec18 mammalian homolog, as a PA binding protein (Manifava 
et al., 2001). Further investigation showed that Sec18, like NSF, is a PA binding protein and that 
its regulation could be tied to PA levels at the vacuole (see Chapter 2). Additional experiments 
showed addition of exogenous short chain dioctanoyl PA (diC8-PA) potently inhibits vacuole 
fusion by inhibiting Sec18 priming activity. SNARE pulldown experiments confirmed an increase 
in PA levels prevents Sec18 from being efficiently recruited to inactive cis-SNARE complexes. 
Recent work showed PA binding to Sec18 leads to a conformation change that may influence the 
hexamerization of the protein controlling its enzymatic activity (see Chapter 3). 
 
Regulation of the Ypt7 nucleotide exchange factor Mon1-Ccz1 by PI3P 
Vacuoles lacking the PA phosphatase Pah1show decreased levels of the PI-3 kinase Vps34 and 
the Rab GTPase Ypt7 and its nucleotide exchange factor Mon1-Ccz1 (Sasser et al., 2012). The 
lack of Vps34 suggests that Pah1 activity could influence PI3P levels and thus microdomain 
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assembly at the vertex ring. Previous work in C. elegans showed the Mon1 orthologue SAND-1 is 
recruited to late endosomes in a PI3P dependent manner (Poteryaev et al., 2010). Later work in 
yeast revealed that Mon1 specifically associates with PI3P at the vacuole (Lawrence et al., 2014). 
This association is reversed by phosphorylation of Mon1 by the casein kinase Yck3. These results 
were consistent with previous studies that showed Mon1 is released from vacuole membranes in 
an ATP dependent manner (Wang et al., 2003a). Taken together these studies highlight a potential 
role for PA or DAG in regulating PI3P and its associated protein factors at the vertex ring of 
vacuole. 
 
Modulation of SNARE function by regulatory lipids 
The lipid regulation of SNAREs first occurs with their organization during docking. It has long 
been known that the soluble SNARE Vam7 associates with vacuole membranes through 
interactions between its PX domain and PI3P (Boeddinghaus et al., 2002). This assists in both the 
formation of active 3Q-SNARE complexes and in tethering apposed membranes (Xu and Wickner, 
2010). More recently it was determined that a polybasic region of amino acids in the middle 
domain of Vam7 reduces the overall protein’s affinity for PI3P (Miner et al., 2016). Mutating these 
basic amino acids to alanine increases binding of the protein to PI3P while also reducing its ability 
to catalyze fusion. Additional regulation of SNARE function occurs during the fusion stage and is 
tied to the fluidity of the lipid bilayers surrounding them. Non-canonical SNARE complexes 
containing the mutant Vam7Q283R are unable to facilitate fusion leading to a buildup of hemifused 
intermediate compartments (Fratti et al., 2007; Karunakaran and Fratti, 2013). Addition of the 
small molecule chlorpromazine relieves the fusion inhibition of these compartments likely by 
increasing membrane fluidity and reducing the force requirement of membrane restructuring (Fang 
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and Iwasa, 2007; Karunakaran and Fratti, 2013). Similar experiments utilizing vacuoles containing 
a lipid anchored mutant version of the SNARE Vam3 also showed CPZ rescue of a predominantly 
hemifused intermediate (Karunakaran and Fratti, 2013). Together, these results showed that the 
fluidity of the vacuole membrane, which is dependent on its lipid composition, mediates the ability 
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CHAPTER 2: PHOSPHATIDIC ACID SEQUESTERS Sec18 FROM cis-SNARE 




Yeast vacuole fusion requires the activation of cis-SNARE complexes through priming carried out 
by Sec18p/NSF and Sec17p/a-SNAP. The association of Sec18p with vacuolar cis-SNAREs is 
regulated in part by phosphatidic acid (PA) phosphatase production of diacylglycerol (DAG). 
Inhibition of PA phosphatase activity blocks the transfer of membrane associated Sec18p to 
SNAREs. Thus, we hypothesized that Sec18p associates with PA-rich membrane microdomains 
before transferring to cis-SNARE complexes upon PA phosphatase activity. Here we examined 
the direct binding of Sec18p to liposomes containing PA or DAG. We found that Sec18p 
preferentially bound to liposomes containing PA compared to those containing DAG by 
approximately five-fold. Additionally, using a specific PA-binding domain blocked Sec18p 
binding to PA-liposomes and displaced endogenous Sec18p from isolated vacuoles. Moreover, the 
direct addition of excess PA blocked the priming activity on isolated vacuoles in a manner similar 
to chemically inhibiting PA phosphatase activity. These data suggest that the conversion of PA to 
DAG facilitates the recruitment of Sec18p to cis-SNAREs. Purified vacuoles from yeast lacking 
the PA phosphatase Pah1p showed reduced Sec18p association with cis-SNAREs and 
																																																						
1 This chapter appeared in its entirety in the journal Traffic.  
Starr, M. L., Hurst, L. R., and Fratti, R. A. (2016). Phosphatidic acid sequesters Sec18p from cis-
SNARE complexes to inhibit priming. Traffic 17, 1091-1109. 





complementation with plasmid-encoded PAH1 or recombinant Pah1p restored the interaction. 
Taken together this demonstrates that regulating PA concentrations by Pah1p activity controls 





Eukaryotic membrane fusion is a process vital to cellular homeostasis. Trafficking of transport 
vesicles among organelles and the plasma membrane is governed by of a series of events that is 
highly conserved in all eukaryotes from yeast to humans (Jahn and Südhof, 1999). The proteins 
that carry out this process are diverse, but all fusion machinery ultimately facilitates a series of 
membrane contact, fusion, and compartment mixing event (Jahn et al., 2003). We use vacuoles 
from Saccharomyces cerevisiae as a model to examine the regulation of the eukaryotic fusion 
machinery. 
 
Yeast homotypic vacuole fusion has been well described and is characterized by a series of 
experimentally defined stages. The fusion cascade begins with the priming stage in which the 
AAA+ ATPase Sec18p (NSF) and its co-chaperone Sec17p (α-SNAP) disassemble inactive cis-
SNARE complexes. Priming requires ATP hydrolysis by Sec18p and results in the disassociation 
of Sec17p and the soluble SNARE Vam7p from the membrane (Boeddinghaus et al., 2002; Mayer 
et al., 1996). During the tethering/docking stage, the Rab GTPase Ypt7p and its effector complex 
HOPS interact to bring two vacuolar compartments together (Mayer and Wickner, 1997; Seals et 
al., 2000). Vam7p rebinds the vacuolar membrane through interactions with HOPS and the 
regulatory lipid phosphatidylinositol 3-phosphate (PI3P) leading to the formation of trans-SNARE 
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pairing between apposing membranes (Boeddinghaus et al., 2002; Ungermann et al., 1998). At 
this stage the two membranes are closely associated and are enriched in regulatory proteins and 
lipids at the periphery of their interface named the “vertex ring” microdomain (Fratti et al., 2004; 
Wang et al., 2002, 2003). The fusion cascade proceeds through the formation of a hemifusion 
intermediate before pore formation and luminal content mixing occur (Jahn et al., 2003; Reese and 
Mayer, 2005). 
 
Maintenance of SNARE proteins is crucial for turnover of eukaryotic membrane fusion events. 
Upon fusion and compartment mixing, SNAREs exist in a stable cis-SNARE complex in which 
all SNAREs reside on a single membrane rendering them unable to carry out subsequent rounds 
of docking. During priming, homohexameric Sec18p/NSF associates with cis-SNARE complexes 
through binding to Sec17p/SNAPs and generates the necessary force to disassociate inactive 
complexes into active individual SNAREs (Mayer et al., 1996). Recent evidence suggests that NSF 
disrupts cis-SNARE complexes through a “loaded-spring” mechanism (Ryu et al., 2015; Zhao et 
al., 2015). In this model, NSF ATPase activity leads to large conformational changes in the NSF 
N-terminal and D1 domains, which exert enough force on SNAPs to disassemble the SNAREs. 
Direct regulation of this Sec18p/NSF priming activity remains mostly unknown, although protein 
kinase C has been implicated in negative regulation of NSF association with cis-SNARE 
complexes (Matveeva et al., 2001). Of interest, NSF has been found to bind phosphatidic acid 
(PA), a regulatory lipid required for vacuole fusion; however, the effects of Sec18p/NSF lipid 
association are still not well understood (Manifava et al., 2001; Mima and Wickner, 2009; Sasser 
et al., 2012). 
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Regulatory phospholipids on the cytosolic face of the vacuolar membrane serve as key regulators 
of the fusion machinery. A presence of phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
PA, diacylglycerol (DAG), and PI3P is essential for vacuolar fusion to occur and serve as the 
minimal lipid requirements of the fusion reaction (Mima and Wickner, 2009). Additional lipids 
including PI4P, PI(4,5)P2 and ergosterol are also required for optimal homotypic vacuolar 
fusion(Fratti et al., 2004; Karunakaran and Fratti, 2013; Kato and Wickner, 2001; Mayer et al., 
2000). Specific lipid head groups provide a scaffold for the binding and recruitment of proteins 
that actively carry out the stages of fusion. This function relies on direct protein-lipid interactions 
between the membrane and protein machinery as exemplified by the binding of PI3P by the Vam7p 
PX domain (Cheever et al., 2001). Specific lipids also affect the fusion machinery physically 
through changes to membrane dynamics. This role is demonstrated by the dependence of SNARE 
function on lipid microdomain formation and potential allosteric effects exerted on the 
transmembrane domains of SNARE proteins (Fratti et al., 2004; Karunakaran et al., 2012). 
Reversible changes to the concentration of specific lipids within microdomains also mediate 
protein-lipid interactions at the vertex ring and dynamics of vacuole associated actin. 
 
The interconversion of regulatory lipids is catalyzed by a variety of lipid modifying proteins. These 
enzymes respond to varied growth conditions through coordination of genetic and biochemical 
mechanisms. The yeast PA phosphatase Pah1p plays an important role in the regulation of lipid 
synthesis. Pah1p has been shown to have a role in mediation of the transcription of the lipid 
synthesis genes INO1, INO2 and OPI3 through its phosphatase activity (Han et al., 2007; O’Hara 
et al., 2006). This is critical for organelle replication for daughter cells during mitosis as the nuclear 
envelope and endoplasmic reticulum must expand. Unphosphorylated Pah1p generates DAG, 
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which is involved in the synthesis of triacylglycerol, PC, and PE (Karanasios et al., 2010; Choi et 
al., 2011). Recently, it was shown that Pah1p localizes to the nuclear vacuole junction at the 
diauxic shift during acute glucose starvation (Barbosa et al., 2015). 
 
A number of lipid modifying enzymes have been implicated in vacuole fusion or fission events 
and display abnormal morphologies or other observable defects when deleted or mutated. Both PA 
and DAG are essential lipids for vacuole fusion and have been implicated in organelle transport 
and fusion activities. For instance DAG plays a role in Golgi to ER transport and the formation of 
COPI vesicles (Fernandez-Ulibarri et al., 2007), where as PA is important for sporulation and 
stimulating the fusion activity of the SNARE Spo20p (Liu et al., 2007; Nakanishi et al., 2006). In 
addition, the PA phosphatase activity of Pah1p is necessary for endolysosomal maturation and 
vacuole homotypic fusion (Sasser et al., 2012). Deletion of PAH1 leads to the fragmentation of 
immature vacuoles and severely abrogates fusion activity. This phenotype is proposed to come 
from two defects involving the fusion machinery. First, vacuoles harvested from pah1∆ yeast 
contain strikingly reduced levels of factors involved in regulating vacuole fusion including the PI-
3 kinase Vps34p and its product PI3P, Ypt7p and its guanine exchange factor Mon1p-Ccz1p, as 
well as the HOPS subunit Vps39p (Sasser et al., 2012; Lawrence et al., 2014). Second, deletion of 
PAH1 or inhibition of PA phosphatase activity led to a measurable decrease in priming and 
SNARE-associated Sec18p. Importantly, neither PAH1 deletion nor chemical inhibition of PA 
phosphatase activity alters the total levels of Sec18p associated with vacuoles. Thus, we posit that 
inactive (i.e. SNARE-free) Sec18p remains associated with vacuoles through interactions with PA 
and that modification of PA releases Sec18p to cis-SNAREs to enable priming. In this study, we 
examined the interactions of Sec18p and PA in the regulation of priming. We report that like its 
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mammalian orthologue NSF, Sec18p specifically binds to PA. Additionally, both increased levels 
of PA and the absence of Pah1p on the vacuole inhibited Sec18p-dependent priming and prevent 
recruitment of Sec18p to cis-SNARE complexes. 
 
 
MATERIALS AND METHODS 
 
Reagents  
All reagents were diluted in PS buffer (20 mM PIPES-KOH pH 6.8, 200 mM sorbitol) to a working 
concentration before use in experiments. Antibodies against Sec17p (Haas and Wickner, 1996) 
and Sec18p have been described previously. N-ethylmaleimide (NEM), propranolol 
hydrochloride, and ATPgS were purchased from Sigma Aldrich and dissolved in PS buffer. The 
lipids used in this study: POPA (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate), POPC (1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine), POPE (1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphatidylethanolamine), POG/DAG (1-palmitoyl-2-oleoyl-sn-glycerol), diC8-PA (1,2-
dioctanoyl-sn-glycero-3-phosphate), and diC8-DAG (1,2-dioctanoyl-sn-glycerol) were purchased 
from Avanti Polar Lipids as chloroform stock solutions and stored at -20ºC. 
 
Recombinant proteins 
Recombinant His6-Sec18p was purified from Escherichia coli as previously described (Steel et al., 
1999). Briefly, PQE9-His6-Sec18p plasmid was transformed into Rosetta-2 (DE3) pLysS (EMD 
Biosciences) competent cells and plated on LB agar plates containing 100 µg/ml ampicillin and 
35 µg/ml chloramphenicol. Transformed cells were grown for 14 h in 100 ml LB at 37ºC. Culture 
flasks containing 1 liter Terrific Broth were inoculated with 50 ml of the pre-culture and grown at 
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37ºC to A600 = 0.6. Cells were induced with 1 mM 1-thio-b-D-galactopyranoside at 16ºC for 14 h 
before being collected by centrifugation and washed with lysis buffer (10 mM HEPES-KOH pH 
7.0, 500 mM KCl, 5 mM ATP, 5 mM MgCl2, 2 mM β-mercaptoethanol, 1 mM PMSF and protease 
inhibitor cocktail). Cells were lysed with four passes through a French pressure cell. Lysates were 
cleared by centrifugation (200,000 x g, 30 min, 4ºC), and the cleared lysate was loaded onto a Ni-
NTA agarose column (Thermo Scientific) equilibrated with lysis buffer. The resin was washed 
with 20 column volumes of lysis buffer containing 10% glycerol and 50 mM Imidazole. His6-
Sec18p was eluted from with lysis buffer containing 10% glycerol and 350 mM Imidazole. The 
eluted protein was further purified by gel filtration in GF buffer (20 mM PIPES-KOH pH 6.8, 200 
mM Sorbitol, 125 mM KCl, 5 mM MgCl2, 2 mM ATP, 2 mM DTT and 10% glycerol) and 1 ml 
fractions were collected. Sec18p elutes from the column as three distinct peaks: the hexameric 
pool with a molecular mass of 640 kDa elutes early (approximately 50 ml post injection), and 
dimer and monomeric pools each elute later (approximately 90 and 105 ml post-injection, 
respectively). The hexameric pool of Sec18p was used in all experiments. The recombinant His6-
SUMO-Pah1p construct used was created for this study. The PAH1 gene was cloned from BJ3505 
genomic DNA via PCR amplification using the primers:  Forward 5’ – 
TACTTCCAATCCAATGCAATGCAGTACGTAGGAA – 3’ and Reverse 5’ – 
TTATCCACTTCCAATGTTATTATTAATCTTCGAATTCATCTTCG – 3’. The amplified gene 
was inserted into pET His6 Sumo TEV LIC cloning vector (2S-T) (Addgene plasmid #29711) 
using the restriction enzyme SspI and the LIC method previously described to create the plasmid 
pSP1 (Aslanidis and de Jong, 1990). Three liters of Rosetta2(DE3)pLysS (EMD Millipore) cells 
transformed with pSP1 were grown in auto-inducing media supplemented with 2 mM MgSO4 at 
37oC to an OD600 of 4.0, and cells were harvested by centrifugation (Studier, 2005). Cells were 
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lysed by freeze-thaw and sonication in buffer containing 50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 
2 mM MgCl2, 10 mM imidazole, and 1mM phenylmethanesulfonyl fluoride (PMSF).  Lysates 
were centrifuged for 1 hour at 140,000 x g, and the supernatant was applied to Ni-NTA agarose 
resin (Invitrogen). The resin was washed with lysis buffer supplemented with 25 mM imidazole 
and 0.5 mM ATP, and bound proteins were eluted with lysis buffer supplemented with 300 mM 
imidazole. Eluted protein was dialyzed into PS buffer containing 125 mM KCl. Recombinant GST-
DEP, GST-C1b, GST-ENTH and GST-Vam7p were purified as described and dialyzed into PS 
buffer containing 125 mM KCl (Capelluto et al., 2014; Johnson et al., 2000; Rosenthal et al., 1999; 
Fratti et al., 2007). The plasmid for GST-DEP expression was a gift from Dr. D. Capelluto 
(Virginia Tech University).  
 
Strains  
BJ3505 (MATa pep4::HIS3 prb1-D1.6R his3-200 lys2-801 trp1D101(gal3) ura3-52 gal2 can1) 
and DKY6281 (MATa  leu2-3 leu2-112 ura3-52 his3-D200 trpD1-901 lys 2-801) were used for 
standard vacuole fusion assays (Haas et al., 1994). BJ3505-CBP-Vam3p vacuoles were used for 
the isolation of Sec18p-SNARE complexes (Collins and Wickner, 2007). PAH1 deleted strains 
RFY17 and RFY18 and WT Pah1p plasmid complemented strain RFY19, RFY20 have previously 
been described (Sasser et al., 2012). 
 
Vacuole Isolation and in vitro vacuole fusion assay 
Vacuoles were isolated from yeast strains by density gradient floatation as previously described 
(Haas et al., 1994). Fusion reactions (30 µl) contained 3 µg each of vacuoles from BJ3505 (pep4∆ 
PHO8) and DK6281 (PEP4 pho8∆), fusion assay buffer (125 mM KCl, 5 mM MgCl2, 20 mM 
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PIPES-KOH pH 6.8, 200 mM sorbitol), ATP regenerating system (1 mM ATP, 29 mM creatine 
phosphate, 0.1 mg/ml creatine kinase), 10 µM CoA, and 283 nM Pbi2p. Reactions were incubated 
at 27°C for 90 min and the Pho8p activity was measured in 250 mM Tris-Cl PH 8.5, 0.4% Triton 
X-100, 10 mM MgCl2, 1 mM p-nitrophenyl phosphate. Fusion-dependent alkaline phosphatase 
maturation was measured by the amount of p-nitrophenylate produced. p-Nitrophenylate 
absorbance was measured at 400 nm. 
 
Liposome Preparation and Co-Floatation Assay  
Small unilamellar liposomes containing various lipid compositions were prepared using the 
sonication method (Mima and Wickner, 2009). Briefly, stock lipids in chloroform were mixed to 
produce a lipid mixture with the desired lipid mole percentages of 2.6 µmoles of total 
phospholipids. The lipid mixture was dried under a gentle stream of nitrogen and dried in a speed-
vacuum for an additional 60 min. The tubes were placed under vacuum in a desiccator for an 
additional 14 h. To the dried lipids, 2.6 ml of 1X PBS solution was added. Tubes were covered 
with parafilm and incubated at room temperature for 1 h. The lipids were resuspended with 
vortexing and disrupted in a water bath sonicator for 30 min. To measure protein binding to the 
liposomes we used a floatation assay as described (Matsuoka et al., 1998). Briefly, 40 µl of lipid 
binding domain/PBS mixture was incubated with 150 µl of the 1 mM liposome suspension for 5 
minutes at 30ºC before 20 µg of recombinant His6-Sec18p was added. Samples were incubated for 
an additional 10 min at 30ºC and 630 µl of 1.65 M sucrose (PBS) was added. Samples were loaded 
into the bottom of a centrifuge tube and layered with 840 µl of 0.75 M sucrose (PBS), and 1X PBS 
to the top of the tube. Samples were centrifuged (200,000 x g, 90 min, 4ºC) and 200 µl of floated 
liposomes were recovered from the top of the 0.75 M sucrose layer. The bottom 100 µl fraction 
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was recovered and SDS sample buffer was added to sample unbound protein levels. Liposomes 
were resuspended in 1 ml of 1X PBS and isolated by centrifugation (16,000 x g, 10 min, 4ºC). 
SDS sample buffer was added to the final liposome pellet and bound proteins were resolved by 
SDS-PAGE. The proteins were transferred to nitrocellulose and probed by Western blotting. 
Images were acquired using a ChemiDoc MP Imaging System (Bio-Rad). 
 
Vacuole Competition Binding Assay 
Vacuoles were harvested from DKY6281. Each sample contained 12 µg of vacuoles suspended in 
binding assay buffer (125 mM KCl, 5 mM MgCl2, 20 mM PIPES-KOH pH 6.8, 200 mM sorbitol) 
to a final volume of 60 µl. Recombinant GST-DEP, GST-C1b, or GST-ENTH in binding assay 
buffer was added to the indicated concentrations and samples were incubated at 4ºC for 10 min. 
Whole vacuole samples with no added lipid binding domain were saved for input controls. 
Supernatant and pellet fractions were isolated by centrifugation (16,000 x g, 5 min, 4ºC) and 
suspended in 1X SDS sample buffer. Samples were heated at 95ºC for 5 min, resolved by SDS-
PAGE, and transferred to nitrocellulose. Presence of Sec18p in the input controls and supernatant 
fractions was probed by Western blot. 
 
Priming Assay  
Priming activity of Sec18p was assayed as previously described (Mayer et al., 1996). Briefly, 
vacuoles were harvested from BJ3505. The equivalent of two standard fusion reactions was 
incubated at 27ºC with buffer, NEM, diC8-PA, or diC8-DAG. At the indicated times, vacuoles 
were removed by centrifugation (16,000 x g, 5 min, 4ºC) and SDS sample buffer was added to the 
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supernatants. Samples were heated at 95ºC for 5 min, resolved by SDS-PAGE, transferred to 
nitrocellulose, and probed by Western blot.  
Sec18p-SNARE Complex Detection using CBP-Vam3p Pull-down  
Analysis of the formation of Sec18p-cis-SNARE complexes was assayed as previously described 
(Sasser et al., 2012). Briefly, vacuoles used were isolated from BJ3505-CBP-Vam3p. Isolation of 
Sec18p-cis-SNARE complexes was performed in large-scale fusion reactions (480 µl) using 96 
µg of vacuoles. Reactions were incubated at 27ºC for the indicated time and treated with buffer or 
propranolol. Reactions treated with ATPgS were treated with buffer and ATP regenerating system 
containing ATPgS in place of ATP. Separate reactions were kept on ice as 0 min samples and 
without ATP regenerating added as No ATP samples. After incubation, samples were placed on 
ice for 5 min and 30 µl samples were withdrawn to assay fusion activity. Remaining samples were 
centrifuged (13,000 x g, 15 min, 4ºC) and supernatant fractions were removed. The membrane 
fractions were gently resuspended in ice-cold solubilization buffer (20 mM Tris-Cl, pH 7.5, 150 
mM NaCl, 1 mM MgCl2, 0.5% Nonidet P-40 alternative, 10% glycerol) with protease inhibitors 
(0.46 µg/ml leupeptin, 3.5 µg/ml pepstatin, 2.4 µg/ml Pefabloc-SC, 1 mM PMSF). Solubilization 
buffer was added to a final volume of 600 µl and samples were mixed by nutation (20 min, 4ºC). 
Insoluble debris was removed by centrifugation (16,000 x g, 15 min, 4ºC) and supernatants were 
transferred to fresh tubes. A 60 µl sample was withdrawn for input samples. The remaining extracts 
were brought to 2 mM CaCl2 and incubated with 50 µl of equilibrated calmodulin-Sepharose 4B 
(GE Healthcare) (4°C, 14 h, nutating). Beads were collected by centrifugation (4,000 g, 2 min, 4 
°C) and washed 4 times in solubilization buffer. Bound proteins were eluted with SDS sample 
buffer containing 5 mM EGTA and heated at 95ºC for 5 min. The samples were resolved using 




Sec18p-SNARE Complex Detection using GST-Vam7p Pull-down  
Analysis of the formation of Sec18p-cis-SNARE complexes in mutant strains was assayed 
essentially the same as in CBP-Vam3p containing strains with some modifications. Vacuoles were 
isolated from pah1D strains (RFY17 and RFY18) or pPAH1-complemented strains (RFY19 and 
RFY20). Large-scale reactions were used (480 µl) using 96 µg of vacuoles. Recombinant GST-
Vam7p was added to reactions (200 nM) prior to addition of ATP regenerating system and 
incubated at 27ºC for 30 min. ATP regenerating system was then added to samples and incubated 
for the indicated times at 27ºC. Fusion assay buffer was added in place of ATP regenerating system 
in the “no-ATP” sample. The 0 min sample was kept on ice throughout the duration of the 
incubation step. Solubilization buffer differed from the CBP-Vam3p solubilization buffer (20 mM 
HEPES-KOH, 100 mM NaCl, 2mM EDTA, 0.5% Nonidet P-40 alternative, 1 mM DTT, 20% 
glycerol, 1 mM PMSF, 0.46 µg/ml leupeptin, 3.5 µg/ml pepstatin, and 2.4 µg/ml Pefabloc-SC) and 
Glutathione Sepharose 4B resin (GE Healthcare) was used for the pull-down of complexes. The 
same method was used for Sec18p-SNARE complex detection in diC8-PA and diC8-DAG treated 
samples using vacuoles isolated from BJ3505. 
 
Statistical analysis  
All statistical analysis was calculated using one-way ANOVA. P values of ≤ 0.05 were considered 
significant. Half-times for the gain of resistance fusion assay were calculated using first-order 





Sec18p binds preferentially to membranes containing phosphatidic acid  
The yeast PA phosphatase Pah1p regulates endolysosomal maturation leading to impaired 
homotypic vacuolar fusion (Sasser et al., 2012). Inhibition of PA phosphatase activity with the 
small molecule propranolol suggested that phosphatidic acid potentially had a specific role in 
mediating the priming activity of the SNARE chaperone. Treatment with propranolol blocked the 
binding of Sec18p to cis-SNARE complexes, while the total levels of vacuole associated Sec18p 
remained constant. Importantly, vacuoles from pah1∆ cells harbor wild type levels of Sec18p. 
Thus, we hypothesized that the conversion of PA to DAG led to a transition of Sec18p from a PA 
bound state to a cis-SNARE bound state. The Sec18p mammalian orthologue NSF was previously 
shown to specifically bind resin-conjugated PA, but the purpose of this binding remained unknown 
(Manifava et al., 2001). Here we asked if Sec18p also binds PA, a relationship that could be 
controlled by PA phosphatase activity. To test this we used a liposome-binding assay to detect 
Sec18p binding to membranes of different lipid compositions. Recombinant Sec18p was incubated 
with liposomes containing mixtures of the lipids PC, PE, PA, and DAG. Liposome-bound Sec18p 
was separated from unbound protein by floatation. Sec18p showed light binding to PC:PE 
liposomes alone, however this binding was significantly weaker compared to liposomes containing 
PA (Figure 2.1A). Liposomes containing DAG also showed little Sec18p binding relative to 
liposomes containing PA. This stark difference in binding between PA and DAG containing 
membranes is consistent with a requirement for Pah1p activity in regulating Sec18p recruitment 
from the membrane to cis-SNARE complexes. Next, we tested to see if the concentration of PA 
or DAG specifically had an effect on Sec18p binding to liposomes. Similar liposome floatation 
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assays were carried out but included liposomes of increasing PA or DAG concentrations. 
Membrane-bound Sec18p was present at higher levels in liposomes that contained elevated levels 
of PA (Figure 2.1B). Strikingly, an increase in the concentration of DAG in the liposomes had a 
significant negative effect on the level of Sec18p membrane association (Figure 2.1B). These data 
suggest that Sec18p binds preferentially to membranes containing PA and that the presence of 
DAG may promote the release of Sec18p from binding to membrane lipids directly. Taken 
together, this suggests that the conversion of PA to DAG may affect Sec18p membrane localization 
dynamics and Pah1p may specifically play a role in controlling the state Sec18p membrane lipid 
association. 
 
We next tested whether the specificity of Sec18p binding to membranes extends beyond a 
nonspecific electrostatic interaction. The cytosolic face of the yeast vacuolar membrane contains 
a wide array of regulatory anionic phospholipids (Li and Kane, 2009). Because of this we asked if 
Sec18p would show preferential binding to PA or if it would also bind to other vacuolar membrane 
lipids carrying a negative charge. We performed liposome-binding assays with liposomes that 
contained PS, an anionic phospholipid that, like PA, localizes to the outer leaflet of the yeast 
vacuolar membrane. We again observed preferential Sec18p binding to liposomes of increasing 
PA concentration (Figure 2.1C). Sec18p binding to liposomes containing PS showed no significant 
binding suggesting that Sec18p lipid binding has specificity for PA and not anionic lipids in 
general. It is also important to note that the absence of liposomes in our binding assays gave no 
signal and detection of liposome-associated Sec18p was non-random (Figure 2.1D). These results 
highlight a specific binding interaction between Sec18p and PA that is likely present at the yeast 
vacuolar membrane.  
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To further probe Sec18p binding to specific membrane lipids, we performed binding competition 
assays in the presence of the PA-specific binding domain GST-DEP from the mouse protein Dvl2 
(Capelluto et al., 2014). The addition of GST-DEP was expected to disrupt Sec18p binding to 
liposomes containing PA by occupying potential binding sites on the membrane. The addition of 
GST-DEP showed no significant effect on the level of Sec18p bound to PC:PE liposomes, but 
severely affected the ability of Sec18p to bind liposomes containing PA (Figure 2.2A, P<0.005). 
This suggests that the observed membrane binding of Sec18p was specifically dependent on the 
presence of PA. Surprisingly, the addition of GST-DEP also lowered the level of Sec18p binding 
to membranes containing DAG (P<0.05). We suspect that GST-DEP has some non-negligible 
amount of binding to DAG as many characterized PA-binding domains contain essential 
hydrophobic residues that embed in membranes(Kooijman et al., 2007). The absence of a large 
headgroup on DAG could allow for GST-DEP to sit very close to the acyl chain region within the 
bilayer promoting hydrophobic residue interactions with DAG or adjacent lipids. Considering this 
and the significant increase in binding to membranes containing PA when compared to those 
containing DAG, the data suggest that Sec18p membrane lipid binding is dependent on the 
presence of PA. To further characterize this interaction, we performed a binding competition assay 
that utilized PA-containing liposomes and the addition of increasing concentrations of GST-DEP. 
In the absence of competitor, significant binding of Sec18p to the liposomes was observed, and 
this binding was perturbed by the addition of GST-DEP in a dose-dependent manner (Figure 2.2B). 
These data further indicate that Sec18p has specific binding to PA.  
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To probe for specific Sec18p-lipid interactions on vacuole membranes, we used a binding 
competition assay that contained purified vacuoles in place of liposomes. Vacuoles were harvested 
from yeast and incubated on ice with the lipid-specific binding domains GST-DEP, GST-C1b 
(protein kinase C βII), and GST-ENTH (rat epsin 1) to bind to PA, DAG, and PI(4,5)P2 
respectively and displace vacuolar proteins bound to each (Johnson et al., 2000; Rosenthal et al., 
1999). C1b and ENTH have been previously shown to cause the release of HOPS and Vam7p from 
vacuoles (Fratti et al., 2004; Stroupe et al., 2006). Samples were separated into bound and unbound 
fractions by centrifugation and Sec18p levels were assayed by Western blot. The percentage of 
Sec18p in the unbound fraction significantly increased with the addition of GST-DEP in a dose 
dependent manner when compared to the control similar to what was seen in the liposome-binding 
assays described above (Figure 2.2C). Addition of GST-C1b showed a slight increase in the 
proportion of unbound Sec18p from the untreated control condition however this release was 
independent of the concentration added and was statistically insignificant. Addition of GST-ENTH 
led to an increase of Sec18p release at the highest concentration used; however, the amount of 
released Sec18p was not statistically significant. Taken together, these data suggest that disruption 
of Sec18p binding to membrane lipids is most affected when PA is specifically occupied. This 
further supports the notion that Sec18p binding to vacuolar membranes occurs in a PA dependent 
manner. From this experiment we cannot rule out potential interactions between Sec18p and 
vacuolar DAG or PI(4,5)P2. However, considering the lack of dose independent effect using GST-
C1b along with our previous observations, the direct binding of Sec18p to DAG seems unlikely. 
Sec18p interactions with PI(4,5)P2 are an interesting possibility that were not further investigated. 
However, it is not difficult to envision Sec18p having specific interactions with multiple regulatory 
phospholipids at different points of regulation or perhaps even during a single binding event. It is 
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important to note that ENTH and C1b disrupt vertex microdomain organization (Fratti et al., 2004), 
thus the limited release of Sec18p caused by binding PI(4,5)P2 and DAG here could be due to the 
redistribution of PA on vacuoles.  
 
Phosphatidic acid inhibits vacuolar fusion during the priming stage  
Sec18p, like its mammalian orthologue NSF, performs the necessary priming activity within the 
membrane fusion cascade. During this priming step, Sec18p hydrolyzes ATP to disassemble 
inactive cis-SNARE complexes and reactivate them for additional rounds of SNARE-pairing and 
fusion. Sec18p priming activity is necessary for membrane fusion to occur within the cell, and its 
importance to organelle trafficking and maintenance is highlighted by the fact that its null mutant 
strains are inviable. Because its function is vital for fusion activity and cell survival, we believe 
Sec18p is a target for a key regulation point within the vacuolar fusion cascade. This combined 
with the PA-specific binding previously seen and the regulatory role of Pah1p has in membrane 
fusion led us to investigate whether the lipids PA and DAG had an effect on Sec18p activity and 
vacuolar fusion. 
 
To measure vacuolar fusion we employed the well-characterized proPho8p maturation vacuole 
content mixing assay as previously described (Haas et al., 1994). To test the effects of specific 
lipids on fusion, we used dioctanoyl-PA (diC8-PA) and diC8-DAG (Dong et al., 2010; Siddiqui et 
al., 1995). We first assayed if the addition of diC8-PA or diC8-DAG showed a significant effect 
on overall vacuolar fusion activity. Addition of diC8-PA led to potent inhibition of vacuolar 
content mixing in a dose-dependent manner (Figure 2.3A), whereas adding the same 
concentrations of diC8-DAG did not affect fusion (Figure 2.3B). Importantly, inhibition by diC8-
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PA could be reversed by the addition of recombinant Sec18p suggesting a direct interaction 
between the protein and lipid (Figure 2.3C). We then wanted to test if sequestering PA with the 
PA-specific binding domain GST-DEP would have a measureable effect on fusion activity. 
Addition GST-DEP had a minimal effect on fusion except at the highest concentration tested (10 
µM), which reduced fusion by approximately 50% (Figure 2.3D). Higher concentrations were not 
used due to buffer interference with the fusion assay. The inhibition of fusion by GST-DEP is in 
keeping with the vacuole competition binding assay in Figure 2.2C where GST-DEP at ≥10 µM 
significantly displaced Sec18p from the membrane. We reason that fusion inhibition caused by 
addition of GST-DEP may occur at higher concentrations because of a decrease of the overall 
Sec18p level on the membrane to below a threshold required for priming activity to occur. 
Alternatively, this inhibition may be due to general crowding on the membrane and not from an 
inaccessibility of PA to the fusion machinery. Taken together the data suggest that increased 
concentrations of PA within the vacuolar membrane have an inhibitory effect on membrane fusion 
activities but increased concentrations of DAG do not. 
 
Previous work suggested that Pah1p activity regulates Sec18p priming activity through its control 
of PA concentrations in the vacuolar membrane (Sasser et al., 2012). Because we observed 
Sec18p-PA binding and the inhibition of fusion by excess PA, we expected that this lipid could be 
potentially blocking the priming stage of the fusion cascade. To test this, we wanted to use an 
inhibitor that would block Sec18p activity for comparison. NEM is a known inhibitor of NSF 
priming activity however its effects on Sec18p-mediated priming activity have not been fully 
investigated. Because NEM is known to alkylate NSF we reasoned that a similar modification 
could take place with Sec18p and perturb priming activity. We found that NEM potently inhibited 
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fusion at ≥1 mM suggesting that NEM might modify and inhibit Sec18p (Figure 2.3E). To test 
whether diC8-PA, dic8-DAG, or NEM had priming specific inhibition we employed a variant of 
the content mixing assay that utilizes a Vam7p bypass of priming. Previous work has shown that 
priming-specific inhibition with an inhibitor such as α-Sec17p IgG can be rescued by the addition 
of recombinant Vam7p, a soluble SNARE protein (Fratti and Wickner, 2007; Fratti et al., 2007). 
We expected that a priming-specific defect caused by addition of diC8-PA or NEM should also be 
rescued in this manner. Surprisingly, a Vam7p bypass did not rescue fusion activity in the presence 
of diC8-PA or NEM (Figure 2.3F). These data suggest that diC8-PA and NEM could additionally 
be affecting stages downstream of priming in the fusion cascade. It should be noted that Vam7p 
function is related to the presence of the ABC transporter Ycf1p that contains multiple free Cys 
required for its activity (Sasser et al., 2013; Wei et al., 2014). Thus, alkylating Ycf1p could prevent 
Vam7p bypass of the effect of NEM on Sec18p. To probe whether diC8-PA or NEM could be 
inhibiting a later fusion stage we performed a temporal acquisition of resistance assay in which 
inhibitors were added at different time points throughout the fusion reaction (Mayer et al., 1996; 
Haas et al., 1995). Here fusion reactions gain resistance to an inhibitor once enough time had 
passed for its target to carry out its relevant activity. Therefore, fusion would recover at earlier 
time points for inhibitors that specifically target machinery early in the fusion reaction (e.g. α-
Sec17p IgG) while inhibitors targeting later stages would gain resistance later in the reaction (e.g. 
GDI). We compared diC8-PA inhibition kinetics to that of α-Sec17p IgG, propranolol, NEM, and 
GDI through calculated gain of resistance half-times using first-order exponential decay fitting 
(Figure 2.3G) (Mayer et al., 1996; Sasser et al., 2012). Interestingly, diC8-PA showed similar 
recovery of fusion to that of the tethering stage inhibitor GDI (Figure 2.3H). This suggests that PA 
could be inhibiting fusion during a stage downstream of priming, independent of Sec18p, however 
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we cannot rule out that diC8-PA may be blocking additional rounds of fusion. It is important to 
note that these results can only point to the last stage of fusion that is targeted by an inhibitor and 
that PA may be regulating multiple fusion stages including priming. NEM showed early recovery 
of fusion similar to that of α-Sec17p IgG and propranolol suggesting that it likely has an inhibitory 
effect on priming activity.  
 
Next we determined if increased levels of PA had a noticeable effect on Sec18p activity during the 
priming stage. To do this we examined the release of Sec17p upon Sec18p-mediated priming 
(Mayer et al., 1996). Sec17p associates with the membrane through binding to cis-SNARE 
complexes, which recruits Sec18p to stimulate its priming activity. Upon recruitment Sec18p 
hydrolyzes ATP to disassemble the cis-SNAREs leading to Sec17p dissociation from the 
membrane. Here we monitored Sec17p release by fractionating soluble and membrane-bound 
proteins followed by Western blotting. Vacuolar fusion assays were carried out in the presence of 
diC8-PA, diC8-DAG, or NEM after which we monitored the release of Sec17p from vacuolar 
membranes as a measure of priming. We found that NEM potently reduced Sec17p release relative 
to the untreated control condition, suggesting that Sec18p activity was blocked by NEM in a 
similar fashion to what is seen with NSF (Figure 2.4A). When diC8-PA was tested, we found that 
Sec17p release was severely inhibited. This is in keeping with the notion that diC8-PA inhibits 
priming by sequestering Sec18p. In contrast, diC8-DAG had no effect as predicted based on the 
content mixing assays. A previous study showed that NEM did not have an effect on Sec18p 
ATPase activity, however priming activity was not specifically examined (Steel et al., 1999). It is 
possible that Sec18p alkylation by NEM may affect its ability to disassemble cis-SNARE 
complexes in a manner independent of its ATPase activity. It is clear that in the presence of the 
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full fusion machinery Sec18p priming activity is inhibited by NEM. We then tested Sec18p activity 
on pah1∆ deletion vacuoles using the same priming assay to further examine the effect of increased 
PA on priming. As expected, vacuoles lacking pah1∆ showed significantly decreased levels of 
Sec17p release when compared to the wild type control (Figure 2.4B). Taken together, these data 
illustrate that priming activity is blocked by an increase in PA at the vacuole and that this inhibition 
is specific. 
 
Phosphatidic acid regulates Sec18p recruitment to cis-SNARE complexes  
Thus far we have found that cis-SNARE priming by Sec18p is blocked by the presence of increased 
PA while unaffected by the presence of increased DAG. This relationship supports the idea that 
the conversion of PA to DAG through PA phosphatase activity may have a regulatory role in the 
priming stage of fusion. Previous work showed that the PA phosphatase Pah1p had a regulatory 
role in endolysosomal maturation and was also proposed to regulate the localization of Sec18p on 
the membrane (Sasser et al., 2012). Sec18p has been shown to stay associated with the membrane 
throughout priming while its co-chaperone Sec17p is released (Mayer et al., 1996). This suggests 
that Sec18p stays attached to the membrane independently of Sec17p and SNAREs. Given our 
previous observations we identified PA as an alternate Sec18p membrane-binding site and asked 
if shifting dynamic membrane PA and DAG levels would also affect the association of Sec18p to 
SNAREs. To address this question, we utilized cis-SNARE pulldown assays in which recombinant 
GST-tagged Vam7p was introduced to fusion reactions in the absence of ATP to allow the 
formation of cis-SNARE complexes with free cognate SNAREs (Thorngren et al., 2004). It was 
previously shown that all vacuole-associated Vam7p is bound in cis-SNARE complexes 
suggesting SNARE complexes formed were appropriate Sec18p priming targets (Collins et al., 
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2005). The fusion reactions were then started with the addition of ATP and pulldowns of the GST-
Vam7p containing cis-SNARE complexes were performed across various time points. The level 
of Sec18p associated with the newly formed cis-SNARE complexes was analyzed by Western blot. 
To further test the effect of altering the PA:DAG ratio on priming we harvested vacuoles from 
pah1∆ strains to remove PA phosphatase activity relevant to fusion. The recruitment of Sec18p to 
cis-SNARE complexes was severely inhibited on pah1∆ vacuoles compared to wild type vacuoles 
across at each time point tested (Figure 2.5A-B). To confirm that the effect on Sec18p was only 
due to the lack of Pah1p, we used vacuoles from pah1∆ yeast complemented with plasmid-encoded 
PAH1 (Sasser et al., 2012). Complementation fully reversed Sec18p recruitment to cis-SNARE 
complexes (Figure 2.5C). Addition of recombinant Pah1p also fully reversed the recruitment 
defect seen on pah1∆ vacuoles (Figure 2.5D). Taken together these data suggest that PA levels in 
the membrane play a significant role in the regulation of Sec18p recruitment to cis-SNARE 
complexes for priming.  
 
To further examine the potential role PA could have in Sec18p recruitment to cis-SNAREs we 
employed a similar pulldown approach but included the addition of the small molecule inhibitor 
propranolol. Here we reasoned that the addition of propranolol, a known inhibitor of PA 
phosphatase activity, should lead to similar Sec18p-cis-SNARE association levels as our pah1∆ 
vacuoles. Because propranolol inhibition of vacuolar fusion can be rescued by the addition of 
exogenous Vam7p we instead carried out pulldowns using vacuoles that harbor the syntaxin 
orthologue Vam3p containing an internal calmodulin-binding domain (CBP-Vam3p) (Collins and 
Wickner, 2007). As expected, inhibition of Pah1p activity by the addition of propranolol 
significantly decreased the levels of Sec18p associated with cis-SNARE complexes relative to 
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control levels (Figure 2.6A). This is consistent with the effect seen in pah1∆ vacuoles and further 
supports a role for PA in the regulation of SNARE priming. 
 
A previous study showed that mammalian NSF bound PA in a nucleotide-dependent fashion 
wherein the ADP bound state of the protein had greater binding to PA than the ATP bound state 
(Manifava et al., 2001). We asked if the nucleotide-bound state might also play a role in Sec18p 
binding to PA and ultimately its recruitment to cis-SNARE complexes. We reasoned that if ATP 
is replaced with the slowly hydrolyzable analog ATPgS, then PA binding by Sec18p could be 
lessened and a larger pool would be available to bind to cis-SNARE complexes. Sec18p is known 
to bind to the cis-SNAREs in an ATP-bound state so we expected levels associated with cis-
SNARE complexes to be at wild type levels or greater. Using either our GST-Vam7p (not shown) 
or CBP-Vam3p pulldown assays, we tested the effect of ATPgS on Sec18p recruitment to cis-
SNARE complexes. Sec18p association to SNAREs was similar to control conditions with ATP 
(Figure 2.6B). We next tested Sec18p interactions with PA directly using a liposome floatation 
assay in the presence of Mg2+, EDTA, or ATPgS to assay the dependence of the nucleotide-bound 
state (Figure 2.6C). We observed no significant difference between the nucleotide states tested 
suggesting that unlike NSF, binding of Sec18p to PA was independent of such effects.  
 
Phosphatidic acid blocks the recruitment of Sec18p to cis-SNARE complexes  
We next wanted to determine if Pah1p could regulate Sec18p association with cis-SNAREs 
through its maintenance of membrane PA and DAG levels. The absence of Pah1p from the 
membrane likely increased the level of PA present, allowing the lipid to bind to Sec18p and 
sequester it from cis-SNAREs ultimately stalling its priming activity. To test this, we utilized the 
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GST-Vam7p pulldowns of cis-SNAREs as mentioned above, in the presence of inhibitory 
concentrations of diC8-PA or the equivalent concentration of diC8-DAG. Addition of diC8-PA 
abolished Sec18p association with cis-SNARE complexes when compared to the untreated 
vacuoles (Figure 2.7A). The total level of membrane-bound Sec18p was not affected. Addition of 
the same concentration of diC8-DAG did not significantly affect the level of Sec18p associated to 
cis-SNARE complexes compared to the control (Figure 2.7B). These findings support the idea that 
Pah1p could regulate Sec18p recruitment to cis-SNARE complexes through its maintenance of PA 
and DAG levels on the membrane. By controlling the dynamic levels of PA and DAG present in 





The protein machinery involved in the regulation of membrane fusion has been well characterized, 
however the regulatory effects of phospholipids on these proteins are still not well understood. The 
dynamic changes that these lipids undergo throughout the fusion cascade are only beginning to be 
explored. Yeast homotypic vacuole fusion utilizes a set of regulatory lipids that helps mediate each 
stage in a series of defined events. Lipids likely fulfill multiple roles during membrane fusion 
events including controlling the physical properties of the membrane, and providing a scaffold for 
the protein fusion machinery to bind, and organization of proteins into microdomains where fusion 
occurs. These lipids are currently known to include ergosterol, phosphoinositides, DAG, and PA, 
which are maintained and modified by a diverse group of kinases, phosphatases, and lipases.    
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PA has a regulatory role in multiple fusion pathways including Glut4 trafficking, mitochondrial 
fusion, and prospore membrane fusion (Nakanishi et al., 2006; Vicogne et al., 2006; Choi et al., 
2006). Additionally, PA has been identified as one of the minimum lipid requirements required for 
SNARE-dependent fusion of reconstituted proteoliposomes (RPLs) and promotes the association 
of Sec18p and HOPS with vacuolar SNARE RPLs (Mima and Wickner, 2009). However, it 
remains uncertain whether PA directly interacts with these proteins or if it participates in 
establishing a conducive environment for optimal protein function. PA is converted to DAG during 
the fusion cascade and inhibition of PA phosphatase activity blocks fusion at the priming stage. 
The importance of DAG in vacuole fusion is demonstrated in part by the effect of the DAG-binding 
domain C1b, which disrupts the organization of the vertex microdomain resulting in the potent 
inhibition of fusion (Fratti et al., 2004; Jun et al., 2004). DAG is a fusogenic lipid due to its negative 
curvature and ability to disrupt lipid bilayers (Das and Rand, 1984; Seddon, 1990). These features 
also allow DAG to trigger the fusion of protein-free liposomes (Sánchez-Migallón et al., 1995; 
Villar et al., 2000). While the potential importance of PA and DAG to vacuole fusion has been 
highlighted, no specific regulatory mechanisms have been described. Previously, it was found that 
the yeast PA phosphatase Pah1p has a significant regulatory role in the vacuolar fusion cascade 
suggesting that the balance of PA and DAG at the site of fusion is critical in mediating fusion 
related events (Sasser et al., 2012; Lawrence et al., 2014). 
 
Our earlier studies suggested that Pah1p regulated fusion in part by triggering the priming stage of 
the fusion cascade (Sasser et al., 2012). We theorized that prior to engaging cis-SNARE complexes 
Sec18p resided as part of a resting pool of protein bound to the membrane in a PA-dependent 
manner. Pah1p activity would convert PA to DAG leading to the release of Sec18p from the 
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membrane facilitating its recruitment to cis-SNARE bundles bound to Sec17p. In keeping with 
this model this study showed that deletion of PAH1 or chemical inactivation of its phosphatase 
activity led to the retention of Sec18p bound to the PA enriched membrane and blocking its 
translocation to Sec17p-bound cis-SNAREs. This is further bolstered by our findings that Sec18p 
binds preferentially to liposome membranes that contain PA. This interaction is specific as 
replacement of PA with other acidic or small head group lipids abolishes Sec18p binding. PA is a 
unique phospholipid in that it is both anionic and promotes negative membrane curvature, a 
property favorable for protein insertion at the head group region of the membrane bilayer 
(Kooijman and Burger, 2009). It is likely that a Sec18p lipid-binding site would interact with the 
vacuolar membrane in a way dependent on both electrostatic forces and curvature effects, however 
we did not detect significant binding of the protein to membranes that contained DAG, another 
lipid that promotes negative curvature. Considering this and the finding that Sec18p does not bind 
other anionic phospholipids we expect that the lipid association we observed is specific for PA. 
These results parallel previous work that showed the Sec18p mammalian orthologue NSF is also 
a PA binding protein (Manifava et al., 2001). While no sequence orthologue has been described 
for PA binding regions, most that have been described contain a combination of adjacent basic and 
hydrophobic amino acids (Kooijman and Burger, 2009). The basic residues in PA binding domains 
are able to preferentially bind the lipid phosphomonoester head group through hydrogen bonding 
as described by the electrostatic-hydrogen bond switch model (Kooijman et al., 2007). The 
presence of hydrophobic residues often allows for PA binding proteins to insert into the membrane 
and interact with adjacent lipid acyl chains (Van Den Brink-Van Der Laan et al., 2004). Based on 
our data, we propose that Sec18p association with PA requires electrostatic interactions between 
a lipid-binding region on the protein and the phosphomonoester head group of PA. This binding 
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is likely enhanced by surrounding hydrophobic interactions but these interactions alone are not 
strong enough to support the entire binding event. We propose that upon Pah1p-dependent 
conversion of PA to DAG, crucial electrostatic interactions between Sec18p and PA are interrupted 
and Sec18p is released from the membrane.  
 
Specific lipids have been shown to be of crucial importance in regulating the different stages of 
membrane fusion (Boeddinghaus et al., 2002; Fratti et al., 2004; Sasser et al., 2012; Karunakaran 
and Fratti, 2013; Karunakaran et al., 2012; Lawrence et al., 2014; Stroupe et al., 2006; Jun et al., 
2004). In this study, we show that PA has an inhibitory effect during the priming stage of fusion 
while DAG does not. Previous studies have shown that addition of ergosterol ligands or antibody 
against PI(4,5)P2 also potently inhibit Sec18p priming activity (Kato and Wickner, 2001; Mayer 
et al., 2000). Interestingly, mammalian NSF does not bind PI(4,5)P2 alone (Manifava et al., 2001). 
It is possible that Sec18p and NSF have distinct lipid interactions, however it is also important to 
consider the roles of both ergosterol and PI(4,5)P2 at the site of fusion. Each of these lipids is a 
requirement for functional microdomain formation at the vertex ring (Fratti et al., 2004). 
Disruption of these microdomains with exogenous ligands may compromise the organization of 
necessary protein and lipid machinery at the site of fusion ultimately resulting in a priming defect. 
We have demonstrated direct physical interaction between Sec18p and PA, and we believe this 
association accounts for PA-specific priming inhibition.  
 
There are two primary ways that we considered PA could inhibit the priming activity of Sec18p 
directly. First, PA could decrease the ability of Sec18p to disassociate cis-SNARE complexes 
through allosteric effects. Alternatively, PA could act to sequester Sec18p away from cis-SNARE 
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complexes effectively stalling priming. In this study, we provide evidence in accord with the latter 
possibility. We observed a decrease in recruitment of Sec18p to cis-SNAREs on vacuoles from a 
pah1∆ deletion strain, as well as by inhibition of PA phosphatase activity with propranolol, and 
upon addition of exogenous PA. Taken together, we propose that dynamic PA and DAG levels 
mediate Sec18p localization on the vacuolar membrane and recruitment to cis-SNARE complexes. 
 
The stark contrast in effects that PA and DAG have on priming activity frame Pah1p as a potential 
initiator of the fusion cascade. Reactivation of SNAREs and turnover of fusion may be controlled 
by Pah1p through its modulation of local PA concentrations at the vertex ring. We propose a model 
in which Sec18p is initially recruited to the vacuolar membrane through binding to organized PA 
pools (Figure 2.8). Once recruited, Sec18p remains bound to PA pools where it is unable to access 
SNAREs during non-priming stages of fusion. Upon completion of compartment fusion and 
generation of cis-SNAREs, Pah1p converts pools of PA to DAG effectively lowering local PA 
concentrations. Sec18p is freed from the membrane and is able to be recruited to cis-SNARE 
complexes for priming. It is possible that conversion of PA to other regulatory phospholipids 
through a CDP-DAG intermediate may also serve as an initiator of priming. Under this model, PA 
could serve as a global regulator of Sec18p localization in the cell. However, previous work has 
shown that Sec18p levels at the vacuole are not increased in pah1∆ cells (Sasser et al., 2012). It is 
possible that there is an upper limit to PA dependent membrane association of Sec18p, or there 
may be compensatory enzymatic activity of other lipid modifiers such as Phospholipase D. Further 
work is needed to investigate these possibilities and probe organelle specificity of Sec18p 
regulation by PA. 
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While the PA binding region of Sec18p/NSF is not clear, the potential effects of this lipid 
interaction are interesting to consider. The role of each of the three domains in Sec18p/NSF has 
been previously described, and binding of any of these to PA could have inhibitory effects on its 
overall function. The nucleotide binding domains of Sec18p/NSF (D1 and D2) are responsible for 
ATPase activity and formation of a homohexamer respectively (Whiteheart et al., 1994; Hanson 
et al., 1997). It is possible that PA binds to the D1 domain and disrupts the ability of Sec18p to 
hydrolyze ATP making it unable to generate the necessary force for cis-SNARE complex 
disruption. It is also possible that PA binds to the D2 domain and blocks the formation of the active 
Sec18p homohexamer. This could force Sec18p into a monomeric state preventing it from 
effectively associating with cis-SNARE complexes. The N-terminal domain of Sec18p is 
responsible for association with Sec17p and cis-SNARE complexes (Babor and Fass, 1999). 
Binding of the N-terminal domain to PA could block the basic groove needed for Sec17p binding 
preventing recruitment of Sec18p to cis-SNARE complexes. This potential association of the N-
terminal domain to PA is consistent with our observations and model, however additional work is 
necessary to identify the specific PA binding region of Sec18p to understand the mechanism of 
this regulation. 
 
It is clear that phosphatidic acid can modulate membrane fusion through its control of Sec18p 
priming activity at the vacuole. Additional work is needed to identify the PA-binding region on 
Sec18p. Also of interest will be determining the upstream regulation of PA content on the vacuole. 
PA is produced from DAG by Dgk1p, from PC by Spo14p, and from PE by PE-PLD making all 
of these enzymes potential regulators of SNARE priming (Han et al., 2008; Sreenivas et al., 1998; 
Waksman et al., 1997). Sec18p regulation by phosphatidic acid provides another example of the 
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highly organized interplay between protein and lipid machinery that helps to carry out membrane 





Figure 2.1. Sec18p preferentially binds to liposomes containing phosphatidic acid. 
Recombinant His6-Sec18p (2 µg) was incubated with liposomes of the indicated compositions for 
10 min at 30°C. Liposomes were isolated by centrifugation and washed with 1X PBS before bound 
proteins were resolved by SDS-PAGE. Bar graphs show average normalized densitometry values 
measured for 3 separate experiments. Binding was observed in liposomes with PA or DAG (A), 
with increasing concentrations of PA or DAG (B), with increasing concentrations of PA or PS (C), 





































































































































































































































Figure 2.2. The PA-binding domain DEP reduces Sec18p binding to membranes. (A) 
Liposomes of the indicated compositions were incubated without Dvl2-DEP or with 20 µM Dvl2-
DEP for 5 min at 30°C. Recombinant His6-Sec18p (2 µg) was added to the sample and incubated 
for 10 min at 30°C. (B) GST-DEP titration and Sec18p binding to liposomes was performed as 
described above in the presence of the indicated concentrations of GST-DEP. (C) Vacuoles were 
harvested from wild type DKY6281 and incubated with GST-DEP, GST-C1b domain, or GST-
ENTH domain. Bound and unbound fractions were separated by centrifugation and resolved by 
SDS PAGE. Bar graphs show the percentage of unbound Sec18p in each sample normalized to 



































































































































































Figure 2.3. Addition of exogenous phosphatidic acid or N-ethylmaleimide causes a severe 
membrane fusion defect. Vacuoles were harvested from wild type BJ3505 and DKY6281 and 
tested for fusion by luminal mixing and proPho8p maturation. Fusion reactions containing 3 µg 
of each vacuole type were incubated in the presence of diC8-PA (A), or diC8-DAG (B) at the 
indicated concentrations. (C) Fusion reactions containing 100 µg/ml diC8-PA were incubated in 
the presence of 188 nM recombinant Sec18p. Fusion reactions containing 3 µg of each vacuole 
type were incubated in the presence of GST-DEP (D) or NEM (E) at the indicated 
concentrations. Fusion results were normalized to untreated wild type vacuoles at standard 
conditions. (F) Exogenous recombinant Vam7p (200 nM) was used to bypass fusion inhibitors. 
(G) Gain of resistance kinetics assays were performed in the presence of 140 µg/ml a-Sec17p 
IgG, 2 mM propranolol, 300 µM diC8-PA, 1 mM NEM, or PS buffer. Data was fit using first-
order exponential decay with weights and errors. (H) Calculated half-times from first-order 
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Figure 2.4. Addition of exogenous phosphatidic acid but not diacylglycerol inhibits the 
priming activity of Sec18p. (A) Vacuoles from BJ3505 yeast were assayed for priming activity 
as detected by the release of Sec17p from the membrane fraction. Fusion reactions of 3 µg of 
vacuoles were incubated in the presence of buffer, 1 mM NEM, 300 µM diC8-PA, or 300 µM 
diC8-DAG. Vacuoles were pelleted by centrifugation at the indicated times and proteins in the 
supernatant fraction were resolved by SDS-PAGE and imaged by Western blot. Densitometry 
values were normalized against input sample for each condition. Graphs show the normalized 
averages (n=3). (B) Vacuoles from BJ3505 and pah1D yeast were assayed for priming activity as 


































































Figure 2.5. Vacuoles from a pah1∆ deletion strain have a decrease in the level of Sec18p 
bound to cis-SNARE complexes. Vacuoles were harvested from BJ3505, RFY17 (BJ3505 
pah1∆), and RFY19 (BJ3505 pah1∆, pPAH1) strains and assayed for Sec18p binding to cis-
SNARE complexes. (A) Recombinant GST-Vam7p was added to fusion reactions and incubated 
at 27°C for 30 min in the absence of ATP to allow formation of cis-SNARE complexes 
containing GST-Vam7p. Next, ATP regenerating system was added and the samples were 
incubated at 27°C for the indicated times before vacuoles were isolated by centrifugation and 
solubilized. Glutathione Sepharose was used to pull down GST-Vam7p and attached proteins 
were resolved by SDS-PAGE and imaged by Western blot. (B) WT versus pah1D vacuoles. (C) 
WT versus pah1D + pPAH1 vacuoles. (D) WT versus pah1∆ vacuoles + 200 µg/ml rPah1p. 
Densitometry values for Sec18p pull down were normalized against the corresponding pull down 
Vam7p value. Graph shows the normalized average ratios (n=3). The white bars represent the 
pah1D pulldown data from panel B. This is to facilitate visualization of the effect of adding 
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Figure 2.6. Vacuoles treated with the Pah1p inhibitor propranolol have a decreased level of 
Sec18p bound to cis-SNARE complexes. Vacuoles were harvested from BJ3505 yeast 
expressing CBP-Vam3p and assayed for Sec18p binding to cis-SNARE complexes. Fusion 
reactions were incubated at 27°C for the indicated times in the presence of propranolol or ATPgS 
or fusion buffer. At the indicated times, vacuoles were isolated by centrifugation and solubilized. 
Calmodulin agarose was used to pull down CBP-Vam3p and attached proteins were resolved by 
SDS-PAGE and imaged by immunoblotting. Fusion reactions were treated with PS buffer, 2 mM 
propranolol (A) or 1 mM ATPgS (B). (C) Liposome binding and effect of the nucleotide-binding 
state of Sec18p was tested using liposomes containing 10% PA. His6-Sec18p (2 µg) was 
incubated with PA liposomes in binding buffer alone or in the presence of 1 mM Mg2+, 1 mM 

































































































































































Figure 2.6 (cont.)  
corresponding pull down Vam7p value. Graph shows the normalized average ratios (n=3). * 






Figure 2.7. Vacuoles treated with diC8-PA have a decrease in the level of Sec18p bound to 
cis-SNARE complexes. Vacuoles were harvested from BJ3505 and assayed for Sec18p binding 
to cis-SNARE complexes. Recombinant GST-Vam7p was added to fusion reactions and incubated 
at 27°C for 30 min in the absence of ATP to allow formation of cis-SNARE complexes containing 
GST-Vam7p. Next, ATP regenerating system was added and the samples were incubated at 27°C 
for the indicated times before vacuoles were isolated by centrifugation and solubilized. Glutathione 
Sepharose was used to pull down GST-Vam7p and protein complexes were resolved by SDS-
PAGE and examined by Western blot. Fusion reactions were treated with PS buffer, 300 µM diC8-
PA (A) or 300 µM diC8-DAG (B). Densitometry values for Sec18p pull down were normalized 
against the corresponding pull down Vam7p value. Graph shows the normalized average ratios 






































































































Figure 2.8. Working model of Sec18p regulation by PA. Sec18p associates with vacuole 
membranes through direct interactions with PA. Upon PA hydrolysis by Pah1p, Sec18p is no 
longer sequestered on the membrane away from cis-SNAREs and is recruited to them to carry 
out priming activity. Red ovals depict PA’s phosphate head group. Blue ovals depict generic 
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CHAPTER 3:  PHOSPHATIDIC ACID INHIBITS SNARE PRIMING BY INDUCING 




Eukaryotic homeostasis relies on membrane fusion catalyzed by SNARE proteins. Inactive 
SNARE bundles are re-activated by Sec18/NSF driven disassembly to enable a new round of 
fusion. We previously found that phosphatidic acid (PA) binds Sec18 to sequester it from 
SNAREs. Dephosphorylation of PA dissociates Sec18 from the membrane allowing it to engage 
SNARE complexes. We now report that PA induces conformational changes in Sec18 protomers, 
while hexameric Sec18 cannot bind PA membranes. The association of Sec18 with PA was shown 
to be sensitive to membrane curvature, suggesting that regulation could vary on different 
organelles in a curvature dependent manner. Molecular dynamics showed that PA binding sites 
exist on the D1 and D2 domains of Sec18 and that residues needed for binding were masked in the 
hexameric form of the protein. Together these data indicate that PA regulates Sec18 function 





Membrane fusion is necessary for all eukaryotes to effectively transport cellular components 
between organelles. Vesicle trafficking is carried out through a series of events that are highly 
conserved across eukarya (Jahn and Südhof, 1999). Many proteins that drive the process differ 
between eukaryotic species, but all perform similar roles allowing compartment contact, bilayer 
fusion, and luminal content mixing (Jahn et al., 2003). The final stage of membrane fusion, and 
luminal content mixing, is catalyzed by SNARE proteins. Each participating membrane 
contributes either an R-SNARE or three Q-SNARE coils that wrap around each other to form a 
parallel four-helical trans-SNARE complex that brings membranes into close apposition. The 
formation of such complexes releases free energy that is transmitted to the membranes to trigger 
fusion. Once fusion occurs and membranes are merged, the four helical SNARE bundle, now a 
cis-SNARE complex, is inactive and requires reactivation in order to undergo a new round of 
fusion.  
 
The activation cis-SNAREs, also known as Priming, is carried out by the AAA+ protein 
Sec18/NSF and its adaptor protein Sec17/a-SNAP (Mayer et al., 1996). Current models suggest 
that NSF primes cis-SNAREs through a “loaded-spring” mechanism triggered by cis-SNARE 
recognition and ATP hydrolysis (Ryu et al., 2015). NSF binds to cis-SNAREs with the help of a-
SNAP to form what is known as the 20S complex (Chang et al., 2012; Söllner et al., 1993; Wilson 
et al., 1992; Zhao et al., 2015). In its active form, NSF forms a homohexamer which surrounds the 
cis-SNAREs and a-SNAP proteins to form the 20S particle (Fleming et al., 1998). Association 
with cis-SNARE-a-SNAP complexes triggers ATP hydrolysis which leads to a large 
 72 
conformational change in the protein. This generates enough force to disrupt the 20S complex and 
separate the individual SNAREs from each other effectively reactivating them. 
 
Previous work identified that both NSF and Sec18 bind to the regulatory glycerophospholipid 
phosphatidic acid (PA) (Manifava et al., 2001; see Chapter 2). PA has been shown to have 
regulatory effects in multiple vesicular trafficking pathways including sporulation, regulated 
exocytosis, lysosomal maturation, and homotypic vacuole fusion (Liu et al., 2007; Nakanishi et 
al., 2006; Rogasevskaia and Coorssen, 2015; Sasser et al., 2012; see Chapter 2). In the case of 
Sec18, increased PA levels lead to reduced priming activity likely due to a decrease in recruitment 
to cis-SNAREs (see Chapter 2). On yeast vacuoles, PA is converted to diacylglycerol (DAG) by 
the PA phosphatase Pah1, an ortholog of mammalian Lipin1. In the absence of Pah1 activity, PA 
levels remain intact and sequester Sec18 from cis-SNARE complexes to prevent priming and arrest 
the fusion pathway (Sasser et al., 2012). DAG can be converted to PA through the action of the 
DAG kinase Dgk1, whose inactivation leads to elevated DAG concentrations that enhance fusion 
through modulating the activity of the Rab GTPase Ypt7 (see Chapter 4). Thus, the interconversion 
of PA and DAG serves as a regulatory switch to control vacuole fusion.  
 
Here we asked what effects PA-binding has on the overall architectural dynamics of Sec18/NSF 
that could lead to a decrease in its priming activity. To do so, we measured binding of monomeric 
and hexameric Sec18 to different forms of PA. We report that monomeric Sec18 has significantly 
stronger binding than the hexameric form to all forms of PA. We probed changes to the architecture 
of Sec18 when bound to short-chain PA and found that the protein exists in a significantly different 
conformation in its PA-bound state, without significant changes to its secondary structure. To 
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study the mechanism of Sec18 binding to PA, molecular dynamics simulations were performed 
using the mammalian version of Sec18, namely NSF.  NSF was used as it has high identity to 
Sec18 and has more structural information available at the protein data bank (PDB ID: 3J94) (Zhao 
and Brunger, 2016). The molecular dynamic simulations performed suggest NSF binds to PA at 
regions of the protein that are only exposed in the monomeric state of the protein. Taken together, 
we propose that PA regulates the priming activity of NSF/Sec18 by limiting the formation of its 
active hexamer. 
 
MATERIALS AND METHODS 
 
Reagents 
POPA (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate), POPC (1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphatidylcholine), POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanolamine), 
C8-PA (1,2-dioctanoyl-sn-glycero-3-phosphate), C8-DAG (1,2-dioctanoyl-sn-glycerol), and C8-
PS (1,2-dioctanoyl-sn-glycero-3-phospho-L-serine) were purchased from Avanti Polar Lipids 
(Alabaster, AL, USA) as chloroform stock solutions and stored at -20°C. CM7 and Ni-NTA 
(Standard and S series) sensor chips, and Regeneration buffers (Glycine pH 1-3) were procured 
from GE Healthcare (Buckinghamshire UK). Ni-NTA Atto 488 dye was procured from Sigma-
Aldrich Corp. (St. Louis Missouri). Monolith NT.115 standard treated capillaries for 






Plasmid for expression of Sec18His8 was created by amplification of SEC18 by PCR from genomic 
DNA of the yeast strain DKY6281 using primers containing NdeI and XhoI restriction cut sites 
(Forward: 5’-ACGTACGTCATATGTTCAAGATACCTGGTTTTGG-3’, Reverse: 5’-
ATCGAATGCTCGAGT-GCGGATTGGGTCAT CAACT-3’). PCR Product was inserted into 
pET42a using NdeI and XhoI in frame with a C-terminal 8xHis tag sequence under the control of 
a T7 promoter to create pSec18H8. 
 
Plasmid for expression of GST-Sec18 was created using primers containing EcoRI and XhoI 
restriction cut sites (Forward: 5’-ATGCAATGGAATTCATGTTCAAGATACCTGGTTTTGG-
3’, Reverse: 5’-ATCGAATGCTC GAGTTATGCGGATTGGGTCATCAACT-3’). PCR product 
was inserted into pParallel GST using EcoRI and XhoI to create pGSTSec18. Plasmid for 
expression of GST-N terminal domain was created in the same way using a different reverse primer 
(Forward: 5’-ATGCAATGGAATTCATGTTCAAGATACCTGGTTTTGG-3’, Reverse: 5’-




For purification, pSec18His8 was transformed into Rosetta 2 (DE3) pLysS Competent Cells 
(Novagen) and Sec18His8 expression was carried out using auto-inducing medium (AIM) (Studier, 
2014). Cells were grown in AIM until reaching stationary phase (37°C, 18 hours, shaking) and 
harvested by centrifugation. Cells were resuspended in lysis buffer (20 mM HEPES pH=6.8, 300 
mM NaCl, 0.1% Triton-100, 2 mM 2-mercaptoethanol, 20 mM imidazole, 10% glycerol, 1 mM 
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ATP, 1 mM PMSF, and 1X cOmplete Protease Inhibitor Cocktail (Roche)) and lysed by French 
press. Lysates were cleared by centrifugation (50,000 x g, 20 min, 4°C) and incubated with Ni-
NTA resin (Invitrogen) overnight at 4°C. Resin was washed with 100 bed volumes of wash buffer 
(lysis buffer with 50 mM imidazole) before protein was eluted in 1 ml fractions (lysis buffer with 
250 mM imidazole). Protein was concentrated before being run through gel filtration (Superose 6) 
using size exclusion buffer (20 mM HEPES pH 6.8, 300mM NaCl, 1 mM 2-mercaptoethanol, 10% 
glycerol). Sec18His8 elutes in two peaks corresponding to monomeric and hexameric pools. Each 
pool was collected and concentrated before use. For circular dichroism experiments, Sec18His8 was 
purified using the same approach with different buffer compositions. CD lysis buffer (50 mM 
phosphate buffer pH 6.8, 20 mM imidazole, 1mM PMSF), CD wash buffer (50 mM phosphate 
buffer pH 6.8, 50 mM imidazole), CD elution buffer (50 mM phosphate buffer pH 6.8, 250 mM 
imidazole), and CD SEC buffer (50 mM phosphate buffer pH 6.8) were used. GST-Sec18 was 
purified similarly using Rosetta 2 (DE3) pLysS Competent Cells transformed with pGSTSec18 
but with the following changes. GST lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 5 mM 
EDTA, 1 mM ATP, 1 mM PMSF, and 1X cOmplete Protease Inhibitor Cocktail) was used through 
the lysis and chromatography wash steps. Protein was eluted with GST elution buffer (20 mM 
HEPES pH 7.2, 150 mM NaCl, 10 mM reduced glutathione) and dialyzed against 1X HBS pH 7.2 
before being aliquoted and stored at -80°C. GST-N was purified in the same way using cells 
transformed with pGST-N. The DEP PA binding domain from murine Dvl2 was purified as a GST-
fusion as described (Capelluto et al., 2014). Membrane scaffold protein 1D1 (MSP1D1-His) was 





Lipid composition of PA nanodiscs consisting of 3.023 µmol POPC diC16, .098 µmol PA diC16, 
and .78 µmol POPE and PC nanodiscs consisting of 3.121 µmol POPC diC16 and .78 µmol POPE 
were combined, dried, and desiccated overnight. Lipids were then dissolved in 20 mM sodium 
deoxycholate in TBS (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, and .02% NaN3) and sonicated. 
MSP1D1 membrane scaffold protein (MSP) was then added in a ratio of 70:1 lipid to protein and 
detergent removed with Bio-Beads® SM-2 (Bio-Rad). Nanodiscs were isolated using size 
exclusion chromatograph and quantified using a NanoDrop and the extinction coefficient of 21,000 
L mol-1 cm-1 for MSP1D1 (24.66 kD), and the resultant mg/mL divided by two because there are 
two MSP proteins per nanodisc (Sparks et al., 2016). 
 
Surface Plasmon Resonance  
Surface plasmon resonance (SPR) measurements were performed on a Biacore T200 instrument 
equipped with an Ni-NTA chip. Approximately 2000 RU of 5% PA nanodiscs were immobilized 
non-covalently using 100 mM NiSO4 flowed at 10 µL/s followed by a blank buffer injection of 
HEPES pH 7.4, 150 mM NaCl (HBS Buffer). Injections were performed in HBS buffer at a flow 
rate of 30 µl/min with an association time of 90 sec, dissociation time of 300 sec., and binding was 
measured in relative response units (RU) as described (Sparks et al., 2016). Regeneration with 
EDTA was performed at flow rate 30 µL/s for 120 s using 100 µM EDTA buffer. Proteins were 
injected using 1:1 dilutions from highest concentration and steady state was obtained using GE 
BIAcore T200 evaluation software version 3.0 (BIAevaluate). Proteins were injected using 1:1 
dilutions for Sec 18 monomer (3.64 µM, 1,82 µM, 911 nM, and 455 nM), DEP PA binding domain 
(57.5 µM, 28.8 µM, 14.4 µM, 7.2 µM, 3.6 µM, 5.8 µM), and N domain from Sec18 (84.3 µM, 8.4 
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µM, 4.2 µM, 1.1 µM, 527 nM, and 1.69 µM) with one concentration from each titration run in 
duplicate. Steady state data was fitted and exported using BiaEvaluate software into GraphPad 
Prism 7.00 for Windows, GraphPad Software (La Jolla, CA). 
 
Microscale thermophoresis 
Thermophoresis measurements were performed using a Monolith NT.115 labeled thermophoresis 
machine. Sec18His8 was labeled with Ni-NTA Atto 488 according to the manufacturer’s protocol. 
M.O. Control software was used for operation of MST. Target protein concentrations were 50 nM 
for all His-tag labeled proteins Sec 18 monomer, Sec18 hexamer, PA nanodiscs, and PC nanodiscs. 
LED excitation power was set to 90% and MST set to high allowing 3 seconds prior to MST on to 
check for initial fluorescence differences, 25 s for thermophoresis, and 3 s for regeneration after 
MST off. Analysis was performed using M.O. Affinity Analysis Software as the difference 
between initial fluorescence measure in the first 5 s as compared with thermophoresis at 15 s. All 
measurements were performed in PBS buffer (137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 
2 mM KH2PO4, pH 7.4) without Tween except for Sec18 Hexamer, which was performed in 50% 
PBS buffer and 50% Storage buffer (20 mM HEPES pH=6.8 300 mM NaCl 1 mM beta-
mercaptoethanol 10% glycerol) and binding affinity was generated using Graphpad Sigmoidal 4PL 
fit from points exported from M.O. Affinity Analysis software using KD Model with target 
concentration fixed at 50 nM generating bound and unbound, and fraction bound data exported to 






Cleavage reactions were carried out in proteolysis buffer (20 mM HEPES pH 7.2, 150 mM NaCl, 
2 mM ATP, 2 mM MgCl2). Sec18His8 (2 µM) was added to proteolysis buffer and incubated with 
indicated lipid concentration on ice for 5 min. Trypsin or thrombin diluted in 1X HBS was added 
to assay tubes at indicated concentrations and incubated at 25°C for 30 min. Cleavage reactions 
were stopped with the addition of SDS sample buffer containing 1 mM PMSF. Samples were 
resolved with SDS-PAGE and gels were stained using Coomassie Blue. Gels were destained with 
methanol/acetic acid solution (50%/7%) and imaged using a ChemiDoc MP Imaging System (Bio-
Rad). 
 
Tryptophan Fluorescence Spectroscopy 
Sec18His8 (500 nM) was incubated with the indicated concentrations of C8-PA in fluorescence 
assay buffer (20 mM HEPES pH 7.2, 150 mM NaCl, 1 mM MgCl2, 1 mM ATP). Lipid dilutions 
were first prepared in assay buffer and measured for background fluorescence before Sec18His8 
was added and incubated at 25°C. Intrinsic tryptophan fluorescence measurements were made 
using a fluorimeter with Peltier temperature control (Agilent Technologies). Samples were excited 
at 295 nm and the emission spectra were collected from 300-400 nm. Samples were measured in 
a 100 µL cuvette (Starna Cells). Initial background fluorescence spectra for each lipid 
concentration were subtracted from final measurements. 
 
1,8-ANS Fluorescence Spectroscopy 
ANS binding experiments were carried out in fluorescence assay buffer with 5 µM 1-anilino-8-
naphthalenesulfonate (ANS) (Cayman Chemical). Initial spectra were taken without Sec18His8 to 
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measure any background fluorescence from buffer or added lipids (ex. 350 nm, em. 390-620 nm). 
Sec18His8 diluted in assay conditions was then added to the assay to the indicated concentration 
and incubated at 25°C for 5 min before spectra were obtained. Initial background fluorescence 
spectra for each lipid concentration were subtracted from final measurements. 
 
Circular Dichroism 
Monomeric Sec18His8 purified in phosphate buffer was incubated with and without C8-PA to 
equilibrium (25°C, 15 min). Protein concentration used was 5 µM and lipid concentration used 
was 100 µM. Circular dichroism was measured using a spectropolarimeter (JASCO). All spectra 
were recorded from 260 nm to 200 nm at 50 nm min-1 and measurements were taken in a 1 mm 
pathlength cuvette.  
 
 
Differential Scanning Fluorimetry 
Sec18 (2.75 mg/mL) was diluted to a final concentration of 0.11 mg/mL in phosphate buffer 
containing 1 mM ATP, 1 mM MgCl2, and 4X SYPRO orange dye. Next, 22.5 µL of this mix was 
added to a white hard-shell 96-well PCR plate (Bio-Rad) which contained 2.5 µL of serial dilutions 
of C8-PA in phosphate buffer. The plates were then sealed with Microseal ‘B’ film (Bio-Rad), and 
samples were allowed to equilibrate at room temperature for 30 min before beginning the assay. 
Melting curves were performed using a Bio-Rad CFX Connect real-time detection system. The 
melt curve protocol was 25oC for 3 min followed by a 25-90oC gradient with 0.5oC increments. 
Each temperature was held for 10 seconds and the fluorescence intensity was measured (Ex = 490 
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nm, Em = 560 nm). The first derivative of the fluorescence readings was used to determine the 
melting temperature(s) for each condition. 
 
Preparation of D1-D2 monomer and hexamer models 
The D1-D2 monomer model (residues 215-737) was derived from an Cryo-EM structure of ATP-
bound NSF complex (PDB 3J94 - chain A) (Zhao et al., 2015). Missing residues [335-346, 458-
478 in PDB 3J94 (chain A)] were built via homology modeling using the crystal structure of the 
homologous N-D1 domain of p97 (PDB 1E32) as a template by MODELLER 9.19 (Blundell et 
al., 1993). The complete D1-D2 hexamer model was prepared (Jo et al., 2014) using the same PDB 
3J94 as the monomer. Missing loops in each monomer were modeled in CHARMM GUI to ensure 
that no clashes or topological errors exist in the complex structure. Cis-peptide bonds in both 
monomer and hexamer structures were examined and fixed manually using Cispeptide plugin in 
VMD (Schreiner et al., 2011). A further refinement of loops built in the hexamer was performed 
via MDFF (Trabuco et al., 2008). 
 
Equilibrium MD simulations of D1-D2 monomer and D1-D2 hexamer 
The MD simulations were performed with NAMD 2.12 using CHARMM36m force field (Phillips 
et al., 2005; Huang et al., 2017). Langevin dynamics and Langevin piston Nosé−Hoover methods 
were used to maintain constant temperature at 310.15 K and pressure at 1 atm (Feller et al., 1995; 
Martyna et al., 1994). The long-range electrostatic forces were evaluated using the particle mesh 
Ewald (PME) method with a 1 Å grid spacing (Darden et al., 1993; Essmann et al., 1995). The van 
der Waals interactions were calculated with a cutoff of 12 Å and a force-based switching scheme 
after 10 Å. Integration time step was set at 2 fs with SETTLE algorithm applied (Miyamoto and 
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Kollman, 1992). VMD 1.9.3 was used for MD trajectory visualization and analysis (Humphrey et 
al., 1996). The D1-D2 monomer model was first equilibrated for 20 ns with harmonic restraints 
(0.05 kcal/mol/Å2) on protein Cα atoms except modelled loops, then followed by 200 ns 
equilibration without restraints. 
 
PA lipids flooding simulations of D1-D2 monomer and D1-D2 hexamer 
All the structures of D1-D2 monomer and hexamer were combined with a lipid grid of 5 x 5 x 5 
short-chain PA lipids consisting of protein, solvent, and lipid with overlapping lipids on protein 
removed. The flooding box was then solvated and ionized with the SOLVATE and AUTOIONIZE 
plugins within VMD [PMID: 8744570] with a final NaCl concentration of 150 mM.  The 
constructed D1-D2 monomer (ATP-bound and ATP-free) and D1-D2 hexamer (ATP-bound) were 
simulated in a short-chain PA solution for 120 ns each for monomer and 166 ns for hexamer, 
termed 𝐹𝑙#$%&', 𝐹𝑙(#$
%&')*+,, and 𝐹𝑙-,.%&'.  Final simulation systems include for monomer ~80 mM PA 
lipids in water and for hexamer short-chain PA solution (120 mM, 223 PA molecules in a 188 Å 
x 187 Å x 133 Å water box) for 𝐹𝑙(#$,%&'  𝐹𝑙-,.%&', and 𝐹𝑙(#$
%&')*+,,. Harmonic restraints were applied 
on protein Cα atoms except modelled loops throughout the simulation, to preserve protein 
secondary structure. 
 
Binding Site Simulations on NSF for PA 
To characterize C8-PA and D1-D2 monomer interactions, molecular ensemble docking of PA was 
done on D1-D2 monomer using AutoDock Vina (Pande et al., 2010). The previously mentioned 
equilibrium simulation of D1-D2 was used to fully sample the dynamics of D1-D2 for molecular 
docking, where snapshots were taken every 100 ps of the 200 ns trajectory. For each snapshot, an 
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80Å by 94Å by 108Å grid box was used to fully sample the entire structure. Each snapshot was 
docked with an exhaustiveness of 10, yielding a total of 2000 PA docked poses, with the affinities 
of each poses obtained from the resultant log files. These poses where then clustered using a hybrid 
K-centers and K-medoids clustering algorithm using root-mean-square deviation (RMSD) method, 
for which three main clusters where identified (Beauchamp et al., 2011). These clusters where then 
compared to SiteMap (Halgren, 2009). Schrodinger SiteMap was used on equilibrated D1-D2 NSF 
monomer indicating top potential ligand binding regions of NSF D1-D2 monomer including 
shallow binding sites.  
 
Statistics 
Results are expressed as the mean ± S.E. where n = number of replicates. SPR experiments were 
analyzed using GE BIAevaluation Software, MST experiments were analyzed using M.O. Affinity 





Sec18 monomer binds to PA with higher affinity than the hexameric form  
Our previous work showed that Sec18 preferentially bound to liposomes containing 
phosphatidylcholine (PC), phosphatidylethanolamine (PE) and PA relative to those composed of 
only PC and PE, or ones where PA was replaced with DAG (see Chapter 2). This was in keeping 
with older findings showing that mammalian NSF bound to resin-linked PA (Manifava et al., 
2001). Here our studies were extended to further define how Sec18 binds to PA. To start we used 
microscale thermophoresis (MST) to acquire binding affinities to dioctonyl PA (C8-PA), which 
prevents Sec18 from binding cis-SNARE complexes, consequently precluding priming from 
occurring (see Chapter 2). We used both monomeric and hexameric Sec18 with a range of C8-PA. 
The C-terminal 8xHistidine tag of Sec18 was labeled with Ni-NTA Atto 488. As shown in Figure 
3.1A, monomeric Sec18 (mSec18) bound to C8-PA with a KD of 1.4±0.68 µM (blue circles), 
whereas the hexameric form (hSec18) had a KD of 29±8.6 µM (red squares). This suggested that 
either hSec18 has residues occluded for PA binding or is in an inappropriate conformation to bind 
C8-PA in hexameric form. It is possible that a small soluble C8-PA could access a binding site on 
Sec18 that is obscured in the hexamer, where membrane contained PA is unable to reach PA 
binding regions on Sec18 when Sec18 is hexamerized, especially regions contained in the 
hexamerization interface of Sec18 hexamer. 
 
Due to the difference in binding affinities to C8-PA, we next asked if limiting the mobility of PA 
to two dimensions would show a similar disparity between the monomer and hexamer. To this aim 
we used sonicated liposomes as previously reported as well as extruded 0.8 µm diameter liposomes 
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to approximate the diameter of yeasts vacuoles. We found that mSec18 bound sonicated PA 
liposomes with a KD of 9.3±1.32 µM (red circles) and 0.8 µm PA liposomes with a KD of 97.7±10.9 
µM (blue triangles) (Figure 3.1B). In both cases, mSec18 bound with a lower affinity relative to 
C8-PA, supporting the notion that membranous PA is limited in its interactions with Sec18. As a 
control for PA specificity we tested sonicated liposomes containing only PC and PE (purple 
squares), and found that Sec18 did not appreciably bind, which is in keeping with our previous 
study. Importantly, we found that hSec18 did not bind 0.8 µm PA liposomes (orange diamonds) 
or 0.1 µM PA liposomes (not shown). This data is indicative of two major conclusions. First, it is 
apparent that membrane curvature affects Sec18 binding to PA, similar to other PA binders (Putta 
et al., 2016). Second, and more importantly, is that the hexameric Sec18 lacks the ability to bind 
PA, potentially by masking a binding site or by restricting conformational changes needed to bind 
PA.  
 
Membrane curvature affects Sec18 binding to PA  
To further test the role of membrane curvature we generated PA liposomes using extrusion with 
diameters of 0.1, 0.4 and 0.8 µm. These were used in parallel to sonicated liposomes with an 
average diameter of 30-50 nm (Lapinski et al., 2007). MST experiments showed that the affinity 
for PA was reduced as the diameter of membranes increased. Sonicated PA liposomes bound 
mSec18 with a KD of 9.3±1.32 µM, while the KD values of 0.1 µm, 0.4 µm and 0.8 µm liposomes 
were 45.1±11.8 µM, 56.8±15.6 µM, and 97.7±10.9 µM, respectively (Figure 3.1C). Although not 
a linear effect, it is clear that membrane curvature alters the ability of Sec18 to bind PA. This also 
suggests that the effect of PA on Sec18 mediated SNARE priming could vary depending on the 
local curvature of an organelle.  
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ATP can reduce PA binding by Sec18 
Sec18/NSF like many other AAA+ proteins contains two nucleotide binding domains (NBD) each 
residing in a one of the domains that make up the rings of the hexameric protein. The D1 ring of 
Sec18 hydrolyses ATP to generate the mechanical force needed to disrupt cis-SNARE bundles 
whereas the D2 ring binds ATP to stabilize the hexameric form of the protein. This is reflected in 
the different affinities for ATP found between the two NBDs. In NSF the D1 NBD binds ATP 
with a KD of 15-20 µM, while the D2 NBD binds with a KD of 30-40 nM (Matveeva et al., 1997). 
Here we asked ATP binding, which is linked to large conformational changes during SNARE 
priming, would affect PA binding. First we determined the affinity of mSec18 for ATP using MST 
and found that mSec18 had a KD of 56±16 µM, which likely reflects the low-affinity binding site 
in D1 (Figure 3.1D). We were unable to detect the high affinity binding to be expected of the D2 
NBD. We then tested if ATP binding altered PA binding. mSec18 was pre-incubated with 0.8 µm 
PA liposomes, then introduced to 100 nM ATP, 100 µM ATP, or buffer alone (no ATP). This 
showed that in the presence of 100 nM ATP, a saturating concentration for the D2 NBD (not 
shown), there was no effect on PA binding as the curve overlapped with the no ATP control (Figure 
3.1E, blue circles vs red squares, respectively). Both conditions bound to PA with a KD of 
approximately 100 µM. In contrast, saturating both NBDs with 100 µM ATP completely blocked 
binding to PA liposomes (green diamonds). As a negative control we incubated hSec18 with PA 
liposomes in the absence of ATP, which showed no binding at concentrations of PA liposomes 





Sec18 binds PA with similar affinity to DEP PA binding domain  
In our previous study we competed Sec18 binding to PA liposomes with GST-DEP, a well 
characterized PA binding domain from the murine protein Dvl2 (Capelluto et al., 2014). Here we 
compared the binding affinity of DEP to mSec18. Because we previously used GST-DEP, we 
measured its binding in comparison to GST-Sec18. We also wanted to verify our MST data with 
surface plasmon resonance (SPR) and PA nanodiscs (PA-ND), which were linked to Ni-NTA SPR 
chips through the 6xHis tags of the ND scaffold proteins. These experiments showed that GST-
Sec18 bound to PA-ND with a KD of 2.7±2 µM (Figure 3.2A), whereas GST-DEP had a KD of 
18±2 µM (Figure 3.2B), indicating that Sec18 binds PA with a higher affinity relative to the bona 
fide PA-binding domain DEP. This was also seen using MST, where GST-Sec18 bound to PA-ND 
with a KD of 0.6±.096 µM whereas GST-DEP had a higher KD of 2.4±0.42 µM, and N Domain 
had a Kd of 8.5±14.4 µM. The increased affinity for PA nanodiscs is possibly due to the fact that 
nanodiscs as opposed to liposomes are quantified by actual number of nanodiscs and not total lipid 
concentration as in C8-PA and liposome measurements respectively. Alternatively, increased 
affinity of PA binding in comparison to the values in Figure 3.1 are attributed to the effect of GST 
dimerization or GST stabilization of conformation, which could contribute to an increase in avidity 
relative to His-tagged mSec18, similar what was seen with the protease inhibitor cystatin (Tudyka 
and Skerra, 1997).  
 
Due to the PA inhibition of Sec18 binding to cis-SNARE complexes, we asked if the Sec18 N-
terminal domain could bind to PA by itself. This notion is supported by the crystal structure of the 
NSF N-terminal domain showing the presence of a positive polybasic surface adjacent-to and 
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lining the a-SNAP binding groove (Yu et al., 1999). SPR measurements of GST-N-domain from 
Sec18 binding to PA-ND showed a KD of 31.8±3.7 µM (Figure 3.2C). Interestingly, the N-domain 
bound ND containing only PC and PE with a KD of 11±1.6 µM (Figure 3.2D), suggesting that the 
N-domain has no lipid-binding specificity. Because full length Sec18 binds to PA and not PC, we 
conclude that the N-domain does not contribute to the regulatory association with PA. This is 
further supported by our MST data showing that mSec18 binds to PA-ND with an affinity that is 
nearly two orders of magnitude higher relative to the N-domain alone (Figure 3.2E, blue circles vs 
red triangles).  
 
Phosphatidic acid alters the conformation of Sec18 
Our data thus far suggests that Sec18 undergoes conformational changes that allow mSec18 to 
bind PA while hSec18 lacks the ability to bind the lipid. To further probe for conformational 
changes to Sec18 we tested whether PA significantly alters binding of 8-Anilino-1-
naphthalenesulfonic acid (ANS) to Sec18. ANS is a dye that has been extensively used to test 
lipid-binding proteins because it associates with solution exposed hydrophobic motifs (Heyduk 
and Lee, 1989; Roberts et al., 1999). Binding of ANS to a protein results in an increase in 
fluorescence yield and a blue-shifted emission. Because we have previously seen PA binding to 
mSec18 we expected ANS to also bind the protein in our assay. As expected, we observed ANS 
binding to mSec18 in a dose-dependent fashion (Figure 3.3A-B). We next wanted to test for any 
conformational changes upon PA binding that altered ANS binding to Sec18. To do this, we 
titrated increasing amounts of C8-PA into our assay and measured changes in the ANS 
fluorescence spectra. Because C8-PA is partially hydrophobic, ANS was first incubated with each 
lipid concentration to obtain a background spectrum before protein was then added to the assay, 
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and fluorescence was again measured. The difference spectra from these measurements shows that 
addition of C8-PA increases the binding of ANS to Sec18 (Figure 3.3C and F). To verify that the 
changes in ANS fluorescence were specific to PA binding, we tested the addition of DAG, the 
product of Pah1 activity on PA. No change in ANS fluorescence was detected in the presence of 
C8-DAG, which is consistent with inability of Sec18 to bind to DAG (Figure 3.3D and F). We 
also tested the anionic lipid phosphatidylserine (PS). Similar to what we observed with DAG, the 
addition of C8-PS had no effect on ANS fluorescence (Figure 3.3E and F). In toto these data 
suggest that C8-PA binding to Sec18 results in a conformational change in the protein that exposes 
additional hydrophobic pockets to solution. Such a change may account for the differences 
previously seen in Sec18 priming activity and cis-SNARE association (see Chapter 2). 
 
To further probe for conformational changes to Sec18 induced by PA we utilized a limited 
proteolysis assay. Proteins can exhibit differences in their proteolytic cleavage profiles when 
bound to a ligand that significantly changes their overall architecture (Heyduk and Lee, 1989). 
Because we observed an increase in solution exposed regions of Sec18 in the presence of PA, i.e. 
increased ANS fluorescence, we expected to also see an increased sensitivity to protease 
degradation in the same conditions. To measure this, mSec18 was incubated with increasing 
concentrations of trypsin with and without C8-PA addition. As expected, mSec18 sensitivity to 
trypsin degradation increased in the presence of C8-PA, whereas the presence of DAG had no 
effect (Figure 3.4A-B).  
 
Additionally, we performed the same limited proteolysis assay using thrombin in place of trypsin. 
Thrombin displays much higher specificity than trypsin and should only cleave proteins at specific 
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recognition sites. Incubation of Sec18 with thrombin alone showed no proteolytic degradation of 
the protein indicating that no recognition sites were accessible to the protease. However, upon 
addition of C8-PA thrombin was able to cleave Sec18 (Figure 3.4C-D). Once again, inclusion of 
C8-DAG did not show a similar effect indicating once again that the observed conformation 
change was PA specific. Finally, we titrated C8-PA into a thrombin cleavage assay keeping the 
concentration of the protease constant. Cleavage of Sec18 by thrombin showed dose dependence 
for C8-PA (Figure 3.4E-F). These data illustrate that C8-PA binding to Sec18 alters the 
conformation of the protein allowing for the exposure of an otherwise shielded thrombin 
recognition site. Sec18 has one predicted thrombin recognition site (after R638) which is located 
in the D2 domain of the protein [exPASy]. The D2 domain is responsible for the multimerization 
of Sec18 to its active hexamer when it is in a nucleotide bound state (Lenzen et al., 1998; Yu et 
al., 1999). This further suggests that PA alters the conformation of the Sec18 D2 domain, or 
potentially the conformation of D2 with respect to D1 allowing binding to PA. Changes to the D2 
domain structure could alter nucleotide binding or disrupt key interactions between protomers 
thereby decreasing Sec18 hexamer formation. Sec18 is known to associate with cis-SNAREs in 
its active hexameric form, so inhibition of hexamer formation could decrease its ability to properly 
recruit to inactive SNARE complexes. This idea is consistent with previous observations that 
showed increased PA at the vacuole led to decreased recruitment of Sec18 to cis-SNARE 
complexes (see Chapter 2).  
 
Phosphatidic acid has no significant effect on the secondary structure of Sec18   
Because we observed significant changes in the conformation of Sec18 upon binding to C8-PA we 
next wanted to monitor changes in the secondary structure of the protein when bound to the lipid. 
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To do this we observed the α-helix and β-sheet content of Sec18 in the presence of PA using 
circular dichroism (CD). CD spectra of mSec18 were obtained in the absence and presence of C8-
PA to determine if the protein’s secondary structure was significantly affected by binding the lipid. 
The spectrum obtained for mSec18 alone showed that the protein was well folded (Figure 3.5A). 
Upon addition of C8-PA, no significant changes were seen in the spectrum suggesting the lipid 
binding does not alter secondary structure features within the protein.  
 
To rule out any denaturation caused by binding of C8-PA to Sec18, intrinsic tryptophan 
fluorescence was measured with and without lipid addition. Sec18 contains three tryptophan 
residues (W88, W91, and W632) in its N and D2 domains. Upon denaturation of Sec18 with SDS, 
Trp fluorescence was red-shifted and showed decreased intensity (Figure 3.5B). Upon incubation 
with C8-PA, no shift or intensity change was observed. This suggests that PA binding to Sec18 
did not lead to denaturation, i.e. causing a conformational change large enough to alter the local 
environment of any of the Trp residues found in the protein.  
 
Finally, to test whether binding PA altered the thermal stability of Sec18, we used differential 
scanning fluorimetry (DSF) (Miner et al., 2016). Sec18 was labeled with SYPRO orange dye, 
incubated with different concentrations of C8-PA in separate wells, and equilibrated prior to 
starting a melting curve. Fluorescence was scanned across a temperature gradient of 20 to 95°C 
and the first derivative of the fluorescence data was be used to determine the Tm for each condition. 
DSF has the ability to show multiple melting transitions (Hew et al., 2015; Vollrath et al., 2014). 
Our data show that mSec18 has three melting transitions. The first mSec18 transition (TM1) 
occurred at ~45°C, while TM2 and TM3 were at 60°C and 64°C, respectively (Figure 3.5C). The 
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addition of C8-PA had no effect on TM2 and TM3, as the curves overlapped with the that of apo-
Sec18. That said, C8-PA has a striking effect at TM1 where we observed a dose-dependent increase 
in fluorescence. This likely mirrors the conformational changes seen with limited proteolysis and 
ANS fluorescence. Taken together these observations lead us to conclude that PA binding to Sec18 
induces a significant change to the architecture of the protein but does not denature the protein 
nonspecifically. 
 
NSF D1-D2 undergoes large conformational change during transition between hexameric 
and monomeric forms 
To examine the Sec18 conformational changes we observed previously at a more detailed level, 
atomic molecular dynamics (MD) simulations were performed using NSF, the mammalian 
homolog of Sec18. The NSF D1-D2 monomer extracted from the cryo-EM structure of an ATP-
bound NSF complex (pdb 3J94) after removing bound ATPs was equilibrated with restraints for 
20 ns and then relaxed for 200 ns. Based on the overall alpha carbon (Cα) RMSD, the monomer 
undergoes conformational changes up to 15 Å apart from the form originally adopted in the 
hexamer (Figure 3.6A). Calculation on the secondary structure components showed that only the 
modeled loop region from residue 458 to 478 transitioned from helix during the relaxation to turn 
and coil (data not shown). This is expected as the loop was poorly resolved in cryo-EM and was 
only stabilized by interactions with the N-domain in the template crystal structure (the N-D1 
domain of p97) used in homology modeling. The stable secondary structure observed in D1 and 
D2 domains indicated that the large deviation did not come from secondary structural changes, 
further verifying CD experiments. Instead, we observed that the conformational change was 
accompanied by an opening-up process of D1 and D2 domains during the relaxation (Figure 3.6A). 
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The observation was in agreement with the hypothesis that NSF hexamerization might require 
certain conformations of D1-D2 monomer and that the conformation required could be further 
stabilized at the hexamer interface.  
 
 
Residues of NSF shown to bind to C8PA are not available for PA binding when it is in the 
hexameric form  
Computational flooding studies were performed for both monomeric and hexameric form of the 
NSF D1-D2 domains, based on the structural information of mammalian NSF (Figure 3.6B). 
Analysis of binding was performed using percent bound as determined by proximity (H-bond 
distance between phosphate oxygens of PA and between a basic amino acid residue) of PA against 
time PA ligands were in set proximity. Residues determined to have highest percent bound were 
determined for both monomeric and hexameric forms of D1-D2. Our flooding simulations of NSF 
hexamer showed that residues having the highest percent bound PA in the monomer (Figure 3.6C) 
were shielded to block lipid binding in the hexameric NSF D1-D2 construct (Figure 3.6D).  This 
suggests that PA binding specificity lies somewhere within the hexameric interface.  
  
Binding Prediction and Clustering Analysis of PA Binding Regions of NSF 
Ensemble molecular docking of C8-PA to NSF monomer was performed using the aforementioned 
D1-D2 equilibrium simulation (Trott and Olson, 2010). Snapshots from the equilibrium trajectory 
were utilized for molecular docking every 100 ps to fully sample conformational dynamics. The 
resulting docked C8-PA poses were clustered and an average affinity (DG) was determined for 
binding clusters of monomeric NSF showing similar affinity for C8-PA (~-5 kcal) approximating 
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the MST binding measurements of mSec18 to C8-PA, which is within a ± 2 kcal error prediction 
ratio used for many docking software programs such as Schrodinger Glide (Figure 3.7A) 
(Beauchamp et al., 2011; Friesner et al., 2006).  To verify cluster analysis, SiteMap was used and 
the top 5 site scores taken (Figure 3.7B).  Figure 7B depicts SiteMap site 1 corresponding to the 
largest cluster obtained from the ensemble docking (Figure 3.7A), which lies in the hexamerization 
interface illustrated in Figures 3.7C-D demonstrating the potential importance of this region for 




Membrane fusion is a necessary process for all eukaryotes, and Sec18/NSF is the only known 
protein responsible for utilizing energy from ATP to prime SNAREs (Mayer et al., 1996; Zhao et 
al., 2015; Ryu et al., 2015). To achieve compartmental specificity, unique SNARE combinations 
are utilized by defined organelles as well as smaller transport vesicles budding from such 
organelles (Jahn and Scheller, 2006). Each organelle varies in both size and function, and must 
contain its own unique combination of protein and lipid factors to allow for specificity in 
trafficking and membrane fusion events. Regulation of Sec18/NSF is of special significance due 
its direct role in maintenance of fusion and compartmentalization throughout the eukaryotic cell. 
Therefore, it is important to understand the role that regulatory factors have on ubiquitous fusion 
machinery such as Sec18/NSF to adequately model how specificity and efficiency are balanced 
and maintained at different locations in the cell. 
  
Protein function can be regulated directly through posttranslational modifications or through their 
interactions with other molecules, including lipids. The vacuole fusion pathway is regulated at 
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various stages by distinct lipids such as phosphoinositides, ergosterol, DAG and PA 
(Boeddinghaus et al., 2002; Fratti et al., 2004; Jun et al., 2004; Kato and Wickner, 2001; 
Karunakaran et al., 2012; Karunakaran and Fratti, 2013; Mayer et al., 2000; Miner et al., 2016; 
Sasser et al., 2012; Stroupe et al., 2006; see Chapter 2; see Chapter 4). The priming stage requires 
the presence of ergosterol, PI(4,5)P2, as well as the conversion of PA to DAG (Kato and Wickner, 
2001; Mayer et al., 2000; Sasser et al., 2012; see Chapter 2). 
 
Previously we found that vacuolar PA sequestered Sec18 from cis-SNAREs and that the PA 
phosphatase Pah1/Lipin1 was required to convert PA to DAG to allow Sec18 dissociation from 
the membrane and recruitment to SNARE complexes (see Chapter 2). Although PA turnover is 
needed for priming, the presence of the lipid is also required downstream for mechanisms that 
remain to be characterized. Deletion of PAH1 or the DAG kinase DGK1 alters the balance of PA 
and DAG on vacuole to dramatically affect membrane fusion (Sasser et al., 2012; see Chapter 4). 
We thus postulate that enzymatic changes that alter PA levels can in turn shift the equilibrium of 
Sec18 from a lipid-bound to a to a SNARE-associated state. Such changes would likely have 
significant effects on SNARE activation and the overall progression of the membrane fusion 
cascade. 
 
In this study, we demonstrated that Sec18 directly binds PA with high affinity on par with a known 
PA-binding domain. Moreover, only monomeric Sec18 could bind both PA membranes and 
soluble C8-PA, whereas hexameric was only able to bind C8-PA. This signifies that C8-PA could 
access PA-binding residues that are blocked in the hexamer to prevent membrane association. 
Sec18/NSF exists as both a monomer (non-enzymatic) and a hexamer (enzymatic). Our findings 
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indicate that Sec18 exists in both a monomeric lipid-bound pool and SNARE-bound hexamers. 
Because ATP is required for Sec18 hexamerization, we tested PA liposome binding at two 
concentrations of ATP. The D1 domain of NSF has KD of ~20 µM for ATP, while the D2 
hexamerization domain has a KD of ~40 nM. PA binding was unaffected 100 nM ATP that should 
predominantly bind D2; however, at 100 µM ATP mSec18 binding to PA was abolished. This 
suggests that the nucleotide bound state of the D1 domain is important in specific PA binding of 
Sec18/NSF, likely due to conformational changes in the ATP bound state. Alternatively, the higher 
ATP concentration may shift the monomeric pool of Sec18 used to a predominantly hexameric 
pool decreasing its affinity for PA.  
 
During priming, Sec17/ α-Snap is recognized by Sec18/NSF in an ATP bound state at D1 before 
subsequent ATPase activity occurs. We posit that Sec18 exists in both lipid-bound and SNARE-
bound states and that the presence of ATP at the D1 NBD may determine the state in which the 
protein primarily exists. Membrane PA may prevent the association of ATP with the D1 NBD 
locking the protein in an inactive lipid-bound state preventing recruitment to inactive SNARE 
complexes. This is in line with our data in this study and with observations from previous work 
(see Chapter 2). 
 
The fact that Sec18 monomer binding to PA liposomes was inhibited at a saturating ATP 
concentration for the D1 NBD could indicate that the PA binding site for Sec18 lies near the D1 
ATP binding site. Alternatively, it is possible the conformation of Sec18 in its ATP bound state 
shields the protein’s unique PA binding site. The idea that Sec18 binding to PA may not 
specifically depend on the D1 ATP binding site was supported by computational flooding 
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experiments performed on both hexamer and monomer in the presence and absence of ATP. 
Flooding experiments allowed for C8-PA to equilibrate with NSF monomer, and binding was 
measured using the length of time a PA molecule resided near a given residue of NSF. Many of 
the long term amino acid residues sharing the longest contact time to PA were predictably basic 
residues, especially lysine and arginine. However, dramatic differences in these residues were not 
noticed between the ATP and non-ATP simulations. Furthermore, many of the residues with longer 
PA binding time were not of importance for PA binding in the hexamer simulation. This result is 
in corroboration with the high binding affinity of Sec18 monomers to PA liposomes vs the 
hexameric form. This further indicates that the Sec18 monomer and hexamer are differentially 
regulated. Furthermore, it suggests that PA may influence the formation of the active hexamer by 
controlling the availability of its inactive monomer at membranes. 
 
We propose that Sec18/NSF PA regulation is achieved by sequestration of Sec18/NSF monomer 
on PA containing membranes blocking its ability to form active hexamer. This sequestration 
regulates the ability of Sec18 to perform its enzymatic function of activating SNAREs. 
Additionally, it is possible that PA at the site of priming could increase localization of Sec18/NSF 
to the membrane in preparation of SNARE priming. Additional factors, such as the PA 
phosphatase Pah1/Lipin, could serve to activate Sec18/NSF once the fusion cascade was required 
to proceed (Sasser et al., 2012; see Chapter 2). In this way, PA could serve as a temporal regulator 
of SNARE priming activity and of the membrane fusion process as a whole. 
 
Two additional modes of regulation are suggested by our data. First, PA membrane concentrations 
may play either a local or organelle-dependent role for the regulation of Sec18/NSF by lipid 
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binding. Depending on the concentration and localization of PA at a given membrane Sec18 
sequestration by PA could either play a larger or less prominent role in regulating the priming of 
SNAREs. Second, we have found that curvature plays a role in Sec18 regulation by PA. Therefore, 
Sec18 regulation by PA could be differentially managed in the cell based on vesicle or organelle 
size. 
 
This work has shown that Sec18/NSF binds to membranes containing PA with high affinity 
and that this lipid binding is greater to the monomeric version of the protein. Upon binding PA, 
Sec18/NSF undergoes a significant conformational change that coincides with a reduction in the 
protein’s SNARE priming activity. Molecular dynamics simulations show that monomeric 
Sec18/NSF has greater conformational flexibility than hexamer. Equilibrium simulations indicate 
a large scale conformational change when NSF hexamer is converted to monomer (Figure 3.6B). 
We propose that binding to PA by Sec18/NSF may serve a regulatory role in preventing the 
formation of the active hexamer thereby throttling the priming of SNAREs. There are two main 
reasons we think this form of regulation is needed: 1) To keep NSF from freely priming any cis-
SNARE complex around, and 2) To keep NSF nearby without allowing priming (Yavuz et al., 
2018). 
 
We have identified regions of NSF that are potential high PA binders (Figure 3.7A-B).  
Additionally, we have identified residues of NSF that show potential PA binding in monomeric 
form that are not capable of binding PA in hexameric form (Figure 3.6B). In order for Sec18 to 
form hexamer, according to our model, Sec18 would have to be removed from the membrane, and 
we have previously shown that the only PA phosphatase that plays a role in membrane fusion is 
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Pah1 (Sasser et al., 2012). It is possible that an additional chaperone may be involved in alleviating 
the transition of Sec18 monomer towards hexamerization.  
 
Based on our computational studies, it appears that there are numerous candidate residues 
that might contribute to Sec18 PA binding. HMMM simulations have been performed (data not 
shown); however, due to the size and flexibility of Sec18 monomer, long time scales in the micro 
second range may be required to show final binding events sequestering Sec18 to a PA containing 
membrane. We plan to further probe this binding event using HMMM at a longer time scale to 
capture the exact binding event of Sec18 to a PA membrane, and to specifically identify the 





Figure 3.1. Sec18 Hexamer and monomer binding affinity for PA. (A) C8-PA MST 
measurements were performed using purified Sec18 monomer and hexamer labeled with Ni-NTA 
Atto-488 dye in the blue channel at 90% LED and High MST using NT.115 Labeled 
Thermophoresis. Binding affinity was measured using thermophoresis at 15 sec mixing separate 
reactions of half 100 nM Atto 488 labeled Sec18 monomer and half 1:1 titrations of C8-PA with 
highest concentration 370 µM according to Graphpad Sigmoidal 4PL curve. (B) The KD of ATP 
for Sec18 monomer was measured using labeled Sec18 monomer with Ni-NTA Atto 488 dye as 
in Figure 3.1A with 1:1 titrations of ATP Solution in PBS. (C) The KD of Sec18 monomer and 
hexamer to sonicated and 800 nm diameter PA liposomes (10% PA, 70% PC, and 20% PE) and  
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Figure 3.1 (cont.) 
PC liposomes (80% PC, 20% PE) was measured using MST as in Figure 3.1A. Concentrations of 
lipid of 1.3 mM maximum were titrated as in Figure 3.1A for both PA and PC liposomes and 
affinities for both Sec18 hexamer binding to PA liposomes as well as monomer binding to PC 
liposomes was not measurable as they did not saturate. (D) ATP competition with mSec18 binding 
to 800 nm PA liposomes was measured as in Figure 3.1A was measured using MST ATP 
concentrations of 100 nM (D2 saturating) and 100 µM (D1 saturating) and compared to the KD of 
monomer and hexamer in the absence of ATP. (E) Sec18 monomer affinity for different size of 
PA liposomes was measured using MST as in Figure 3.1A for sonicated, 100 nm, 400 nm and 800 
nm. Curve fitting was performed using Graphad sigmoidal 4PL curve All measurements taken at 





Figure 3.2. Sec18 Binding Affinity Compared to DEP PA Binding Domain for PA Nanodiscs. 
(A) SPR analysis of Sec18 monomer was performed with approximately 2000 RU of 5% PA 
nanodiscs attached to a Ni-NTA chip using a Biacore 300 Ni-NTA with flowrate 20 µL/s. The 
steady state fit was exported from BIAevaluate software to GraphPad at 4 seconds before injection 
stop set at 90 s with disassociation of 120s. (B) SPR Analysis of DEP with 5% PA nanodiscs. (C) 
SPR analysis of N domain for Sec18 monomer with 5% PA nanodiscs. (D) SPR analysis of PC 
nanodiscs for Sec18 monomer. (E) MST performed with mSec18, DEP, and N-domain with 100 
nM Ni-NTA Atto 488 labeled 5% PA nanodiscs using 90% LED and 60% MST. M.O. Affinity 
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Figure 3.3. Short chain phosphatidic acid alters the binding of 1,8 ANS to Sec18. Increasing 
concentrations of Sec18His8 were incubated with ANS (5 µM) in assay buffer and a representative 
fluorescence spectrum (ex. 390, em. 400-600 nm) is shown (A). Relative fluorescence at 460 nm 
(B). Sec18His8 (0.5 µM) was incubated with increasing concentrations of short-chain lipids in the 
presence of ANS (5 µM) and fluorescence spectra were taken (ex. 390, em. 400-600 nm). A 
representative spectrum for each lipid tested is shown: C8-PA (C), C8-DAG (D), and C8-PS (E). 
(F) Maximum fluorescence for each lipid concentration was normalized against overall maximum 
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Figure 3.4. Short chain phosphatidic acid alters the proteolytic cleavage profile of Sec18. 
Sec18His8 was incubated with C8-PA (red), C8-DAG (green), or alone (black) before incubation 
with increasing concentrations of trypsin (A) or thrombin (C). Densitometry values of the 
uncleaved band were measured for each concentration and normalized against the input lane for 
trypsin (B) and thrombin (D). Sec18His8 was incubated with increasing concentrations of C8-PA 































































































Figure 3.5. Sec18 does not have significantly altered secondary structure in the presence of 
short chain phosphatidic acid. (A) Circular dichroism spectra were measured (260 to 200 nm, 
50 nm min-1) for Sec18His8 in the presence and absence of C8-PA (100 µM). (B) Sec18His8 (500 
nM) was incubated with increasing concentrations of C8-PA and fluorescence spectra were 
measured (ex. 295, em. 300-400 nm). The fluorescence (em. 333 nm) for each concentration tested 
was normalized against the no lipid control and is shown. (C) Differential scanning fluorimetry 
first derivative melting curves were measured (SYPRO orange: ex. 490, em. 560 nm) for 
increasing concentrations of C8-PA. 
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Figure 3.6. Computational Simulations Show Large Scale Conformational Change Between 
D1 and D2 Subunits of NSF and Indicate Potential PA binding Regions of NSF.  (A) D1-D2 
monomer undergoes large conformational change during relaxation. In the first 20 ns, D1-D2 
monomer was equilibrated with a 0.05 kcal/mol/Å^2 harmonic restraint on protein Cα atoms.  
Blue: D1-D2 monomer Cα RMSD; green: center of mass distance between D1 and D2 domains.  
(B) Protomer chain A from hexamer cryo-EM structure (PDB: 3J94) was simulated in short-
tailed PA solution (119mM, 61 PA molecules in a 95Å x 94Å x120Å water box) for 350 ns with 
ATP binding and 200 ns without ATP.  Binding percentages were measured according to amount 
of time a PA molecule was within a hydrogen bonding distance from a given amino acid residue 
of NSF according to heatmap on right side of Figure 3.6C with residues of NSF indicated on the 
X axis and model flooded on Y axis.  Both monomer (C) and hexamer (D) are shown with key 
residues from Figure 3.6B indicated on Figure 3.6C monomer and Figure 3.6D hexamer 
























































































Figure 3.7. Ensemble Molecular Docking and Binding Site Prediction of NSF D1-D2 
Monomer. (A) Small red spheres indicate positions on NSF monomer where short chained PA 
was docked.  The circles 1, 2, 3 indicate clusters identified from the top short-chain PA ensemble 
docking results.  (B) SiteMap predicted a high affinity binding region of NSF indicated by circle 
1, which corresponds to the top ensemble docking cluster from Figure 3.7A where yellow 
indicates potential hydrophobic binding regions, blue indicates potential acidic binding regions, 
and red indicates potential basic binding regions on NSF. (C) A top down D1-D2 depiction of 
NSF D1-D2 hexamer is shown indicating clusters as described in Figure 3.7A are shown relative 
to the hexamer.  (D) A side-view D1-D2 depiction of NSF D1-D2 hexamer is shown indicating 
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CHAPTER 4:  DELETING THE DAG KINASE Dgk1 AUGMENTS YEAST VACUOLE 





Diacylglycerol (DAG) is a fusogenic lipid that can be produced through phospholipase C activity 
on phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2], or through phosphatidic acid (PA) 
phosphatase activity. The fusion of Saccharomyces cerevisiae vacuoles requires DAG, PA and 
PI(4,5)P2, and the production of these lipids is thought to provide temporally specific 
stoichiometries that are critical for each stage of fusion. Furthermore, DAG and PA can be 
interconverted by the DAG kinase Dgk1 and the PA phosphatase Pah1. Previously we found that 
pah1D vacuoles were fragmented, blocked in SNARE priming and showed arrested endosomal 
maturation. In other pathways the effects of deleting PAH1 can be compensated for by 
additionally deleting DGK1, however deleting both genes did not rescue the pah1D vacuolar 
defects. Deleting DGK1 alone caused a marked increase in vacuole fusion that was attributed to 
elevated DAG levels. This was accompanied by a gain in resistance to the inhibitory effects of 
PA as well as inhibitors of Ypt7 activity. Together these data show that Dgk1 function can act as 
																																																						
2 This chapter appeared in its entirety in the journal Traffic.  
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augments yeast vacuole fusion through increased Ypt7 activity and altered membrane fluidity. 
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a negative regulator of vacuole fusion through the production of PA at the cost of depleting DAG 




The movement of vesicles in eukaryotic cells is tightly regulated to prevent the missorting of cargo. 
Each route of membrane trafficking in the endocytic and secretory pathways is regulated by 
homologous sets of proteins that are conserved throughout eukarya. The final stage of cargo 
delivery occurs through the merger of two distinct membranes in a fusion reaction catalyzed by 
SNARE proteins (Jahn and Scheller, 2006). The fusion reaction pathway can be divided into stages 
that start with the disassembly of inactive cis-SNARE bundles. This process, known as priming, 
is executed by the SNARE chaperone NSF/Sec18 and its adaptor protein a-SNAP/Sec17 (Mayer 
et al., 1996). Membranes are subsequently brought into contact by the activity of Rab GTPases 
and their cognate tethering effectors (Stenmark, 2009). In Saccharomyces cerevisiae, vacuolar 
lysosomes undergo fusion with vesicles from the endocytic pathway, AP-3 coated membranes 
from the Golgi, autophagosomes, as well as with other vacuoles (Piper et al., 1997; Ishihara et al., 
2001; Cabrera et al., 2010; Wickner, 2010). Homotypic vacuole fusion requires the Rab Ypt7 and 
its effector complex HOPS for tethering (Mayer and Wickner, 1997; Seals et al., 2000). During 
docking, trans-SNARE complexes form between partner membranes leading to the release of 
luminal Ca2+ stores prior to fusion (Merz and Wickner, 2004a). Docked vacuoles become tightly 
apposed forming a flattened region where they are in contact that is referred to as the boundary 
domain. The proteins and lipids that drive fusion become enriched at the edge of the boundary 
termed the vertex ring microdomain (Fratti et al., 2004; Wang et al., 2002, 2003b). Fusion occurs 
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around the vertex ring leading to the internalization of the boundary membrane and degradation of 
boundary-localized factors. DAG becomes enriched at the both the vertex and the boundary 
membrane leading to the potential degradation of this lipid after fusion occurs.  
 
The regulation of membrane trafficking and fusion also involves a group of signaling lipids that 
play multiple roles in controlling these pathways. Yeast vacuole fusion requires diacylglycerol 
(DAG), phosphatidic acid (PA), as well as multiple phosphoinositides (PI) and ergosterol (Fratti 
et al., 2004; Boeddinghaus et al., 2002; Jun et al., 2004; Karunakaran and Fratti, 2013; Kato and 
Wickner, 2001; Lawrence et al., 2014; Sasser et al., 2012a; Stroupe et al., 2006). During the 
docking stage of fusion, these lipids accumulate into membrane microdomains that organize the 
SNAREs, Ypt7, HOPS and actin at the site of fusion (Fratti et al., 2004; Karunakaran and Fratti, 
2013). The stoichiometry of these lipids is not static and requires the function of multiple lipid 
kinases, phosphatases and lipases at different time points to modify lipids to activate (or inactivate) 
their roles at each fusion stage. For instance, the PI 3-kinase Vps34 produces PI3P allowing the 
binding of Mon1, HOPS, and the soluble SNARE Vam7 leading to membrane tethering and 
docking (Lawrence et al., 2014; Stroupe et al., 2006; Cabrera et al., 2014; Cheever et al., 2001; 
Miner et al., 2016). Similarly, the PA phosphatase Pah1 converts PA to DAG leading to the transfer 
of PA-bound Sec18 to cis-SNARE complexes for priming (Sasser et al., 2012; see Chapter 2).  
 
Pah1 is the yeast Lipin1 orthologue and its activity is required for endoplasmic reticulum and 
nuclear envelope homeostasis as well as lipid drop formation (Adeyo et al., 2011; Han et al., 2007). 
In addition, we have found that Pah1 activity is required for endosomal maturation. Deletion of 
Pah1 leads to the exclusion of Vps34, Mon1, Ypt7 and Vps39 from vacuolar membranes causing 
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vacuole fragmentation and abolished fusion (Lawrence et al., 2014; Sasser et al., 2012a). Others 
have shown that the activity of Pah1 can be countered by the DAG kinase of Dgk1 to replenish 
PA (Han et al., 2008a; b). The morphological defect of the endoplasmic reticulum and nuclear 
envelope seen in pah1D cells is reversed by the concomitant deletion of DGK1, illustrating the 
effects of interconverting PA and DAG on organelle homeostasis. DAG produced by Pah1 is used 
for the synthesis of triacylglycerol and the formation of lipid droplets as well as feeding into the 
Kennedy pathway for the production of phosphatidylethanolamine and phosphatidylcholine 
(Adeyo et al., 2011; Karanasios et al., 2010; Choi et al., 2011). DAG is a fusogenic lipid due to 
the induction of negative curvature and destabilization of lipid bilayers (Das and Rand, 1984; 
Seddon, 1990). The fusogenicity of DAG is further demonstrated by its ability to promote the 
fusion of protein-free liposomes (Sánchez-Migallón et al., 1995; Villar et al., 2000). These features 
are linked to its requirement for efficient vacuole fusion.  
 
In this study we examined the role of Dgk1 in vacuole fusion. We first determined that deleting 
DGK1 in pah1D background strains did not restore the blocked endosomal maturation, 
fusogenicity, or the vacuole fragmentation phenotype caused by deleting PAH1 alone. This 
indicates that Pah1 and Dgk1 functions are not concurrent in vacuole homeostasis unlike their 
offsetting activities in other pathways. Importantly, the single dgk1D mutation led to an augmented 
fusion phenotype. We focused on finding the mechanism for the increased fusion of dgk1D 
vacuoles. These vacuoles contained elevated levels of the fusogenic lipid DAG and displayed an 
enhanced fusion phenotype. This was further characterized with increased resistance to the 
inhibitory effects of PA and elevated Ypt7-mediated vesicle tethering. 
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MATERIAL AND METHODS 
 
Reagents  
Reagents were dissolved in PS buffer (20 mM PIPES-KOH, pH 6.8, 200 mM sorbitol). 
Recombinant GST-FYVE, His6-MTM-1, GST-C1b, His6-SigD, GST-ENTH, MBP-FAPP1-PH, 
His6-DgkB, GST-Vam7 and GST-Vam7Q283R, Gdi1, His6-Gyp1-46, His6-Yck3, and Pbi2 were 
prepared as described and stored in PS buffer with 125 mM KCl (Gillooly, 2000; Taylor et al., 
2000; Johnson et al., 2000; Marcus et al., 2001; Rosenthal et al., 1999; DOWLER et al., 2000; 
Miller et al., 2008; Fratti et al., 2007; Starai et al., 2007; Wang et al., 2003a; Hickey et al., 2009; 
Slusarewicz et al., 1997). The plasmid for expressing His6-DgkB was a gift from Dr. C. Rock (St. 
Jude Children’s Research Hospital, Memphis, TN). Antibodies against Sec17, Sec18, Vam3, 
Nyv1, Vps33, Ypt7 were prepared as described (Mayer et al., 1996; Haas and Wickner, 1996; 
Nichols et al., 1997; Ungermann et al., 1998; Seals et al., 2000; Mayer and Wickner, 1997). diC8-
PA (1,2-dioctanoyl-sn-glycero-3-phosphate), diC8-DAG (1,2-diC8-sn-glycerol) and POG/DAG 
(palmitoyl-2-oleoyl-sn-glycerol) were purchased from Avanti Polar Lipids as chloroform stock 
solutions and stored at -20ºC. Filipin III was dissolved in DMSO at a stock concentration of 10 
mM. Propranolol (Sigma) was dissolved in PS buffer.  
 
Strains  
Vacuoles from BJ3505 and DKY6281 were used for fusion assays (Table 4.1) (Haas et al., 1995). 
Strains lacking PAH1 or YCK3 were described previously (Sasser et al., 2012a; Haas et al., 1994). 
DGK1 was deleted by homologous recombination using PCR products amplified using 5’-DGK1-
KO and 3’-DGK1-KO primers with homology flanking the DGK1 coding sequence (Table 4.2). 
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The PCR product was transformed into yeast by standard lithium acetate methods and plated on 
YPD media containing G418 (250 µg/µl) to generate BJ3505 dgk1D::kanMX6 (RFY60) and 
DKY6281 dgk1D::kanMX6 (RFY61). DGK1 was deleted from pah1D strains using PCR products 
amplified from pFA6A-hphMX4 and plated on YPD media containing hygromycin to generate 
RFY62 and RFY63. For complementation of dgk1D, RFY60 and RFY61 were transformed with 
pRS416 plasmids encoding DGK1 or DGK1D177A inserted between the EcoRI and NotI sites to 
generate RFY64-67. The DGK1 open reading frame was cloned using 5’-DGK1 and 3’-DGK1 
primers using genomic DNA as a template. Point mutations generated using 5’-DGK1D177A and 
3’-DGK1D177A primers. Transformants were selected on complete synthetic media lacking uracil. 
For cellular distribution analysis, DGK1 was fused in frame to GFP. DKY6281 was transformed 
with a PCR product amplified from pFA6a-GFP(S65T)-KanMX6 with homology flanking the stop 
codon of DGK1 with 5’-DGK-GFP and 3’DGK-GFP primers. Transformants were plated on YPD 
medium containing G418 to generate RFY68 (Wach et al., 1997). PAH1 was deleted from RFY68 
using PCR products amplified with 5’-PAH1-KO and 3’-PAH1-KO primers from pAG32 with 
homology flanking the PAH1 coding sequence to generate RFY71. For immunoblotting DGK1 
was fused in frame to HA3. BJ3505 was transformed with a PCR products amplified from pFA6a-
3HA-kanMX6 with homology flanking the stop codon to generate RFY69 (Longtine et al., 1998). 
Using the 5’-YCK3-KO and 3’-YCK3-KO primers YCK3 was deleted from dgk1D strains to 
generate RFY72-73. 
 
Vacuole isolation, cell fractionation, and in vitro vacuole fusion  
Vacuoles were isolated as described (Haas et al., 1995). In vitro fusion reactions (30 µl) contained 
3 µg each of vacuoles from BJ3505 and DKY6281 backgrounds, reaction buffer (20 mM PIPES-
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KOH pH 6.8, 200 mM sorbitol, 125 mM KCl, 5 mM MgCl2), ATP regenerating system (1 mM 
ATP, 0.1 mg/ml creatine kinase, 29 mM creatine phosphate), 10 µM CoA, and 283 nM Pbi2 
(Protease B inhibitor). Reactions were incubated at 27°C and Pho8 activity was assayed in 250 
mM Tris-Cl, pH 8.5, 0.4% Triton X-100, 10 mM MgCl2, 1 mM p-nitrophenylphosphate. Fusion 
units were measured by determining the p-nitrophenolate produced and absorbance was detected 
at 400 nm.  
 
For Dgk1 localization by immunoblotting, yeast cells were fractionated into a total lysate, a total 
endomembrane fraction (Membranes), cytosol, endoplasmic reticulum (microsomes), and 
vacuoles as previously described (Qiu and Fratti, 2010; Sorin et al., 1997). For the total membrane 
preparation, yeast cells were resuspended in bead buffer (10 mM Tris/HCl, pH 7.4, 0.3 M sorbitol, 
0.1 M NaCl, 5 mM MgCl2) containing 1 mM PMSF at a density of 200 A600 units/ml. Cells were 
disrupted with glass beads by vortexing in five 1-min pulses, with intermittent chilling on ice. 
Lysates were centrifuged in a table-top centrifuge at 100 g for 5 min to pellet large debris and the 
supernatants carefully withdrawn and transferred to ultracentrifuge tubes. The total membrane 
fraction was collected by centrifugation (100,000 g, 1 h, 4°C) and resuspended in PS buffer (20 
mM PIPES-KOH, pH 6.8, 200 mM sorbitol). The supernatant was saved as the cytosolic fraction. 
Endoplasmic reticulum derived microsomes were prepared as described (Grillitsch et al., 2011). 
Briefly, yeast cells were treated with lyticase to produce spheroplasts as performed for vacuole 
preparations. Spheroplasts were resuspended in buffer (5 mM MES, pH 5.0, 0.5 mM EDTA, 0.6 
M sorbitol, 1 mM PMSF) and centrifuged (20,000 g, 0.5 h, 4°C) using a JA-20 rotor. Supernatants 
were collected and microsomes were pelleted by centrifugation (SW-41 rotor, 60,000 g, 0.5 h, 
4°C). The pellet was resuspended in 100 µl of buffer.  
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Quantification of Vacuolar Diacylglycerol by Thin-Layer Chromatography 
Lipids were extracted from purified DKY6281 and dgk1∆ vacuoles (200 µg protein content) by 
the method of Bligh and Dyer then dried overnight under vacuum (Bligh and Dyer, 1959). Purified 
lipids were resuspended in chloroform:methanol (2:1) before being resolved by neutral lipid thin-
layer chromatography as previously described (Churchward et al., 2008). Briefly, Whatman 
Partisil® LK6D Silica Gel Plates (60 Å) were pre-washed with methanol/ethyl acetate (6:4) for 30 
minutes. Individual channels were loaded with the indicated amount of diacylglycerol standard 
(Avanti Lipids) or vacuolar lipids. Plates were run twice with CH2Cl2/ethyl acetate/acetone 
(80:16:4) to 40 and 55 mm then hexanes/ethyl acetate to 68 mm (90:10), 80 mm (95:5), and 90 
mm (100:0). Plates were then sprayed with a solution of 10% copper (II) sulfate in 8% phosphoric 
acid and dried for 10 minutes before charring at 145º C for 10 minutes. Imaging of plates was 
performed using a BioRad ChemiDoc™ MP Visualization System (605/50 filter, Green Epi 
illumination). Densitometry values were measured using Image Lab 4.0.1 software. 
 
GST-Vam7 SNARE complex isolation and bypass fusion  
SNARE complex isolation was performed as described previously using GST-Vam7 (Miner et al., 
2016; Fratti and Wickner, 2007; Fratti et al., 2007). Briefly, 6X fusion reactions were incubated 
with 85 µg/ml anti-Sec17 IgG to block priming. After 15 min, 2 µM Gyp1-56 or 2 mM propranolol 
were added to selected reactions and incubated for an additional 5 min before adding 150 nM GST-
Vam7. After a total of 90 min, reactions were placed on ice and 30 µl aliquots were removed to 
measure Pho8 activity. The remaining 150 µl reactions were sedimented (11,000 g, 10 min, 4°C), 
and the supernatants were discarded before extracting vacuoles with solubilization buffer (SB: 20 
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mM HEPES-KOH, pH 7.4, 100 mM NaCl, 2 mM EDTA, 20% glycerol, 0.5% Triton X-100, 1 
mM DTT) with protease inhibitors (1 mM PMSF, 10 µM Pefabloc-SC, 5 µM pepstatin A, and 1 
µM leupeptin). Vacuole pellets were overlaid with 100 µl SB and resuspended gently. An 
additional 100 µl SB was added, gently mixed, and incubated on ice for 20 min. Insoluble debris 
was sedimented (16,000 g, 10 min, 4°C) and 176 µl of supernatants were removed and placed in 
chilled tubes. Next, 16 µl was removed from each reaction as 10% total samples, mixed with 8 µl 
of 3X SDS loading buffer and heated (95°C, 5 min). Equilibrated glutathione beads (30 µl) were 
incubated with the remaining extracts (15 h, 4°C, nutation). Beads were sedimented and washed 
5X with 1 ml SB (735 g, 2 min, 4°C), and bound material was eluted with 40 µl 1X SDS loading 
buffer. Protein complexes were examined by Western blotting.  
 
Ca2+ efflux assay  
Vacuole lumen Ca2+ efflux was measured as described (Sasser et al., 2012b). Fusion reactions (2X) 
contained 20 µg of vacuoles isolated from BJ3505 backgrounds, fusion reaction buffer and the 
fluorescent Ca2+ probe Fluo-4 dextran at 150 nM (Invitrogen). Reaction mixtures were transferred 
to a black 96-well plate. ATP regenerating system, or buffer was added and reactions were 
incubated at 27°C while monitoring Fluo-4 fluorescence (lex=488 nm; lem=520 nm). 
 
Lipid mixing 
Lipid Mixing assays were conducted using rhodamine B DHPE (Rh-PE; Thermo Fisher) as 
described.41 BJ3505 vacuoles (300 µg) were isolated and then incubated in 400 µl of PS buffer 
containing 150 µM Rh-PE (10 min, 4°C, nutating). Next, 800 µl of 15% Ficoll was added and then 
transferred to an 11 x 60 mm pollyalomar ultracentrifuge tube, overlaid with 1.2 ml of 8% and 4%, 
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and 0.5 ml of PS buffer. Labeled vacuoles were isolated by centrifugation (105,200 X g, 25 min, 
4°C, SW-60 Ti rotor) and recovered from the 0-4% Ficoll interface. Lipid mixing assays (90 µl) 
contained 2 µg of labeled vacuoles and 16 µg of unlabeled vacuoles in fusion buffer. Reaction 
mixtures were transferred to a black, half volume 96-well flat-bottom microtiter plate on ice. The 
plate was transferred to a fluorescence plate reader at 27°C to start the reactions. Measurements 
were taken every 60 sec for 40 min yielding fluorescence values (lex=544 nm; lem=590 nm) at the 
onset (F0) and during the reaction (Ft). After 40 min 0.45% (vol/vol) Triton X-100 was added and 
the final 10 measurements were averaged to give the value of fluorescence after infinite dilution 
(FTX100). The relative fluorescence change ΔFt/FTX100 = (Ft - F0)/FTX100 - F0 was calculated. 
 
Microscopy  
Vacuole morphology was monitored by incubating yeast with YPD broth containing the vital dye 
FM4-64 (Vida and Emr, 1995). Cultures were grown to saturation, diluted to ~0.2 OD600 in YPD 
containing 5 µM FM4-64, grown for 1 h in 30°C shaker, washed with PBS, and resuspended in 
dye-free YPD to chase the dye for 3 h at 30°C. Cells were washed in PBS, mixed with 0.6% 
agarose, and mounted on glass slides for observation. Images were acquired using a Zeiss Axio 
Observer Z1 microscope equipped with an X-Cite 120XL light source, Plan Apochromat 63X oil 
objective (NA 1.4), and an AxioCam CCD camera.  
 
Statistical analysis  
Statistical analysis was calculated using one-way ANOVA or two-tailed paired t-test. P values of 
≤0.05 were considered significant. The half maximal inhibitory concentrations (IC50) were 




Vacuole morphology and Dgk1 localization 
Vacuole fusion requires the production and turnover of numerous signaling lipids including PA 
and DAG (Fratti et al., 2004; Jun et al., 2004; Sasser et al., 2012a). Multiple pathways feed into 
the production and interconversion of these lipids. DAG can be produced by the activity of Plc1 
on PI(4,5)P2 or Pah1 on PA (Flick and Thorner, 1993; Han et al., 2007). PA can be produced by 
phospholipase D activity on PC or by Dgk1 on DAG (Han et al., 2008a; Waksman et al., 1996). 
The production of DAG during vacuole fusion is important due to its fusogenic properties (Goñi 
and Alonso, 1999; Chernomordik and Kozlov, 2003). DAG becomes enriched at the vertex ring 
and boundary membrane of docked vacuoles and regulates localization of SNAREs, Ypt7 and 
HOPS to the site of fusion.  
 
We previously found that deletion or inactivation of PAH1 inhibited endosomal maturation that 
was characterized by vacuoles that lacked the late endosomal/lysosomal Rab Ypt7, the HOPS 
subunit Vps39, as well as the PI 3-kinase Vps34 and its product PI3P (Sasser et al., 2012a). The 
lack of Ypt7 was due to the exclusion of its guanine exchange factor Mon1-Ccz1, which is 
recruited to membranes in part through its interactions with PI3P (Lawrence et al., 2014; Cabrera 
et al., 2014). Because deletion of DGK1 restores the effects of deleting PAH1 in other pathways 
we began by testing whether the double deletion would restore the pah1D vacuolar defects. We 
first examined whether the double deletion would restore pah1D vacuole morphology. We found 
that dgk1D cells exhibited wild type vacuole morphology (Fig. 4.1A). Curiously, the dgk1D pah1D 
double deletion cells were fragmented in a manner similar to pah1D cells. Thus, deleting both 
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enzymes did not rescue the pah1D vacuole fragmentation phenotype or blocked fusion. This was 
not in keeping with the effects seen in restoring nuclear/endoplasmic reticulum morphology in 
other pathways. Quantitation of vacuole fragmentation is shown in Figure 4.1B.  
 
Due to the lack of an effect of deleting DGK1 on the pah1D vacuole morphology phenotype we 
examined if Dgk1 was mislocalized in mutant cells. First, we visualized the distribution of Dgk1-
GFP in wild type whole cells. Figure 4.1C shows widefield fluorescent images showing Dgk1-
GFP localization in cells stained with FM4-64 to label vacuoles. Dgk1-GFP localized to ribbon-
like structures of the endoplasmic reticulum similar to what has been previously reported 
(Wolinski et al., 2015). We also observed that the Dgk1-GFP ribbons were often adjacent to 
vacuoles and a fraction of Dgk1-GFP colocalized with FM4-64 suggesting that aside from the 
endoplasmic reticulum, vacuoles also harbor a portion of the enzyme. Dgk1-GFP localization was 
next examined in pah1D cells and we did not detect any appreciable differences in it localization 
relative to the wild type parent strain. Because some Dgk1-GFP appeared to colocalize with 
vacuoles we further examined Dgk1 distribution by cell fractionation and immunoblotting. Yeast 
cells expressing Dgk1-HA were fractionated into crude lysate, cytosol, vacuoles, a total membrane 
pool as well as microsomes containing endoplasmic reticulum. The blots showed that Dgk1-HA 
was present in microsomes and vacuoles (Fig. 4.1D). As a control, we probed for Dgk1-HA in the 
cytosolic fraction and found that this polytopic protein was absent. Ypt7 served as an enrichment 
marker for vacuoles. Sec61 served as a marker for resident endoplasmic reticulum components. 
Sec61 was detected in the vacuole fraction indicating that there was some contamination from the 
endoplasmic reticulum. Although this accounts for the majority of the Dgk1 detected in the vacuole 
fraction, it should also be noted that the ratio of Dgk1 to Sec61 is greater on vacuoles relative to 
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the microsome fraction (Fig. 4.1E). Together with the Dgk1-GFP localization it is apparent that a 
subpopulation of Dgk1 does indeed reside on the vacuolar membrane.   
 
Cells lacking DGK1 accumulate vacuolar DAG 
To determine if deleting DGK1 would have an effect on vacuolar DAG levels we quantitated this 
lipid on vacuoles from wild type and dgk1D cells. Neutral lipids were extracted from wild type and 
dgk1D vacuoles and resolved by thin-layer chromatography as described in the Materials and 
Methods section. Purified DAG was used to generate a standard curve in the first six lanes of the 
plate (Fig. 4.2A). Three of the five trials run were loaded onto the plate shown. We found that 
dgk1D vacuoles consistently contained more DAG than wild type vacuoles. Figure 4.2B shows 
quantitation of five trials (p<0.05). The DAG content of wild type and dgk1D vacuoles was 
calculated using a standard curve of pure DAG and plotted as µg of DAG per 150 µg of vacuole 
protein. These data indicate that vacuoles will accumulate DAG in the absence of Dgk1. However, 
this does not indicate whether the difference in DAG content is due to Dgk1 activity on the vacuole 
or whether the lack of DAG kinase activity elsewhere affects the total amount of this lipid 
trafficked to vacuoles.  
 
The absence of Dgk1 augments vacuole fusion  
To further examine the consequence of deleting DGK1 on vacuole homeostasis we tested fusion 
efficiency. These experiments showed that dgk1D vacuole fusion was markedly increased by ~40% 
relative to wild type (Fig. 4.3A), suggesting that the conversion of DAG to PA by Dgk1 negatively 
regulates fusion. This is in keeping with the notion that DAG is fusogenic and that Dgk1 activity 
is needed to reduce unchecked fusion. We next asked if the rate of fusion itself was increased for 
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dgk1D vacuoles. The slope of the fusion curve for dgk1D vacuoles appeared to be steeper in 
comparison to wild type. However, this appearance could be due to normalizing fusion to the wild 
type maximum. While this shows the overall increase in total fusion, it does not clearly show the 
initial rate of fusion. To better visualize the rate of dgk1D vacuole fusion we re-plotted the data as 
normalized to its own maximal fusion at the end of 90 min (Fig. 4.3A, red circles). This approach 
showed that the adjusted dgk1D fusion curve perfectly overlapped with that of wild type vacuoles, 
indicating that the rates of fusion were identical and that the augmented fusion of dgk1D vacuoles 
was due to other factors. We also asked whether the augmented fusion occurred during different 
rounds of fusion. To this aim we used a method shown to differentiate the first round of fusion 
from later events (Merz and Wickner, 2004b). Previously we used this method to determine that 
deleting NHX1 only affected the first round of fusion without affecting subsequent fusion cycles 
(Qiu and Fratti, 2010). To detect the first round of fusion, a 5:1 excess of effector vacuoles (PEP4 
pho8D) was used. For later rounds of fusion reactions used a 4:2 excess of reporter vacuoles (pep4D 
PHO8). Using this method we found that dgk1D vacuoles showed enhanced fusion for both early 
and late rounds of fusion (Fig. 4.3B), suggesting that the effects of deleting DGK1 was consistent.  
 
Although we have shown that the rate of full fusion and content mixing of dgk1D vacuoles matches 
that of wild type, it was possible that the elevated levels of DAG could destabilize the bilayers 
enough to promote faster hemifusion. Thus, we next measured the mixing of outer leaflet lipids as 
a reporter for hemifusion (Karunakaran and Fratti, 2013; Reese and Mayer, 2005). Here, a 
population of vacuoles is loaded with rhodamine conjugated PE (Rh-PE) at levels that quench 
fluorescence. Rh-PE labeled vacuoles are then incubated with an 8-fold excess of unlabeled 
vacuoles. Upon lipid mixing of labeled and unlabeled vacuoles the Rh-PE is diluted and the 
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fluorescence is de-quenched. This approach showed that dgk1D vacuoles underwent lipid mixing 
at the same rate versus wild type (Fig. 4.3C). Also shown are the negative controls of excluding 
ATP or blocking priming with anti-Sec17 antibody. These data suggest that the fusion phenotype 
of dgk1D vacuoles was not due to an increased rate of fusion of a set amount of vacuoles but 
perhaps is a refection that more vacuoles are initially participating in fusion.  
 
Because changes in fusion, as a measure of Pho8 activity, could theoretically be affected indirectly 
by altered activity of the reporter enzyme itself, we verified that the increased fusion of dgk1D 
vacuoles was real by performing a visual assay to measure changes in vacuole diameter (Merz and 
Wickner, 2004b; Sasser et al., 2012b). Here, vacuole reactions were treated with buffer, anti-Sec18 
IgG or propranolol. Both inhibitors potently inhibit fusion at the priming stage (Mayer et al., 1996; 
Sasser et al., 2012a). Propranolol is a b-adrenergic receptor blocker that also inhibits PA 
phosphatase activity, which is required for Sec18-mediated SNARE priming to occur (see Chpater 
2; Meier et al., 1998). After incubation (90 min, 27°C), fusion reactions were placed on ice and 
stained with FM4-64 for fluorescence microscopy evaluation. In accord with the content mixing 
assay, we found that the diameters of dgk1D vacuoles were significantly larger relative to wild 
type vacuoles (Fig. 4.3D, p<0.05). Incubating reactions on ice as well as treatment with anti-Sec18 
or propranolol blocked the increase in vacuole diameter demonstrating that changes in vacuole 
size were due to fusion.  
 
To determine whether the kinase activity of Dgk1 was linked to the fusion enhancement, dgk1D 
strains were complemented with plasmids encoding either wild type DGK or the inactivated kinase 
mutant DGKD177A (Han et al., 2008b). Complementation with pDGK1 partially restored fusion to 
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near wild type levels (Fig. 4.3E). The lack of full wild type fusion restoration with 
complementation was thought to be due to plasmid loss during growth in non-selective medium 
for vacuole purification. Nevertheless, the difference in fusion between the dgk1D and 
complemented vacuoles was statistically significant (p<0.05). Moreover, the difference between 
wild type fusion and the complement was not significant (p=0.25). Complementation with the 
kinase-dead mutant pDGKD177A did not reverse the increased fusion seen with dgk1D vacuoles 
(Fig. 4.3F). These data demonstrate that the altered fusion seen with dgk1D vacuoles was directly 
due to the kinase activity of Dgk1.  
 
In Figure 4.1A-B we showed that the dgk1D pah1D double deletion did not restore the vacuole 
fragmentation phenotype of pah1D alone. To further verify effect of deleting DGK1 on pah1D 
vacuole function we tested the mutations in content mixing assays. We found that the dgk1D pah1D 
double deletion strains exhibited attenuated fusion similar to what occurs with the single PAH1 
deletion (Fig. 4.3G). As with the morphological examination of the double deletion strain, we 
concluded that the activities of these enzymes do not directly counterbalance each other with 
respect to vacuole homeostasis and fusion. For this reason we focused on the augmented fusion of 
dgk1D vacuoles for the remainder of the study. 
 
Changes in fusion could be attributed to a variety of factors including changes in the concentration 
of regulatory proteins such as SNAREs. Others have shown that increased SNARE levels can 
enhance vacuole fusion (Starai et al., 2007). Deletion of the ABC transporter Ybt1 and the casein 
kinase Yck3 has also been shown to increase vacuole fusion through distinct mechanisms (Sasser 
et al., 2012b; Hickey et al., 2009). To assess if the elevated fusion of dgk1D vacuoles was due to 
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changes in the fusion machinery we performed immunoblotting analysis of known regulators. No 
differences were observed between dgk1D vacuoles and wild type (Fig. 4.3H). Taken together we 
conclude that Dgk1 activity suppresses maximal vacuole fusion and that the increased fusion seen 
with dgk1D vacuoles was not due to a fault in the reporter systems or caused by increased levels 
of the core fusion machinery proteins. 
 
DGK1 deletion does not alter SNARE complex formation 
Vacuole fusion can be augmented by the increase in the copies of SNAREs or by the improved 
efficiency of complex formation (Karunakaran and Fratti, 2013; Starai et al., 2007). As seen in 
Figure 4.3H, the amount of individual SNAREs was unaffected by deleting DGK1, however, their 
effectiveness is not apparent by immunoblotting alone. Thus we examined the efficiency of 
SNARE complex formation. This assay relies on blocking priming with anti-Sec17 IgG and its 
bypass by the addition of recombinant GST-Vam7 to restore fusion (Fratti and Wickner, 2007; 
Fratti et al., 2007). First, we determined if the dosage required for the bypass was different for 
dgk1D vacuoles relative to wild type. Figure 4.4A shows the restoration of fusion upon addition of 
GST-Vam7 at the indicated concentrations. This showed that dgk1D vacuoles responded to the 
addition of GST-Vam7 at the same peak of efficacy compared to wild type.  
 
Next, we performed Vam7 bypass experiments to examine the formation of SNARE complexes 
and HOPS binding. We found that GST-Vam7 interacted with its cognate SNAREs Nyv1 and 
Vam3 with equal efficiency on either wild type or dgk1D vacuoles (Fig. 4.4B-C). Hence, it appears 
that the altered fusion seen with dgk1D vacuoles was not due to increased SNARE complex 
formation. To verify that SNARE complexes were similarly active on both vacuole types we 
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examined the efflux of luminal Ca2+ stores that are released upon trans-SNARE complex 
formation (Merz and Wickner, 2004a). Previously we have found that deletion of the ABC 
transporter Ybt1 strikingly delayed the kinetics of Ca2+ efflux, which was linked to increased 
vacuole fusion.43 However, there was no difference in the kinetics or amplitude of Ca2+ release 
between dgk1D and wild type vacuoles (Fig. 4.4D). Together these data indicated that increased 
fusion of dgk1D vacuoles was not directly due to altered SNARE complex formation.  
 
Deletion of DGK1 confers resistance to PA  
Previous studies showed that reducing, or blocking, DAG inhibited the enrichment of regulatory 
lipids at the vertex ring assembly and blocked fusion (Fratti et al., 2004; Jun et al., 2004). We next 
asked if increasing DAG levels through the deletion of DGK1 would alter the role of regulatory 
lipids in fusion. To this aim we examined the effects of blocking regulatory signaling lipids on 
dgk1D vacuoles. We found that blocking the function of PI3P, PI4P, PI(4,5)P2, and ergosterol with 
the ligands FYVE, FappPH, ENTH, and filipin respectively inhibited dgk1D vacuole fusion 
indistinguishably from wild type (Fig. 4.5A). There was also no difference when PI3P and 
PI(4,5)P2 were modified by the phosphatases MTM-1 and SigD, respectively. This indicated that 
the enhanced fusion phenotype was not due to additional changes in the core fusion machinery or 
due to off pathway mechanisms. Because Dgk1 activity altered DAG levels on isolated vacuoles 
we next tested if dgk1D vacuoles were less sensitive to the DAG ligand C1b. We found that C1b 
inhibited dgk1D vacuole fusion at the same concentration needed to block wild type fusion (Fig. 
4.5B). This suggests that the change in DAG does not directly affect a protein-lipid interaction 
such as the binding of Protein kinase C (PKC) to DAG on other membranes (Stahelin et al., 2004). 
Instead it is likely that the augmented fusion is a result of an indirect effect such as changes in 
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membrane curvature and fluidity. It is also possible that a population of DAG was inaccessible to 
C1b by accumulating in the boundary membrane or by translocating across the bilayer (Fratti et 
al., 2004; Bai and Pagano, 1997).  
 
As is now evident, the conversion of PA to DAG by Pah1 is necessary for vacuolar SNARE 
priming (see Chapter 2). Increasing PA concentrations through inactivation of Pah1 or through the 
addition of short-chain PA (diC8-PA) potently blocked fusion by sequestering Sec18 away from 
SNAREs in a PA-dependent manner. Thus, we asked if the increase in DAG on dgk1D vacuoles 
would shift the DAG:PA ratio in a way that would alter the sensitivity of fusion towards PA. To 
answer this we tested the effect of converting DAG to PA with recombinant His6-DgkB, the soluble 
DAG kinase from Staphylococcus aureus (Miller et al., 2008). We found that DgkB potently 
inhibited wild type vacuole fusion as well as fusion by dgk1D vacuoles (Fig. 4.5C). However, there 
was a right-shift in the inhibition curves for dgk1D vacuole fusion that was statistically significant 
at 130 and 220 µg/ml (p<0.05). Although the shift was not large it was consistent with needing 
more DgkB for the elevated level of DAG at the beginning of the reaction.  
 
To further test the effects of increasing PA on fusion we added diC8-PA to fusion assays. As 
previously shown, the addition of diC8-PA had a marked inhibitory effect on the fusion of wild 
type vacuoles (Fig. 4.5D). Importantly, the inhibitory effect of excess PA was clearly reduced with 
dgk1D vacuoles. The IC50 of diC8-PA on wild type vacuoles was 31.2±5.1 µM whereas the IC50 
was 122.8±15.2 µM for dgk1D vacuoles (*p<0.05). The increased resistance of dgk1D vacuole 
fusion to diC8-PA suggests that the elevated levels of DAG lead to a requirement of more diC8-
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PA to fully inhibit fusion. Together these data indicate that the ratio of DAG to PA is a critical 
component of regulating vacuole fusion.  
 
Augmented dgk1D vacuole fusion is linked to enhanced Ypt7 activity 
To test if the augmented fusion of dgk1D vacuoles was on pathway and regulated by the known 
machinery, we tested a panel of inhibitors that targeted the proteins that regulate vacuole fusion. 
Figure 4.6A shows that antibodies against the SNAREs Nyv1, Vam3, or the HOPS subunit Vps33 
inhibited dgk1D vacuole fusion with similar effects compared to wild type. The relative fusion 
endpoints for both wild type and dgk1D vacuoles were normalized to 100% (Fig. 4.6A). 
Interestingly, dgk1D vacuole fusion showed reduced sensitivity to anti-Ypt7 IgG. To further 
examine the change in sensitivity of dgk1D vacuoles to anti-Ypt7 we performed dose response 
assays to calculate the IC50. This showed that dgk1D fusion was significantly less sensitive to anti-
Ypt7 with an IC50 of 124.9±10.7 µg/ml while the IC50 for wild type was 61.2±8.1 µg/ml (Fig. 4.6B, 
*p<0.05). This suggests that Ypt7 could be more active in dgk1D vacuoles. It is also possible that 
changes in the membrane curvature and fluidity could allosterically induce conformational 
changes in Ypt7 leading to decreased binding by the antibody. Based on the effects of anti-Ypt7 
IgG we also examined the efficacy of the GTPase activating protein Gyp1 and the Rab-GDP 
dissociation inhibitor GDI. We found that both proteins had right-shifted inhibition curves with 
dgk1∆ vacuole fusion. Figure 4.6C shows that dgk1∆ vacuole were less sensitive to Gyp1-46 with 
an IC50 of 4.17±0.06 µM compared to wild type (IC50 = 1.54±0.046 µM, *p<0.05). Similarly, 
dgk1∆ vacuole fusion was more resistant to GDI versus wild type. The IC50 for GDI with dgk1∆ 
vacuoles was 114.7±8.7 nM, while the IC50 with wild type was 209.2±14.1 nM (Fig. 4.6D, 
*p<0.05). Together these data suggest that Ypt7 function is enhanced in dgk1∆ vacuoles. That 
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said, these assays do not distinguish whether dgk1D vacuoles have increased activity per individual 
Ypt7 molecule or if there are simply more numerous activated Ypt7 copies per vacuole. 
Alternatively, it is possible the dgk1D require less Ypt7 to promote fusion.   
 
The dgk1D fusion effect is in parallel to the function of Yck3 
In addition to the effect of deleting DGK1 on Ypt7 function shown here, Ungermann et al. found 
that deleting the type I casein kinase Yck3 resulted in fusion that was resistant to Gdi1 and Gyp7-
47.52 This was linked to augmented vacuole fusion. Yck3 activity reduces fusion by 
phosphorylating Vps41, Vam3 and Mon1 (Lawrence et al., 2014; LaGrassa and Ungermann, 2005; 
Brett et al., 2008). The similar phenotypes of elevated fusion and increased Ypt7 activity in both 
yck3D and dgk1D vacuoles led us to ask if they shared a common pathway. We previously reported 
that the Ypt7 GEF Mon1-Ccz1 was phosphorylated by the casein kinase Yck3 leading to its release 
from the membrane (Lawrence et al., 2014). Deletion of YCK3 or mutation of Mon1 
phosphorylation sites prevented Mon1 from being released from the membrane during fusion. The 
influence of Yck3 on fusion is further illustrated through the inhibitory activity of adding 
exogenous recombinant His6-Yck3 (Hickey et al., 2009). Together, the data suggest that Dgk1 and 
Yck3 lie on the same pathway of regulating vacuole fusion. 
 
The experiments in Figure 4.7 begin addressing the connection between Dgk1 and Yck3. First, we 
immunoblotted for Yck3 on wild type and dgk1D vacuoles and found that the kinase was present 
at equal levels on membranes from both strains (Fig. 4.7A-B). This shows that Yck3 does not 
require Dgk1 for its recruitment to vacuoles. Next we examined if Yck3-dependent Mon1 release 
occurred on dgk1D vacuoles. Figure 4.7C shows that Mon1 was released at the same rate on both 
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sets of vacuoles, indicating that Yck3 function was normal on dgk1D membranes. Figure 4.7D 
shows quantitation of Mon1 retention over time. Although Mon1 release was not affected on 
dgk1D we went on to test if the addition of recombinant Yck3 would differentially affect the two 
types of vacuoles. We found that added His6-Yck3 inhibited the fusion of wild type and dgk1D 
vacuoles with identical dose responses (Fig. 4.7E). Thus far, it appears that Yck3 and Dgk1 
functions are likely in parallel pathways. To further determine if the underlying mechanisms of the 
dgk1D and yck3D fusion phenotypes are linked, we constructed yck3D dgk1D double deletion 
strains. We hypothesized that if the two functions were in parallel we would observed additive 
increases in vacuole fusion relative to either yck3D or dgk1D single deletions. The lack of further 
augmented fusion would suggest that the Dgk1 and Yck3 pathways overlap. We found that both 
yck3D and dgk1D single deletions had enhanced fusion as seen previously. Unexpectedly, the 
double yck3D dgk1D double deletion fused to a similar extent the wild type parent strains (Fig. 
4.7F, p>0.05). The loss of augmented fusion suggests that Yck3 and Dgk1 function in different 
pathways. Although evidence is lacking, it is not unlikely that the altered function of Ypt7 due to 
the lack of Dgk1 was negatively affected by the retention of unphosphorylated Mon1 due to the 
lack of Yck3 resulting in a return to normal overall function. That said, further studies would be 
required to explore this possibility, which go beyond the scope of this study.  
 
Exogenously added DAG enhances fusion of wild type vacuoles 
Because dgk1∆ vacuoles contain increased levels of DAG, we next asked if adding the lipid 
exogenously to wild type vacuoles would alter fusion. Previously we found that while vacuole 
fusion was inhibited with short chain phosphatidic acid (diC8-PA), fusion was not affected by 
diC8-DAG (see Chapter 2). The effect of diC8-PA was attributed to the interaction of the PA 
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headgroup with Sec18 to prevent SNARE priming. DAG on the other hand is directly fusogenic 
and transmits its effects on membranes through its acyl chains. Thus, the lack of an effect by diC8-
DAG was attributed to the inability of short acyl chains to influence membrane curvature or bilayer 
stability. To better determine the effect of exogenous addition of this lipid we used long chain 
(16:0, 18:1) DAG to wild type and dgk1∆ vacuole fusion reactions. We found that adding DAG 
enhanced the fusion wild type vacuoles by ~17% at 5 nM while it had no effect on dgk1∆ vacuoles 
(Fig. 4.8A, *p<0.05). Higher levels of DAG did not further enhance fusion (not shown). Although 
the addition of DAG did not fully mimic the effect of deleting DGK1, it does support the notion 
that DAG levels alone can modulate the efficacy of fusion. Similarly, the addition of 5 nM DAG 
increased lipid mixing by approximately 20% (Fig. 4.8B, **p<0.01).  
 
The deletion of DGK1 restores the fusogenicity of mutant Vam7Q283R 
In previous studies we found that mutating the ionic zero layer of the Vam7 SNARE motif 
(Q283R) prevented anti-Sec17 bypass fusion (Fratti et al., 2007; Karunakaran and Wickner, 2013). 
Fusion reactions containing Vam7Q283R were arrested at a hemifusion intermediate. Fusion could 
be restored by altering the fluidity and curvature of the vacuole with the cationic amphiphile 
chlorpromazine. We hypothesized that mutant SNARE complexes containing Vam7Q283R 
transferred insufficient energy to the membrane to trigger fusion. Thus, the effect of 
chlorpromazine was thought to be due to lowering the energy barrier for fusion to a level where 
Vam7Q283R could function. Due to the increased DAG concentration in dgk1D vacuoles we asked 
if fluidity and curvature was sufficiently altered to promote Vam7Q283R mediated fusion. Fusion 
reactions blocked with anti-Sec17 IgG were treated with recombinant Vam7Q283R at the indicated 
concentrations. We found that Vam7Q283R was able to promote a modest level of fusion in dgk1D 
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vacuoles whereas wild type vacuole fusion were unresponsive (Fig. 4.8C, **p<0.01). This result 
is consistent with the notion that the increase in DAG on dgk1D lowers the energy barrier for fusion 
in a similar manner to what was seen with chlorpromazine. It is important to consider that 
exogenous Vam7 rescues anti-Sec17 blocked fusion also bypasses the role of Ypt7 dependent 
tethering, which requires Sec17 mediated SNARE priming. Thus, the enhanced Ypt7 activity 




It has been well established that most membrane fusion is catalyzed by SNARE proteins, yet the 
interdependence of the fusion machinery and the membrane itself remains unclear. Among the 
lipids that compose the membrane is a group that is subject to modification by specific kinases, 
phosphatases, and lipases to regulate membrane trafficking. The most studied of these lipids are 
the phosphoinositides that can be differentially phosphorylated on their inositol head groups to 
yield a panel of bioactive molecules that help orchestrate the fusion machinery through direct 
interactions with protein ligands. Specific PIs are necessary at various stages of fusion. For 
instance, vacuole fusion requires PI(4,5)P2 during priming as well as after docking (Collins et al., 
2005; Mayer et al., 2000). PI(4,5)P2 is turned over by Plc1 to yield IP3 and DAG, a fusogenic lipid 
required for vacuole content mixing (Jun et al., 2004). DAG can also be produced through the 
activity of the PA phosphatase Pah1, a pathway that is complemented by the activity of Dgk1 on 
DAG to restore PA levels (Han et al., 2008b, 2006). PA plays important roles in various membrane 
trafficking pathways including sporulation, mitochondrial fusion, and Glut4 trafficking (Choi et 
al., 2006; Nakanishi et al., 2006; Vicogne et al., 2006). Like DAG, PA induces negative curvature 
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(Kooijman and Burger, 2009). However the monophosphoester head group of PA adds a negative 
charge to the membrane that can play a role in binding proteins, including NSF/Sec18 (Matveeva 
et al., 2001; see Chapter 2). Moreover, Pah1 activity is required during Sec18-mediated priming 
(Sasser et al., 2012a; see Chapter 2). Deletion of Pah1 leads to broad cellular defects including the 
enlargement of the endoplasmic reticulum and nuclear membranes, blocked lipid droplet synthesis, 
and inhibited endosomal maturation(Lawrence et al., 2014; Sasser et al., 2012a; Adeyo et al., 2011; 
Han et al., 2007).  
 
In other pathways, such as lipid droplet formation, the effects caused by deleting PAH1 can be 
countered by concurrent deletion of DGK1 illustrating that the interconversion of PA and DAG by 
Pah1 and Dgk1 respectively can negate the effects of inactivating one of the enzymes (Adeyo et 
al., 2011; Han et al., 2008a). Importantly, it shows that the balance struck by these two enzymes 
is consistent during the homeostasis of some pathways. Unlike other pathways deleting DGK1 had 
no effect on the pah1D vacuolar phenotype (Fig. 4.9). This suggested one of two things. First, it is 
likely that the defect seen in pah1D vacuoles was not simply due to a steady-state imbalance of PA 
and DAG. It is possible that the PA:DAG ratio varies throughout the fusion pathway. For example, 
Pah1 activity is needed during priming, indicating that a reduction of PA and increase in DAG is 
necessary (Sasser et al., 2012a). However, inhibiting Pah1 activity after priming has no effect on 
fusion, demonstrating that PA levels no longer need to be reduced. Our previous findings show 
that DAG does not play a role during priming but is instead required after the formation of trans-
SNARE complexes (Jun et al., 2004; Karunakaran and Fratti, 2013; Fratti and Wickner, 2007; 
Fratti et al., 2007). This leads us to propose that the activities of Dgk1 and Pah1 are separated 
temporally on the fusion pathway making it unlikely to balance activities at any time. A second 
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possibility is that DAG generated by Pah1 is fed into lipid synthesis pathways to generate 
phosphatidylethanolamine and phosphatidylcholine through the Kennedy pathway, or into the 
formation of triacylglycerol for storage (Adeyo et al., 2011; Kennedy and Weiss, 1956). However, 
the latter is unlikely as lipid synthesis occurs at the endoplasmic reticulum and not the vacuole. 
Nevertheless, changes in lipid synthesis can propagate throughout the cell via membrane 
trafficking.  
 
Although both PA and DAG are essential for vacuole fusion, their exact function remains to be 
fully elucidated. DAG is a fusogenic lipid due in part to its intrinsic negative curvature in a 
membrane and ability to destabilize lipid bilayers and even trigger the fusion of protein-free 
vesicles (Das and Rand, 1984; Seddon, 1990; Sánchez-Migallón et al., 1995; Villar et al., 2000). 
DAG can also bind fusion regulators such as protein kinase C (PKC) through its C1 domain (Dries 
and Newton, 2008; Johnson et al., 2000). PKC has been shown to affect membrane fusion by 
several pathways including the phosphorylation of NSF to regulate neurotransmitter release, or 
phosphorylating the SNARE Syntaxin4 to control thrombin release from platelets (Matveeva et 
al., 2001; Chung et al., 2000). That said, it has not been determined whether PKC activity occurs 
on isolated vacuoles. 
 
Another potential reason for the enhanced fusion of dgk1D vacuoles is that skewing the lipid 
balance to have less PA versus DAG can have an effect on priming. In a separate study we found 
that PA binds Sec18 to prevent cis-SNARE complex association (see Chapter 2). Conversion of 
PA to DAG by Pah1 releases Sec18 allowing it to engage cis-SNARE bundles. An excess of PA 
or inhibiting Pah1 activity results in the retention of Sec18 on PA domains. Thus we theorized that 
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the converse could occur in the absence of Dgk1 and a likely reduced pool of PA would facilitate 
the recruitment of Sec18 to cis-SNARE complexes and lead to more efficient priming. Enhanced 
priming could result in a functional increase in active SNAREs and would be in keeping with other 
studies showing that overexpression of SNAREs augments vacuole fusion. In our hands however, 
we did not observe a difference in priming activity on dgk1D vacuoles (not shown). Thus, we 
conclude that the effects of deleting DGK1 are mostly due to the physical changes caused by 
elevated DAG. This notion is consistent with bilayer destabilization by the non-lamellar lipid DAG 
and lowering the energy barrier needed for SNAREs to trigger fusion.  
 
One of the striking findings of this study was that fusion showed decreased sensitivity to reagents 
that target Ypt7 activity. Our results showed that fusion gained varying levels of resistance to anti-
Ypt7 antibody, the GAP Gyp1-46, and GDI. One interpretation of these results is that Ypt7 is more 
active on dgk1D vacuoles and that increased activity would manifest in augmented tethering. Even 
though measuring tethering efficiency is difficult to quantitate using light microscopy, we propose 
a model where the lipid composition of the vacuole modulates Rab activity. Alternatively, these 
results could reflect a reduced need of Ypt7 for dgk1D vacuole fusion.   
 
How would an increase in DAG levels affect Ypt7 function? To date there is no direct evidence of 
membrane fluidity affecting Rab proteins. One can imagine that the membrane affects the rotation 
or angle of insertion of the Ypt7 lipid anchor leading to an altered conformational state that 
strengthens its interactions with the HOPS complex, or a yet to be identified binding partner. 
Alternatively, the increase in DAG could lead to the enhanced recruitment of a Rab interacting 
protein. For example, in mammalian renal cortical tubule and mesangial cells the production of 
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DAG promotes the interactions of hmunc13 with Rab34 (Speight and Silverman, 2005). This was 
due to the DAG recruitment of hmunc13 to membranes containing Rab34. The latter is unlikely 
here as the IC50 of C1b was unaltered on dgk1D vacuoles, suggesting that there was no change in 
competition for a protein ligand. Therefore, we favor a model where the physical properties of the 
membrane modulate Ypt7 activity. Although evidence linking Rab activity to the physical 
properties of a membrane is lacking, there are some clues that come from cholesterol storage 
defects. For instance, cholesterol accumulation prevents the mammalian Ypt7 homologue Rab7 
from recruiting its effector protein RILP (Huynh et al., 2008). This is linked with the inhibition of 
fusion between lysosomes and phagosomes and is likely due to decreased membrane fluidity 
caused by the increase in cholesterol as seen Niemann-Pick type C disease cells (Koike et al., 
1998). Decreased fluidity due to excess cholesterol in Niemann-Pick type C disease cells has also 
been shown to reduce the ability of GDI to extract Rab7 (Lebrand et al., 2002). The authors 
subsequently drew the conclusion cholesterol plays a role in the Rab7 cycle. These studies are in 
keeping with our proposed model where membrane fluidity modulates Rab activity. 
 
In summary, our observations indicate that the PA-to-DAG ratio, regulated in part by the non-
concurrent, yet complementary functions of Pah1 and Dgk1, can modulate vacuole fusion. The 
effects of increased DAG in the absence of Dgk1 led to improved Ypt7 activity as shown by the 
increased resistance to Gyp1-46, GDI and anti-Ypt7 antibody. Finally, the changes in the 




FIGURES AND TABLES 
 
Figure 4.1. Dgk1 is localized to the vacuole. (A) Vacuole morphology was examined using wild 
type, dgk1D, pah1D, and dgk1D pah1D yeast. Cells were incubated with 5 µM FM4-64 to label 
vacuoles. (B) Quantitation of vacuole fragmentation. The number of vacuoles per cell was 
determined for each strain (n>300 cells per strain). Cells with 8 or more vacuoles were combined 
into one population. (C) Dgk1-GFP expression in wild type and pah1D strains were double labeled 
with FM4-64 and used for fluorescence microscopy. (D) Immunoblotting of Dgk1-HA3 
distribution in 10 µg samples of whole cell lysates, cytosol, vacuoles, endoplasmic reticulum and 
total membrane fraction using anti-HA antibody. Ypt7 and Sec61 were probed for as a controls for 
vacuole or endoplasmic reticulum enrichment. (E) Western blot analysis. Shown is the vacuolar 
enrichment of Dgk1 on vacuoles relative to contaminating membranes from the endoplasmic 
reticulum. Using densitometry, the relative amount of vacuolar Dgk1 was measured as a ratio to 
the amount of Sec61 in the vacuolar preparation and set to 1. The Dgk1/Sec61 ratio was also 
determined for the microsomal fraction in comparison to the vacuolar ratio. Densitometry was 




































































































Figure 4.2. DAG vacuolar content. (A) Neutral lipids were extracted from wild type and dgk1D 
vacuoles and resolved by thin layer chromatography. Lipids were visualized by charring with 
copper (II) sulfate. (B) Quantitation of DAG from wild type and dgk1D vacuoles (150 µg of by 




























Figure 4.3. Dgk1 suppresses vacuole fusion. (A) Fusion reactions were performed using wild 
type and dgk1D vacuoles. Reactions were incubated at 27°C for the indicated times and assayed 
for Pho8 activity. The red trace represents dgk1D fusion when normalized to its own maximum. 
This reveals the rate of dgk1D vacuole fusion versus wild type. (B) The ratio of effector and 
reporter vacuoles were altered to show early versus late rounds of fusion. To show early rounds of 
fusion an excess of effector vacuoles (5 µg PEP4 pho8D) were incubated with 1 µg of reporter 
vacuoles (pep4D PHO8). To show late rounds of fusion, an excess of reporter vacuoles (4 µg 
pep4D PHO8) were incubated with 2 µg of effector vacuoles (PEP4 pho8D). (C) Lipid mixing 
assay were performed with wild type or dgk1D vacuoles. Reporter vacuoles (2 µg) labeled with 
Rh-PE were incubated with 16 µg of unlabeled vacuoles. Fluorescence (lex=544 nm; lem=590 nm) 
was measured every 60 sec for 40 min. Shown is the average lipid mixing at 40 min. (D) 
Measurement of vacuole diameters after incubation (27°C, 90 min). Fusion reactions were treated 
with PS buffer, 12 µg/ml anti-Sec18, or 2 mM propranolol (Prop.). Measurements were plotted as 
a box plot representing median vacuoles with upper and lower quartile values. The lines extending 
from the boxes represent the minimum and maximum vacuoles in the data set. Outliers are 
displayed as points. (E-F) Fusion assays were performed with vacuoles from wild type, dgk1D, or 





















































































































































































































































































Figure 4.3 (cont.) 
compared between wild type, dgk1D, pah1D, and pah1D dgk1D vacuoles. (H) Analysis of fusion 
components. Vacuoles were isolated from wild type BJ3505 and RFY17 (BJ3505 dgk1D) (5 µg 
protein) and immunoblotted with antibodies against the indicated proteins. To examine the effect 
of deleting DGK1 on Pep4 trafficking, vacuoles were examined from DKY6281 and RFY18 





Figure 4.4. SNARE complex formation and Ca2+ efflux are not affected on dgk1D vacuoles. 
(A) Anti-Sec17 IgG bypass fusion. Fusion reactions were treated with anti-Sec17 IgG to block the 
priming stage of fusion. Recombinant GST-Vam7 was added at the indicated concentrations to 
stimulate fusion. (B) SNARE complex formation as described in the Materials and Methods 
section. (C) Quantitation of three GST-Vam7 pulldown assays. Protein band intensities were 
normalized to wild type at 27°C without inhibitors. (n=3). (D) Fusion reactions (2X) were prepared 
with 20 µg of wild type or dgk1D vacuoles in the presence of 150 nM low affinity Fluo-4 dextran 
in the presence or absence of ATP. A subset of reactions was treated with 2 µM Gyp1-46 to inhibit 
Ypt7 activity and block Ca2+ efflux. Fluo-4 fluorescence was normalized to the average 




































































































































































































































































































































Figure 4.5. Deletion of DGK1 confers resistance to PA (A) Fusion reactions were performed 
using wild type or dgk1D vacuoles. Fusion reactions containing wild type or dgk1D vacuoles 
treated with PS buffer, 2 µM GST-FYVE, 20 µM GST-ENTH, 10 µM MBP-FappPH, 20 µM 
Filipin, 1 µM His6-MTM1 or 1.2 µM SigD. (B-D) Dose response curves of GST-C1b, His6-DgkB 













































































































































Figure 4.6. The augmented fusion of dgk1D vacuoles is linked to Ypt7 function. (A) Fusion 
reactions were performed using wild type or dgk1D vacuoles. Individually, reactions were treated 
with PS buffer (Control), or antibodies against Nyv1 (17 µg/ml), Vam3 (27 µg/ml), Vps33 (5 
µg/ml) or Ypt7 (8 µg/ml). (B-D) Dose response curves of anti-Ypt7 IgG (B), Gyp1-46 (C), and 
GDI (D). Reactions containing wild type of dgk1D vacuoles were incubated for 90 min at 27°C 





































































































































Figure 4.7. The dgk1D fusion effect is in parallel to the function of Yck3. (A-B) 
Immunoblotting and quantitation of Yck3 content on vacuoles from wild type and dgk1D cells. (C) 
Immunoblotting of Mon1 release from vacuoles during the fusion reaction. Fusion reactions were 
incubated for 0, 30, or 60 min after which membranes (bound) and supernatants (unbound) were 
separated by centrifugation (13,000 g, 15 min, 4°C). (D) Quantitation of bound Mon1 at the 
indicated times. (E) Fusion reactions containing were treated with indicated concentrations of 
recombinant His6-Yck3. (F) Fusion of wild type, dgk1D, yck3D and dgk1D/yck3D vacuoles. Fusion 



































































































































Figure 4.8. Fusion of dgk1D vacuoles and resistance to diC8-PA. (A) Exogenous addition of 
DAG at the indicated concentrations to fusion reactions containing wild type or dgk1D vacuoles. 
Inset shows the direct comparison of 5 nM DAG and buffer with an equivalent volume of carrier 
(EtOH). (B) Lipid mixing using wild type and dgk1D vacuoles in the presence of 5 nM DAG or 
buffer with an equivalent volume of EtOH. (C) Anti-Sec17 IgG bypass fusion reactions using wild 
type or dgk1D vacuoles. Individual fusion reactions were treated with recombinant GST-
Vam7Q283R to stimulate fusion. Fusion reactions were incubated for 90 min at 27°C. Error bars 


























































































Figure 4.9. Schematic of role of PA and DAG production and modification on vacuole fusion. 
(A) Wild type fusion (PAH1 DGK1) leads to a reduction of PA by Pah1 and increase in DAG at 
the start of the pathway to promote SNARE priming, Ypt7 activation and support fusion. (B) In 
the absence of Dgk1 there is an accumulation of DAG leading to increased Ypt7 activity and 
augmented fusion. (C) In the absence of Pah1 high PA levels are maintained that sequester Sec18 
from SNARE complexes and preventing priming. Consequently, Ypt7 activity is blocked and 
fusion is abrogated. (D) The double deletion of PAH1 and DGK1 does not restore fusion and 
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Strain Genotype Source 
BJ3505 MATa pep4::HIS3 prb1-D1.6R his3–200 lys2–801 trp1D101 (gal3) 
ura3–52 gal2 can1 
90 
DKY6281 MATa pho8::TRP1 leu2–3 leu 2–112 ura3–52 his3-D200 trp1-
D901 lys2–801 
82 
RFY17 BJ3505, pah1D::kanMX6 19 
RFY18 DKY6281, pahD::kanMX6 19 
CHY53 BJ3505, yck3D::hphMX4 46 
CHY54 DKY6281, yck3D::hphMX4 46 
RFY60 BJ3505, dgk1D::hphMX4 This study 
RFY61 DKY6281, dgk1D::hphMX4 This study 
RFY62  RFY17, dgk1D:: hphMX4 This study 
RFY63  RFY18, dgk1D:: hphMX4 This study 
RFY64 RFY60, pRS416-DGK1 This study 
RFY65 RFY61, pRS416-DGK1 This study 
RFY66 RFY60, pRS416-DGK1D177A This study 
RFY67 RFY61, pRS416-DGK1D177A This study 
RFY68 BJ3505, DGK1::GFP-kanMX6 This study 
RFY69 BJ3505, DGK1::3XHA-kanMX6 This study 
RFY71 RFY68, pah1D:: hphMX4 This study 
RFY72 RFY60, yck3D:: kanMX6 This study 
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CHAPTER 5: GENERAL DISCUSSION 
 
All eukaryotes utilize SNARE dependent membrane fusion to traffic cargo between organelles. 
The membrane fusion process is cyclic, so once it has occurred it can repeat to allow for additional 
cargo transport and delivery. Fusion occurs across the well-defined stages of priming, tethering, 
docking, and fusion. The process has been studied for decades and many of its key players have 
been thoroughly classified. However, studies have mostly focused on the protein machinery 
involved in fusion. It is now clear membrane lipids also serve important roles across the fusion 
stages and are now receiving more attention. In the research including in this dissertation, I have 
presented evidence of fusion regulation by the membrane lipids diacylglycerol (DAG) and 
phosphatidic acid (PA). In this work, the following have been shown: (i) increased diacylglycerol 
levels at the vacuole membrane increases fusion; (ii) phosphatidic acid regulates the activation of 
cis-SNAREs by the SNARE chaperone Sec18; (iii) phosphatidic acid binding to Sec18 affects the 
protein’s overall architecture. 
 
Dgk1 is a negative regulator of vacuole fusion 
In Chapter 4, we found that Dgk1 is a negative regulator of vacuole fusion. Deletion of Dgk1 led 
to a significant increase in measured fusion which interestingly appeared to be independent of the 
rate of fusion. Inhibition of vacuoles lacking Dgk1 with a panel of traditional inhibitors showed 
that the increased fusion is still blocked and fusion still proceeds through the known, canonical 
pathway. However, a shift in sensitivity to fusion inhibition was observed with dgk1∆ vacuoles 
when dioctanoyl-PA (diC8-PA) or inhibitors against the Rab Ypt7 were used. When Dgk1 was 
removed from vacuoles, membrane levels of the regulatory lipid DAG were confirmed to be 
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increased. Furthermore, addition of exogenous DAG to wild type vacuoles increased their levels 
of fusion. These results taken together suggest that DAG directly promotes vacuole fusion. This is 
not surprising as DAG has previously been shown to be a fusogenic lipid that localizes to the 
vacuole vertex domain immediately before the final fusion stage occurs (Jun et al., 2004; Fratti et 
al., 2004). DAG is also a neutral lipid that supports non-bilayer structure formation in membranes 
which is a required component for membrane compartments to completely fuse (Zick et al., 2014). 
It is also not unexpected that dgk1∆ vacuoles have decreased sensitivity to addition of exogenous 
diC8-PA since they should contain decreased levels of endogenous membrane PA. What is more 
surprising is the decreased sensitivity to Ypt7 inhibitors that dgk1∆ vacuoles show. This shift seen 
could be for two distinct reasons. First, increased membrane DAG could promote increased 
activation of Ypt7. Second, increased membrane DAG could decrease the requirement for Ypt7 in 
the vacuole fusion process. 
 
Activation of Ypt7 is dependent on the nucleotide exchange factor Mon1-Ccz1 (Nordmann et al., 
2010). This activation is required for Ypt7 to facilitate tethering of vacuoles. It is known that the 
Mon1-Ccz1 complex relies on the regulatory lipid phosphatidylinositol 3-phosphate (PI3P) for its 
association with vacuole membranes. Our work with dgk1∆ vacuoles suggests that increased DAG, 
or perhaps decreased PA, at the vacuole may influence the activity of Mon1-Ccz1. Activation of 
Ypt7 by Mon1-Ccz1 is stimulated by some anionic lipid species including PI3P and 
phosphatidylserine (PS), however this activity has not been measured on membranes containing 
PA (Cabrera et al., 2014). It is possible that PA interferes with a specific activation of Mon1-Ccz1 
activity by PI3P at the vacuole vertex ring. Future work utilizing reconstituted proteolipsomes 
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(RPLs) could isolate the effects specific lipids have on Mon1-Ccz1 activity and thus the 
downstream tethering activity of Ypt7. 
 
The primary function of Ypt7 is to tether vacuoles via associations with the homotypic vacuole 
fusion and protein sorting (HOPS) complex (Hickey et al., 2009). Interestingly, HOPS alone can 
tether two membranes and is considered the primary agent in tethering (Hickey and Wickner, 
2010). Furthermore, HOPS can carry out tethering via associations with acidic lipids even in the 
absence of Ypt7 (Orr et al., 2015). On dgk1∆ vacuoles we expect a decrease in PA and a 
corresponding increase in DAG. PA is an acidic lipid so it is possible the effect we saw in Chapter 
4 was due to a decrease in HOPS-PA interactions. Decreased HOPS-PA interactions could lead to 
an increase in Ypt7-HOPS complexes formed which could decrease sensitivity to Ypt7 inhibitors. 
This model, however, does not adequately explain why dgk1∆ vacuoles have higher fusion than 
wild type in the absence of all inhibitors. It seems more likely that a decrease in sensitivity to Ypt7 
inhibition would be due to an increase in Ypt7 effectiveness. Ypt7 is lipid anchored to vacuole 
membranes when in its active state (Seabra, 1998; Vetter and Wittinghofer, 2001). The increased 
DAG levels in dgk1∆ vacuole membranes may alter membrane fluidity which could affect Ypt7 
activity via its prenylation anchor. Future work addressing this possibility using RPLs could isolate 
the potential effects membrane lipid dynamics have on lipid anchored protein function. 
 
Phosphatidic acid regulates the priming stage of vacuole fusion 
In Chapter 2, we showed that the regulatory lipid PA blocks Sec18 activity on inactive SNAREs 
during the priming stage of vacuole fusion. Sec18 was shown to be a PA binding protein, and 
higher levels of PA at the vacuole led to decreased priming. We proposed that this may be due to 
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a decrease in the mobility of PA-bound Sec18 which was not effectively recruited to cis-SNAREs. 
The fact that Sec18 directly interacted with PA was not unexpected since previous work had shown 
that mammalian NSF, its homologue, is a PA-binding protein (Manifava et al., 2001). What is 
perhaps less intuitive is the fact that PA inhibits a stage in the fusion cascade. Previous studies had 
shown that PA is a required lipid for vacuole fusion to occur (Mima and Wickner, 2009). Why 
then would it completely block the necessary function of a chaperone whose activity is required 
for the appropriate progression of fusion? We did not isolate the exact function of PA in the work 
presented in Chapter 2, but our observations combined with previous work suggest that PA may 
be preventing Sec18 from being too active. The well-known primary role of Sec18 is to reactivate 
inactive SNAREs after they have been used in a round of fusion. A secondary role of Sec18 that 
has more recently been explored is one that prevents SNAREs from pairing incorrectly. When 
SNAREs form trans-complexes, occasionally they do not properly associate and are blocked by 
chaperone proteins (Starai et al., 2008). Sec17 and Sec18 are recruited to these inactive SNAREs, 
during docking, to reactivate them. However, if this step becomes unregulated or occurs in the 
presence of excess Sec18, all SNARE complexes are disassembled whether active or inactive and 
fusion cannot proceed (Ungermann et al., 1998; Rohde et al., 2003; Mima et al., 2008; Stroupe et 
al., 2009). In the cell, this proofreading process is tightly controlled by Vps33, a subunit of the 
HOPS complex (Lobingier et al., 2014; Schwartz et al., 2017). HOPS assists with the tethering of 
vacuoles in a Ypt7 dependent manner while also preventing Sec18 association with active, 
properly formed trans-SNARE complexes during docking. Taken together, our work combined 
with that from other labs suggests PA at the vacuole membrane may temporally regulate Sec18. 
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Our most current model suggests that Sec18 exists on the membrane in an inactive PA-bound state 
which may be the result of a PA-dependent membrane recruitment step. When inactive cis-
SNAREs form, PA is largely converted to DAG by Pah1, and Sec18 transitions from a PA-bound 
state to a SNARE-bound state where it carries out its priming function. After priming, Sec18 is 
either inactivated by an increase in membrane PA levels or by a release from the membrane. 
During docking, Sec18 is recruited back to the membrane in a PA dependent manner where its 
activity is suppressed by PA and Vps33 until HOPS dissociation and priming-associated Pah1 
activity. This model could be addressed in future experiments using RPLs. By varying PA levels 
in RPLs, Sec18 membrane association, Sec18 recruitment to SNAREs, and overall fusion can all 
be tested with an exclusive dependence on change in PA levels.. This could highlight whether PA 
acts alone in the regulation we have described, or if it works in concert with another fusion factor 
found at the vacuole. Experiments could also test whether cis-SNAREs act as an activator for Pah1 
activity. Additionally, future work describing the effect PA binding has on Sec18 architecture 
could elucidate some of the finer mechanistic details of this regulation (discussed below). 
 
Phosphatidic acid binding alters the architecture of Sec18 
In Chapter 2, we showed regulation of the SNARE chaperone Sec18 by the regulatory vacuole 
lipid PA. This regulation was shown at the organelle level rather than at the protein level. To 
further describe how PA may regulate the priming stage of vacuole fusion we wanted to also 
address its specific effects on the structure of Sec18. In Chapter 3, we show that PA binding to 
Sec18 significantly alters the protein’s conformation and this effect may prevent hexamerization 
of Sec18 to its active state. These results are in line with our previous data that showed Sec18 
recruitment is decreased when PA levels at the vacuole membrane are increased. When Sec18, or 
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its mammalian homolog NSF, binds to inactive SNAREs, it does so as a homohexamer (Fleming 
et al., 1998). Our most recent data suggests that formation of the Sec18 hexamer is blocked by PA 
which locks the protein in a conformation that shields key residues necessary for hexamerization. 
This data provides an additional level of detail to our current model. While it still appears that 
increased PA levels block Sec18 recruitment to cis-SNAREs, we believe it may do so by stabilizing 
an inactive monomeric state of the protein. Moving forward it would be beneficial to acquire 
structural data of Sec18 in a PA-bound state. In the past, this would have been impossible to 
achieve as the Sec18 hexamer is very large. However, with the recent increase in electron 
cryomicroscopy capabilities, structural information about many larger proteins has been gained. 
This includes the structure of the Sec18 homolog NSF (Zhao et al., 2015). Future work will be 
aimed at solving a Sec18-PA structure to gain even greater detail of the mechanism of PA 
regulation of Sec18 at the vacuole. 
 
Summary 
The research included in this dissertation provides evidence of previously undiscovered lipid 
regulation of the stages of vacuole fusion. Evidence is provided for the regulation of Ypt7-
dependent tethering by DAG or PA levels in the membrane. Extensive work looking at the effects 
of PA at the vacuole suggests a regulatory mechanism in which PA specifically regulates Sec18 
priming activity at the vacuole by decreasing its association with cis-SNAREs. This regulation of 
Sec18 by PA appears to be through a direct interaction that alters the overall architecture of the 
protein. Questions remain including the effects other lipids or lipid modifications may have on the 
different stages of fusion. This work provides a baseline level of understanding and approach 
 172 
which can be added to and utilized for further understanding of the roles regulatory lipids play in 





Cabrera, M., M. Nordmann, A. Perz, D. Schmedt, A. Gerondopoulos, F. Barr, J. Piehler, S. 
Engelbrecht-Vandre, and C. Ungermann. 2014. The Mon1-Ccz1 GEF activates the Rab7 
GTPase Ypt7 via a longin-fold-Rab interface and association with PI3P-positive 
membranes. J. Cell Sci. doi:10.1242/jcs.140921. 
Fleming, K.G., T.M. Hohl, R.C. Yu, S. a Müller, B. Wolpensinger,  a Engel, H. Engelhardt,  a T. 
Brünger, T.H. Söllner, and P.I. Hanson. 1998. A revised model for the oligomeric state of 
the N-ethylmaleimide-sensitive fusion protein, NSF. J. Biol. Chem. 
doi:10.1074/jbc.273.25.15675. 
Fratti, R.A., Y. Jun, A.J. Merz, N. Margolis, W. Wickner, and B. Wickner. 2004. Interdependent 
assembly of specific regulatory lipids and membrane fusion proteins into the vertex ring 
domain of docked vacuoles. J. Cell Biol. doi:10.1083/jcb.200409068. 
Hickey, C.M., C. Stroupe, and W. Wickner. 2009. The major role of the Rab Ypt7p in vacuole 
fusion is supporting HOPS membrane association. J. Biol. Chem. 
doi:10.1074/jbc.M109.000737. 
Hickey, C.M., and W. Wickner. 2010. HOPS Initiates Vacuole Docking by Tethering 
Membranes before trans-SNARE Complex Assembly. Mol. Biol. Cell. 
doi:10.1091/mbc.E10-01-0044. 
Jun, Y., R.A. Fratti, and W. Wickner. 2004. Diacylglycerol and its formation by phospholipase C 
regulate Rab- and SNARE-dependent yeast vacuole fusion. J. Biol. Chem. 
doi:10.1074/jbc.M411363200. 
Lobingier, B.T., D.P. Nickerson, S.Y. Lo, and A.J. Merz. 2014. SM proteins Sly1 and Vps33 co-
 174 
assemble with Sec17 and SNARE complexes to oppose SNARE disassembly by Sec18. 
Elife. doi:10.7554/eLife.02272. 
Manifava, M., J.W.J.F. Thuring, Z.Y. Lim, L. Packman, A.B. Holmes, and N.T. Ktistakis. 2001. 
Differential Binding of Traffic-related Proteins to Phosphatidic Acid- or 
Phosphatidylinositol (4,5)-Bisphosphate-coupled Affinity Reagents. J. Biol. Chem. 
doi:10.1074/jbc.M010308200. 
Mima, J., C.M. Hickey, H. Xu, Y. Jun, and W. Wickner. 2008. Reconstituted membrane fusion 
requires regulatory lipids, SNAREs and synergistic SNARE chaperones. EMBO J. 
doi:10.1038/emboj.2008.139. 
Mima, J., and W. Wickner. 2009. Complex lipid requirements for SNARE-and SNARE 
chaperone-dependent membrane fusion. J. Biol. Chem. doi:10.1074/jbc.M109.010223. 
Nordmann, M., M. Cabrera, A. Perz, C. Bröcker, C. Ostrowicz, S. Engelbrecht-Vandré, and C. 
Ungermann. 2010. The Mon1-Ccz1 complex is the GEF of the late endosomal Rab7 
homolog Ypt7. Curr. Biol. doi:10.1016/j.cub.2010.08.002. 
Orr, A., W. Wickner, S.F. Rusin, A.N. Kettenbach, and M. Zick. 2015. Yeast vacuolar HOPS, 
regulated by its kinase, exploits affinities for acidic lipids and Rab:GTP for membrane 
binding and to catalyze tethering and fusion. Mol. Biol. Cell. doi:10.1091/mbc.E14-08-
1298. 
Rohde, J., L. Dietrich, D. Langosch, and C. Ungermann. 2003. The transmembrane domain of 
Vam3 affects the composition of cis- and trans-SNARE complexes to promote homotypic 
vacuole fusion. J. Biol. Chem. doi:10.1074/jbc.M209522200. 
Schwartz, M.L., D.P. Nickerson, B.T. Lobingier, R.L. Plemel, M. Duan, C.G. Angers, M. Zick, 
and A.J. Merz. 2017. Sec17 (α-SNAP) and an SM-tethering complex regulate the outcome 
 175 
of SNARE zippering in vitro and in vivo. Elife. doi:10.7554/eLife.27396. 
Seabra, M.C. 1998. Membrane association and targeting of prenylated Ras-like GTPases. Cell. 
Signal. doi:10.1016/S0898-6568(97)00120-4. 
Starai, V.J., C.M. Hickey, and W. Wickner. 2008. HOPS Proofreads the trans-SNARE Complex 
for Yeast Vacuole Fusion. Mol. Biol. Cell. doi:10.1091/mbc.E08-01-0077. 
Stroupe, C., C.M. Hickey, J. Mima, A.S. Burfeind, and W. Wickner. 2009. Minimal membrane 
docking requirements revealed by reconstitution of Rab GTPase-dependent membrane 
fusion from purified components. Proc. Natl. Acad. Sci. doi:10.1073/pnas.0903801106. 
Ungermann, C., K. Sato, and W. Wickner. 1998. Defining the functions of trans-SNARE pairs. 
Nature. doi:10.1038/25069. 
Vetter, I.R., and A. Wittinghofer. 2001. The guanine nucleotide-binding switch in three 
dimensions. Science (80-. ). doi:10.1126/science.1062023. 
Zhao, M., S. Wu, Q. Zhou, S. Vivona, D.J. Cipriano, Y. Cheng, and A.T. Brunger. 2015. 
Mechanistic insights into the recycling machine of the SNARE complex. Nature. 
doi:10.1038/nature14148. 
Zick, M., C. Stroupe, A. Orr, D. Douville, and W.T. Wickner. 2014. Membranes linked by trans-
SNARE complexes require lipids prone to non-bilayer structure for progression to fusion. 
Elife. doi:10.7554/eLife.01879. 
 
 
